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Drug use among the driving population is a major hazard to road safety and has been 
the subject of widespread research worldwide. In an attempt to detect and 
appropriately prosecute “drug-drivers”, the UK has made legislative changes and has 
introduced Field Impairment Tests (FIT) in the Railway and Transport Safety Act 
2003. These FIT, which are identical to the Standardised Field Sobriety Tests 
(SFST), were devised in the USA in the 1970s to identify clinical signs of 
impairment due to alcohol intoxication, but were not designed or intended to identify 
drug-related driving impairment. Concerns have been expressed that FIT are too 
difficult for their stated function, and are also inappropriate tests, since although they 
have been validated for alcohol effects they have never been validated for the effects 
of drugs. This thesis has sought to clarify matters and has questioned the validity of 
FIT by testing two opposing hypotheses –  
 
 
1) FIT are reliable and valid tests of drug-related impairment to drive - and 
drug-free individuals perform well on all tests.  
 
2) FIT are not reliable and valid tests of drug-related impairment to drive - 











A questionnaire was designed and a postal survey was undertaken of 960 Forensic 
Medical Examiners (FMEs) who were asked to give their opinion on the Field 
Impairment Tests (FIT). The responses of the FMEs were analysed in detail (chapter 
3). FIT were then carried out on three separate groups of 100 subjects in police 
custody who were all known to have used no drugs for a period of at least 8 hours 
prior to the testing process (chapter 4). Group A subjects were opiate dependent; 
Group B were subjects who received legally prescribed methadone; Group C 
individuals denied any form of drug use. All study groups were simultaneously 
examined using conventional psychomotor tests, and the results were compared 




Returned FME questionnaires showed 63% of FMEs considered the tests “about 
right” but a significant number (p<0.0001) of 33% of FMEs stated FIT were “too 
difficult”. The studies on subjects in custody clearly showed 82% of group A; 44% 
of group B; and 19% of group C were unable to complete FIT satisfactorily, although 
only 12% of group A; 2% of group B; and 3% of group C were unable to 
successfully perform conventional psychomotor and cognitive tests. These findings 
clearly supported the assertions held by 33% of FMEs surveyed that FIT were too 
difficult for their stated purpose and that poor performance in FIT could not be 






The results of the research studies conducted have provided very strong support in 
favour of hypothesis 2)   
 
FIT are not reliable and valid tests of drug-related impairment to drive - 
and are too difficult for some groups of drug-free individuals to perform. 
 
 
In an attempt to overcome the problems in respect of FIT, specific proposals have 
been offered including the introduction of a new battery of more relevant clinical 
tests of impairment (CTI); a change in the method and manner in which the proposed 
new tests are applied; and possible legislative and administrative measures which 
might be introduced to more appropriately and effectively tackle this on-going 
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CHAPTER 1.     Introduction.  
 
Drug use, both prescribed and illicit, within the general population is a cause for 
concern in the U.K. and throughout Europe (North 2010; EMCDDA 2011; 
EMCDDA 2012). Of particular concern is drug use within the driving population 
(Assum et al. 2005; Oliver et al. 2006; Officer 2009; Lacey 2010; EMCDDA 2012a). 
Department for Transport studies showed illicit drug use by drivers involved in fatal 
road traffic accidents had increased six-fold from 3% (1985-87) to 18% (1997-1999) 
DETR (1998; Tunbridge, Keigan and James 2001) and these studies clearly 
highlighted the risk to road safety posed by “drug-drivers”. 
 
It has long been acknowledged that there is no specific training for Forensic Medical 
Examiners (FMEs) called by police to examine suspect “drug-drivers” which would 
enable them to reliably diagnose evidence of drug-related impairment in driving 
ability. However in 1998 Strathclyde Police in Scotland awarded a research grant to 
two police officers to visit Los Angeles Police Department in California U.S.A. and 
study their methods of dealing with “drug-drivers”. On their return, the officers 
produced a training package for police officers and police surgeons (Fleming and 
Stewart 1998), which introduced the Field Impairment Tests (FIT). These tests were 
the subject of a pilot study conducted by several police forces in the UK over a 15-
month period from early 1999 to August 2000 prior to their introduction in the 
Railways and Transport Safety Act 2003. However following their demonstration to 
the FMEs, concerns were voiced by some FMEs that FIT were over-complicated 
tests, were difficult for “normal” people to perform and had not been validated by 
any independent researchers. These views echoed my own concerns regarding FIT 




1.1. Synopsis of the thesis. 
This thesis investigates Field Impairment Tests (FIT) in relation to their current use 
as indicators of drug-related impairment of driving ability and questions their 
reliability and validity. This work is important because the findings recorded 
following use of FIT by police officers are led as evidence of drug-related 
impairment in driving ability by Crown prosecutors in courts of law throughout the 
United Kingdom. The work is particularly important because FIT has never been 
validated by any evidence-based research process and has simply been accepted as 
reliable by government legislators, legal representatives and court adjudicators. 
Groups affected by the current use of FIT include police personnel; forensic medical 
examiners (FMEs); legal participants in the court arena; however most importantly 
the suspect driver for whom the consequences of conviction are considerable.  
This work is based on my personal experience of over 30 years working as an FME 
for Strathclyde Police which has involved my examination of drivers suspected to be 
under the influence of alcohol and/or drugs and of my subsequent involvement in the 
legal arena, as a witness both for the prosecution and the defence. The work involved 
in the production of the thesis started in 2002 and concluded in 2012.    
 
The initial research studies of the thesis detailed in chapter 3 relate to postal surveys 
designed and conducted by myself and which involved a survey of FMEs who had 
attended a training session on the use of FIT; a postal survey of all FMEs employed 
by Strathclyde Police in Scotland; and finally a more detailed questionnaire postal 
survey of 960 FMEs throughout the United Kingdom. The purpose was to ascertain 
and evaluate the opinion of the FMEs regarding the suitability of FIT as a diagnostic 




The major research projects of the thesis fully explained in chapter 4 are independent 
of the postal surveys although the responses of the FMEs surveyed provided the 
stimulus for this further work. These studies investigated the findings following 
controlled application of FIT to three separate core groups, each of 100 subjects who 
were specially selected and known to have used no drugs for a period of at least 8 
hours prior to the clinical assessment.  
 
The results of the postal surveys of the FMEs indicated that whilst the majority of 
FMEs considered FIT acceptable or “about right” the majority also felt that at least 
one test in FIT was too difficult. However it was also clearly evident that a 
significant percentage of the FMEs considered FIT too difficult and unacceptable.  
 
The research studies conducted revealed that a high percentage of drug-free subjects 
were unable to complete FIT satisfactorily and this supported the assertions held by a 
significant percentage of FMEs surveyed that poor performance in FIT could not be 
regarded as definitive evidence of impairment in driving ability due directly to drugs.        
 
This work is both original and unique since although FIT has been evaluated in 
subjects given controlled doses of central nervous system (CNS) active drugs, FIT 
has never been evaluated in a controlled drug-free population.  
 
This research is vital since it is essential to understand how a drug-free or “normal” 
population will perform when subjected to FIT; and the findings of this research 
which are evidence-based, add significantly to the knowledge base of this complex 





1.2. Epidemiology of “drugs and driving”.   
Methodology: In order to study the available evidence in relation to driving whilst 
under the influence of drugs, I conducted a comprehensive literature search involving 
the following databases Pubmed; Medline Plus; Cochrane Library; Embase; Scirus; 
Scopus; SpringerLink and search terms, initially “drugs and driving” initially in 
2004. Subsequent to this date I monitored published literature on the same databases 
and collected additional references relevant to the research topic. Only peer reviewed 
articles from scientific journals plus official databases from the Department for 
Transport and the National Highway Traffic Safeway Administration were 
considered.   
 
Reliable data relating to the problem of “drugs and driving” is available from the 
U.K., member countries of the European Union, the U.S.A., Canada, and Australia 
(de Gier 2000; Longo et al. 2000; Fitzpatrick, Daly, Leavy and Cusack 2006; 
Normann et al 2007; EMCDDA 2008; EMCDDA 2009; Lacey 2010; North 2010a; 
North 2010b DRUID 2012). However despite the availability of such evidence there 
is a lack of routine in the collection, extraction and analysis of the data such that a 
clear picture has failed to emerge (Wolff 2013). The term “drugs and driving” is used 
routinely by international advisory bodies including the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA); International Council on Alcohol Drugs 
and Traffic Safety (ICADTS); Driving Under the Influence of Drugs, Alcohol and 
medicines  (DRUID), all of which are concerned principally with illegal drugs of 
abuse and some prescription drugs with abuse potential. This thesis shall consider the 




 Drug use, both medicinal and illicit, is increasing within the general population and 
it has been clearly shown that drug use is also increasing within the driving 
population (Assum et al. 2005; Oliver et al. 2006; Officer 2009; Owens and 
Ramaekers 2009). Research evidence clearly indicates that driving while under the 
influence of illegal drugs regularly occurs and approaches levels of driving under the 
influence of alcohol among younger drivers (Krueger 1995; Augsburger and Rivier 
1997; Seymour and Oliver 1999; Morland 2000; Seymour and Oliver 2000; Smink,	  
Ruiter,	   Lusthof,	   and	  Zweipfennig,	  2001; Drummer et al. 2003; Jones et al. 2003; 
Walsh et al. 2004; EMCDDA 2008; EMCDDA 2009 and Officer 2009).  
 
 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
reported drug use in drivers throughout Europe to be in the region of 1% to 5% for 
illicit drugs, and 5% to 15% for licit drugs EMCDDA (2007). However the research 
database remains incomplete and has not facilitated the implementation of policies 
and legislation directed towards the problem (Gust 2007; North 2010; Wolff 2013). 
 
 
Some drugs commonly detected in drivers are thought to impair the safe driving 
ability of those taking them, although there is lack of consensus in the numerous 
research papers on the subject as to how such impairment is caused and how serious 
it actually is (McKetin et al. 1999; O’Neill et al 2000; Comer et al. 2001; Fishbain et 
al. 2003; Drummer et al. 2004; Silber et al. 2005; Bramness et al. 2006; and 





Kemppainnen (2009) reported around 39,000 people were killed on Europe's roads 
and almost two million injured in traffic accidents in 2008 and approximately 25 % 
of these road fatalities were caused by “impaired” drivers. EMCDDA (2009) reports 
approximately 20 million Europeans have used cannabis during the previous year. Of 
these 9.5 million were classified as “current users” and approximately 3 million 
young adults were estimated to be daily users. In the case of cocaine, 3.5 million 
people admitted previous and 1.5 million were current or daily users.  
The use of prescribed medication by drivers is also a concern in respect of road 
safety (de Gier 1998; de Gier 2000; Tunbridge and Rowe 2000; Normann et al 2007). 
However it remains unclear whether road traffic collisions in this group of drivers 
occur as a direct result of medicinal drug consumption in itself, or whether these 
incidents should be linked to the underlying condition for which the drug was 
prescribed (Skegg 1979; Greenblatt and Shader 1992; Sherwood 1998; and 
Brunnauer and Laux 2010). Indeed it has been reported (Hobi et al. 1982) that 
depressive illnesses can result in impairment of driving ability and that depressed 
patients whose conditions have responded to appropriate medications may show a 
clear improvement in driving as a direct result of the effect of their treatment. This 
view has been supported (Greenblatt and Shader 1992) and more recently by Wingen 
et al. (2005; Berghaus and Hilgers 2009; and Brunnauer and Laux 2010) who have 
suggested that in the patient whose condition has an adverse effect on their driving 
ability, the benefits of treatment in respect of improved alertness, concentration, and 





1.3. Illegal drugs and driving. 
The drugs of most importance to the problem of drugs and driving include - 
• Cannabis 
• Opiates 
• Cocaine and “crack” cocaine 
• Amphetamines; Designer Amphetamines; Methamphetamine & MDMA 
• Ketamine 
• Hallucinogens such as LSD 
 
1.3.1. Cannabis:  
Cannabis is the collective term for the psycho-active substances of the cannabis 
sativa plant and is one of the most abused illicit drugs world-wide. Cannabis 
products are mostly smoked in combination with tobacco by way of a “joint”; they 
can also be ingested in preparations such as tea or cake; however the effect of the 
THC is much higher after smoking than after ingestion.  
 
 
Epidemiology: Cannabis use is widespread in drivers throughout Europe, North 
America and Australia (Mason and McBay 1984; Everest, Tunbridge and Widdop 
1988; Soderstrom et al. 1988; Terhune at al. 1992; Gjerde, Beylich and Morland 
1993; Drummer 1994; Drummer 1995; Logan and Schwilke 1996; Tomaszewski et 
al. 1996; Augsburger and Rivier 1997; de Gier 1998; Hildegard and Berghaus 1998; 
Marquet et al. 1998; Schepens et al. 1998; Dussault, Lemire, Bouchard and Brault 
2000; Longo et al 2000 and 2000a; Swann 2000; Tunbridge and Rowe 2000; Walsh, 




2004; Ramaekers, Berghaus, van Laar and Drummer 2004; Laumon et al. 2005; 
Walsh et al. 2005; Fitzpatrick, Daly, Leavy and Cusack 2006; Mura et al. 2006; 
EMCDDA Insights 2008f; EMCDDA Insights 2008g; Drummer 2009; Drummer 
2009a; Hingson 2010; Lacey 2010).     
 
 
General effects and clinical signs: Classical clinical signs of cannabis use are 
tachycardia (increased heart rate), and hypertension (increased blood pressure from 
normal range). Moderate hyperthermia (increase in body temperature) is frequently 
but not always detected. The only regularly detected abnormality of the eyes is a lack 
of convergence, since nystagmus, either vertical or horizontal, is not a definitive or 
diagnostic feature of cannabis alone. Change in pupil size is not directly related to 
cannabis use since it has been demonstrated that pupil reaction in volunteers varied 
depending upon the dosage and type of cannabis smoked (Stark et al 2003). The most 
commonly reported effects are – a feeling of calmness, well-being and drowsiness, 
with euphoria; increased sociability, friendliness and happiness; altered perception of 
time and place; changes in visual and auditory perception, frequently with 




Cannabis has been shown for many years to have a direct effect in the immediate 
post-dose phase, producing significant decrements in psychomotor and cognitive 




Heishman, Huestis, Henningfield and Cone 1990; Robbe and O’Hanlon 1993; Chait 
and Perry 1994; Robbe 1998; Hindrik, Robbe and O’Hanlon 1999; Compton, Shinar 
and Schechman 2000; Sexton et al. 2000; Hart et al. 2001; Liguori et al. 2002; 
Couper et al. 2004; Ilan et al. 2004; Nicholson et al. 2004; Tunbridge 2004; 
Papafoitiou, Carter and Stough 2005; Ramaekers et al. 2006; Ramaekers et al. 2006a; 
Ramaekers 2007; Bosker et al 2012; Downey et al. 2012; Schwope, et al. 2012). 
  
 
Various studies on simulators and actual on-road driving have clearly indicated that 
cannabis is directly related to performance decrements relating to time and distance 
estimation, sustained vigilance, motor co-ordination, reaction times and tracking 
ability (Hart et al. 2001; Ilan et al. 2004; Sexton et al. 2000; Liguori et al. 2002; 
Nicholson et al. 2004; Ramaekers et al. 2006).  
 
 
There can be no doubt that the effect of cannabis on perception, cognitive functions, 
psychomotor performance, co-ordination, tracking, vigilance and alertness are all 




1.3.2. Opiates – morphine and heroin.  
Opium is the dried milky exudate of the unripe capsules of Papaverum somniferum 
and contains between 4% and 21% of morphine. Heroin (diacetyl morphine) is 




Epidemiology: A strong body of evidence points to widespread use of opiates by 
drivers (Gjerde, Beylich and Morland 1993; Tomaszewski et al. 1996; De Gier 1998; 
Hildegard and Berghaus 1998; Marquet et al. 1998; Schepens et al. 1998; Brault et 
al. 2004; Logan and Schwilke 2004; Laumon et al. 2005; Hingson 2010).  
 
General effects and clinical signs: Heroin used intravenously generally results an 
intense warm feeling or flushing accompanied by a surge of euphoria frequently 
likened to an orgasm commonly called a “rush”, followed by a period of intermittent 
sedation and drowsiness resulting in a state of narcosis with grossly impaired 
cognitive awareness and function. 
The psychological effects claimed are a feeling of well-being and relaxation, 
however these are accompanied by extreme lethargy, and drowsiness, sedation, 
leading to extreme impairment of cognitive awareness and function. 
The standard physiological effects are central nervous system (CNS) depression, 
nausea and vomiting, reduced gastrointestinal motility, constipation, muscle cramps, 
fixed constricted pupils, diminished reflexes, and depressed consciousness, depressed 
heart rate, and respiratory depression. 
 
Psychomotor effects: Laboratory studies have revealed heroin produces subjective 
feelings of sedation for up to 5-6 hours with apathy and indifference to external 
stimuli, poor concentration and delayed reaction time. In several case reports, where 
the subjects tested positive for morphine and/or 6-acetylmorphine, observations 
included slow driving, weaving, poor vehicle control, poor coordination, slow 
response to stimuli, delayed reactions, difficultly in following instructions, and 




it has been noted in some cases that some opioid dependent subjects perform better 
on driving tests after receiving the opioids (Galski, Williams and Ehle 2000; Fishbain 
et al. 2003; Stout and Farrell 2003). It is noteworthy that no experimental studies on 





1.3.3. Cocaine.  
Cocaine is extracted from the leaves of the coca plant. The base is smoked while the 
hydrochloride is snorted intra-nasally. 
 
Epidemiology: Cocaine is less frequently used than cannabis and opiates in drivers 
but is by no means uncommon (Budd, Muto and Wong 1989; Tomaszewski et al 
1996; Marquet et al. 1998; Del Rio and Alvarez 2000; Brault et al. 2004; Logan and 
Schwilke 2004; Laumon et al. 2005; Hingson 2010; Lacey 2010).  
 
General effects and clinical signs: Users claim feelings of generalised well-being, 
coupled with a degree of excitement including sexual arousal, and occasional 
euphoria, with elimination of fatigue and enhanced energy. Less welcome sequelae 
are restlessness, anxiety, tremors, and irritability. Clinical evidence of cocaine effect 
is found in dilated pupils, increased blood pressure and heart rate and, increased body 
temperature (Couper et al. 2004). Observers have noted an increase in simple 
attention and alertness with improvement in simple reaction time although memory 





Psychomotor effects: The acute adverse effects include increased driving speed and 
lack of smooth vehicle control; with potential risk taking procedures being the result 
of the stimulant phase of the drug, which may lead to increased risk taking.  
Although Hopper et al. (2004) found no effect of a low dose of cocaine on measures 
of recall or recognition task performance it is acknowledged chronic use of cocaine 
can lead to cognitive defects, impaired psychomotor performance and impulsive 





1.3.4. Amphetamine; Methamphetamine and “Ecstasy” (MDMA).  
Amphetamine is a CNS stimulant drug, which is rarely prescribed although, has a 
legitimate role to play in the treatment of conditions such as narcolepsy, and 
attention deficit hyperactivity disorder in children. Designer amphetamines include 
methamphetamine (MDA) which is a stimulant and hallucinogen drug with effects 
similar to those of cocaine, whereas “ecstasy” 3,4 Methylenedioxymethamphetamine 
(MDMA) has similar effects with the addition of a psychedelic element.   
 
 
Epidemiology: These drugs are not uncommonly reported in drivers (Christophersen, 
Bjorneboe and Gjerde 1990; Terhune et al. 1992; Gjerde, Beylich and Morland 1993; 
Logan 1996; de Gier 1998; Marquet et al. 1998; Schepens et al. 1998; Walsh, 
Cangianelli, Buchan and Leaverton 2000; Logan and Schwilke 2004; Laumon et al. 





General effects and clinical signs: One of the main effects on the central nervous 
system is the resultant increased alertness and elevation of mood frequently resulting 
in a sense of euphoria which may last for several hours and reduction in fatigue 
which is the basis for treatment of narcolepsy. Physiological signs of use include 
increased heart rate bounding pulse and dilated pupils. The major psychological 
adverse effects are psychotic states including paranoid episodes, which are associated 
with repeated high dose binge episodes.  
 
Psychomotor effects: Laboratory studies of amphetamine on healthy non-fatigued 
volunteers have produced variable results (McKetin et al. 1999; Asghar et al. 2003; 
Silber et al. 2006). Studies on sleep-deprived subjects are similarly unclear 
(EMCDDA Insights 2008d). Mills et al. (2001) reported no improvement in 
performance with low dose amphetamine (10mg) however Wesensten et al. (2005) 
noted the effects on executive function tasks were mixed with improvements in some 
tasks and decrements in others. Drivers under the influence of amphetamines are 
known to drive erratically, have difficulty in maintaining appropriate speed and lane 
control, exhibit lack of caution in their mode of driving resulting in increased risk 
taking manoeuvres, and also may exhibit diminished alertness due to overwhelming 
fatigue in periods of abstinence (Huestis and Smith 2009; Huestis 2010).       
 
Studies of low dose methamphetamine (5 or 10 mg) given to healthy volunteers 
(Comer et al. 2001) have reported no performance decrements in cognitive or 
psychomotor functions however when higher doses were given, (Johnson et al. 2000; 




was reported. Logan (1996) conducted a review conducted a retrospective review of 
drivers arrested or killed in road traffic accidents and who had tested positive for 
methamphetamine. He noted in this group of drivers speeding, erratic driving with 
poor control of lane travel, agitation, disorientation, impulsive or irrational and 
aggressive behaviour and concluded “Methamphetamine at any concentration is 
likely to produce symptoms that are inconsistent with safe driving.”  
 
Studies in respect of “ecstasy” 3,4 Methylenedioxymethamphetamine (MDMA) 
indicate increased impulsivity and decrements in attention during complex tasks 
(Lamers et al. 2003). Laboratory studies have demonstrated changes in cognitive, 
perception and mental associations, instability, uncoordinated gait, and poor memory 
recall. Distortion of perception, thinking, and memory, impaired tracking ability, 
disorientation to time and place, and slow reactions are also known performance 
effects (Smith et al. 2006; Kuypers, Samyn and Ramaekers 2006; Ramaekers, 
Kuypers and Samyn 2006). Single oral doses of MDMA are reported to cause 
subjective excitability, anxiety, perceptual changes, and thought disorders 1 to 3 
hours post dosage (Couper at al. 2004). Regular users of MDMA were assessed (de 
Waard et al. 2000) in an advanced driving simulator study immediately after 
ingestion of MDMA, later in the night and also on a night when they had not taken 
MDMA. The subjects were noted to drive faster and had increased variance in speed 
although their lane control and vehicle tracking was not adversely affected. 
Ramaekers et al. (2006) conducted a double blind crossover study on 18 recreational 
MDMA users in “on the road” driving tests and reported MDMA significantly 





Ketamine is a synthetic CNS sedative mainly used as a veterinary anesthetic and is 
reported to produce a dream-like effect although an hallucinogenic state may also be 
experienced, with a degree of amnesia also reported.  
Epidemiology: Less research studies have been conducted in relation to ketamine use 
by drivers however (Cheng et al. 2007) describe a study in Hong Kong whereas (Chu 
et al. 2012) reported ketamine detected in small numbers of drivers subjected to 
random roadside testing in Australia. 
General effects and clinical signs: Positive effects claimed by users include feelings 
of intense power and energy, plus “dream like” states and “out of body” experiences; 
however disorientation and confusion are not infrequently reported with vivid 
hallucinations and delirium. The adverse of ketamine include anxiety and agitation, 
with paranoia and frank psychotic episodes associated with visual, auditory and 
perceptual hallucinations, whereas the physiological side-effects include irregular 
heart palpitations and chest tightness, plus muscle stiffness and occasionally seizures. 
 
Psychomotor effects: The major safety concerns following ketamine use relate to 
depersonalisation effects including vivid hallucinations and psychotic episodes 
coupled with decrements in higher cognitive functions. Decreased awareness of self 
or surroundings linked with distorted perceptions of space, increased reaction time, 
non-responsiveness, and blurred vision are the major elements responsible for these 





1.3.6. Hallucinogens: LSD.  
Lysergic acid diethylamide (LSD) is an hallucinogenic, psychedelic agent and is 
manufactured from lysergic acid, an ergot alkaloid which occurs naturally in the 
ergot fungus which grows on wheat and rye cereal grains.  
 
Epidemiology: There is a paucity of publications relating to LSD use in drivers 
however Moeller and Kraemer (2002) and Isralowitz and Rawson (2006) report use 
in Germany and Israel respectively. LSD use among dance clubbers in Scotland has 
been reported (Riley et al. 2001).   
 
General effects and clinical signs: Physiological signs of LSD use are CNS 
stimulant and include tachycardia, hypertension, dilated pupils, tremor, sweating, 
occasional pilo-erection (gooseflesh) anorexia, dry mouth and insomnia. 
Psychological effects of LSD are visual and auditory hallucinations with distorted 
sensory perception, abnormal mental state including altered thought processes, 
delusions, temporal distortion, and temporary psychotic episodes. These effects are 
unpredictable and can depend upon the subject’s individual personality and mood.  
 
Psychomotor effects: Due to the distortion of temporal perception induced by LSD 
the detrimental performance effects are related to reaction time, both visual and 
auditory, and both simple and choice.  In addition due to the disordered dream like 
state induced by LSD the subject’s general awareness and alertness are also 
significantly negatively affected. Although epidemiological studies suggest the 
incidence of driving under the influence of LSD is extremely rare there can be no 




1.3.7. “Legal highs” - Mephedrone; BZP; Synthetic Cannabinoids.  
“Legal Highs” are relatively new drugs which were sold legally in the UK since 2007 
and include Mephedrone; BZP and synthetic cannabinoids. However in December 
2009 the Home Office declared BZP and the synthetic cannabinoids illegal under the 
Misuse of Drugs Act 1971. In April 2010 Mephedrone was also declared illegal as a 
Class B drug under the Misuse of Drugs Act 1971. 
 
Little is known regarding the prevalence of these drugs and information is based 
mainly on anecdotal evidence. However the National Addiction Centre conducted a 
survey via a social magazine and received 2,200 responses in relation to use of “legal 
highs” and 59% of respondents admitted use of such substances Jackson and Hilditch 
(2010). The most popular “legal high” was nitrous oxide (59%); Mephedrone (42%); 
Salvia (salvia divinorum - a psychoactive plant) (29%); BZP (26%); Synthetic 
cannabinoids “spice” (13%) and GBL (6%). 
 
Mephedrone: 
Mephedrone is a member of the cathinone group of stimulant drugs which are 
extracted from the khat leaves and which are controlled under the Misuse of Drugs 
Act 1971. The effects described by users are similar to those of “ecstasy” and 
cocaine. Positive effects are claimed to be feelings of increased sociability and 
empathogenic feelings with talkativeness, excitement, alertness and occasional 
euphoria. Negative effects include nausea, vomiting, blurred vision, anxiety, 





Since this substance has effects and side effects similar to the amphetamine 
stimulants, ecstasy and cocaine, it is logical the adverse effects on driving would be 
expected to be similar and these are anticipated to include visual distortion, lack of 
concentration, irritability, disordered awareness, occasional frank hallucinations, and 




BZP is a synthetic CNS stimulant producing similar effects to amphetamines and 
MDMA (ecstasy) but significantly less intense and probably in the range of 10% of 
d-amphetamine. Despite the reduced stimulant and hallucinogenic effect BZP has 
been associated with nausea, vomiting, anxiety, mood swings, confusion and 
hallucinations and paranoia. The CNS stimulant effects will affect safe driving due to 
concentration decrements; anxiety and distorted perception, while the increased risk-
taking and potential hallucinogenic effects clearly are likely to compromise safe 




These compounds mimic the psychoactive effects of delta-9 tetrahydrocannabinol 
(Δ9-THC), which is the active compound in cannabis. They are however much more 
potent than Δ9-THC and used in much lower doses. They are sprayed onto a herbal 
mix and sold as incense known as “Spice”. Regarding the risk to health very little is 




varieties available (Jackson and Hilditch 2010). These high potency cannabinoids 
will carry a significantly greater risk to road safety than “standard” cannabis with 
more severe detrimental effects on the cognitive and psychomotor performance of 
the “users”. It is anticipated severe decrements will be noted in perception, vigilance 




1.4. Medicinal drugs and driving. 
The role of prescription medications used to treat medical conditions and the impact 
on road safety is an area of research, which has produced mixed results. Longo et al. 
(2000) studied 2500 injured drivers and found an increased risk for drivers using 
benzodiazepines at the therapeutic range or above. However other studies (Skegg 
1979; Ray 1992; Leveille et al. 1994; Barbone et al. 1998) have not all shown an 
increase in risk for road traffic collision and benzodiazepine use. Indeed it has been 
reported that treatments for anxiety with benzodiazepines improve the condition 
although not the impaired driving performance of the patient (de Gier 1998).  
 
Starmer (1985) studied the effect of anti-histamine use and highway safety and later 
analysed a prospective study investigating the link between prescription tranquillisers 
and road crash involvement over a two-year period. It was concluded that subjects 
prescribed minor tranquillisers were significantly more likely to be involved in a 
serious road traffic incident, with those involved in a fatal crash being 4.9 times more 




Research studies on depressed patients suggested that treatment with tri-cyclic anti-
depressants can improve the driving ability of the patient, despite the medication 
having sedative properties that would impair the driving ability of non-depressed 
individuals (Hobi et al. 1982; Greenblatt and Shader 1992).  
 
More recent studies have also suggested that in the patient whose condition has an 
adverse effect on their driving ability, the benefits of treatment in respect of 
improved alertness, concentration and attention can compensate for any detrimental 




The medicinal drugs of particular concern in road safety and driving are – 
 
Sedatives and anxiolytics – particularly benzodiazepines. 
Anti-depressants – particularly tri-cyclics. 
Neuroleptic agents (major tranquillisers) – chlorpromazine and haloperidol. 
Narcotic opioids – methadone, diamorphine, buprenorphine. 







1.4.1. Benzodiazepines - Diazepam.  
Benzodiazepines (BZDs) are CNS sedative anxiolytics with a muscle relaxant effect 
and as a result users may experience lethargy, lack of attention, vigilance decrements 
and drowsiness with impaired motor co-ordination and psychomotor functions. 
Although legal, benzodiazepines are drugs of concern in respect of road safety due to 
their widespread use as prescribed drugs, but also due to their widespread availability 
and use as a “street drug” (McCabe and Boyd 2005; North 2010a). Laboratory and 
simulator studies have shown benzodiazepines produce performance decrements 
varying from sedation in low doses to hypnosis in high doses (Stevenson, Pathria, 
Lamping et al 1986; Landauer 1986; Leigh, Link and Fell 1991; Leufkens et al. 
2007).  
 
Epidemiology: Benzodiazepines such as diazepam are widely prescribed not only in 
the U.K. and throughout Europe but also in North America and the southern 
hemisphere and multiple studies have reported the drug detected in drivers’ blood 
samples (Everest Tunbridge and Widdop 1988; Ray, Fought and Decker 1992; 
Terhune et al. 1992; Gjerde, Beylich and Morland 1993; Leveille et al. 1994; 
Augsburger and Rivier 1997; Hemmelgarn et al 1997; Barbone et al. 1998; De Gier 
1998; Hildegard and Berghaus 1998; Schepens et al. 1998; de Gier 2000;  Longo et 
al. 2000 and 2000a; Tunbridge and Rowe 2000; Brault et al. 2004; Fitzpatrick, Daly, 







General effects and clinical signs: At low doses diazepam is a moderate tranquiliser 
which can result in impaired alertness, muscle weakness, lethargy, light-headedness, 
drowsiness and confusion; whereas at higher doses its effects are somewhat similar 
to alcohol intoxication with slurred speech, disorientation, inco-ordination and 
ataxia; while at toxic levels the subject may exhibit dis-inhibition with wild 
excitement, or indeed severe sedation, and on occasion respiratory depression. 
 
 Psychomotor effects: The most important side-effects of benzodiazepines (BZDs), 
which lead to impairment of driving performance, are sedation and somnolence, loss 
of motor co-ordination, memory impairment. BZDs impair driving performance 
notably by interfering with visual perception, speed perception, future events 
perception, and vehicle control. These difficulties stem mainly from the drug’s 
sedative effects, which are strongest when the drug is initially taken and become less 
significant as the patient develops a tolerance to both the effects and side-effects.  
 
Significant performance deficits in psychomotor function and driving related 
functions following benzodiazepine use have been reported (Skegg, Richards and 
Doll 1979; Moskowitz and Smiley 1982; Willumeit, Neubert, Ott and Hemmerling 
1983; Kunsman Manno, Manno et al. 1992; Kunsman, Manno, Przekop et al. 1992; 
Preston, Wolf, Guarino and Griffiths 1992; Van Laar 1992; O’Hanlon et al. 1993; 
Danjou et al 1999; Mintzer and Griffiths 1999; Compton, Shinar and Schechtman 
2000; Van Laar, Volkerts and Verbaten 2001; Matthews, Kirby and Martin 2002; 
Verster at al. 2002; Logan and Couper 2004; Rich, Svoboda and Brown 2006; 





1.4.2. Anti-depressants:  
Antidepressants are CNS psychoactive agents used to treat not only depression, but 
also panic disorders, eating disorders, phobias and obsessive-compulsive behaviour.    
 
Epidemiology: Studies showed that the use of anti-depressants in drivers is 
widespread and may be linked to increase risk of road traffic accidents due to the 
significant sedative effects of the early tri-cyclic antidepressants (Ray et al. 1992; 
Leveille 1994; O’Hanlon 1995; O’Hanlon et al. 1998; McGwim 2000). However it 
has been reported the modern agents venlafaxine, fluoxetine and paroxetine have not 
been associated with impairment of driving (Ramaekers, Muntjewerff and O’Hanlon 
1995; O’Hanlon et al. 1998; Ridout, Meadows, Johnsen and Hindmarch 2003). 
 
General effects and clinical signs: Among the unwanted secondary effects of 
antidepressant drug therapy are sedation, tremor, insomnia, blurred vision, mental 
confusion and dizziness. These effects and their intensity depend on the molecule, on 
the dose, timing of administration and the individual sensitivity. The side-effects of 
the tricyclic compounds can be severe resulting in significant sedation and mental 
dullness however the more modern antidepressants have fewer adverse effects 
although the SSRIs (selective serotonin re-uptake inhibitors) have recently been 
linked to increase in suicide rates (Healy and Whitaker 2003; Gunnel, Saperia and 





Psychomotor effects: These are directly related to the class of drug used with the 
earlier agent being responsible for significantly greater sedation than the modern 
drugs. Multiple studies reported the early tricyclic antidepressants drugs (TCAD) to 
have significant adverse effects on psychomotor assessment (Ramaekers, Swijgman, 
and O’Hanlon 1992; Ramaekers, Muntjewerff, and O’Hanlon 1995; van Laar, van 
Willigenburg, and Volkerts 1995; Ramaekers 2003). However studies of the modern 
SSRI agents report no adverse psychomotor effects (O’Hanlon, Robbe, Vermeeren, 
van Leeuwen and Danjou 1998; Devanand et al. 2003; Constant et al. 2006; Dumont 
et al. 2005; Wadsworth et al. 2005; Wingen et al. 2005; Rose et al. 2006).    
It has been reported that successful anti-depressant therapy can improve the driving 
performance of depressed patients due to the drug relieving the depressive symptoms 




1.4.3. Neuroleptics.  
Neuroleptics are CNS psychoactive sedative agents used in the treatment of 
psychoses characterised by disturbances of the thought processes leading to 
distortions of affective responses (mood) and reality. These drugs are frequently 
prescribed to the not insignificant percentage of the general population who suffer 
from major psychiatric disorders (Carney, Jones and Woolson 2006). Little research 
has been conducted regarding the effects on driving ability in patients using 
neuroleptic agents however it has been reported that schizophrenic patients 
demonstrate improved psychomotor performance during chronic treatment with 




General and psychomotor effects: The major impairing side effects of neuroleptics 
are sedation, deterioration of cognitive function, reduction of visuo-motor abilities 
and of vigilance, aggressive tendencies, and temporary aggravation of psychotic 
problems. It has been reported however, that without adequate treatment, patients can 
demonstrate a variety of cognitive problems, and attention or motor deficits, which 
are more detrimental to safe driving than the adverse affects of the medication. 
Indeed use of neuroleptic agents may allow the patient to resume normal social 
activities including driving Judd (1985). 
 
1.4.4. Methadone.  
Methadone hydrochloride is a synthetic narcotic analgesic and is a schedule II 
controlled substance. Methadone is an analgesic for the relief of moderate to severe 
pain, and is used in detoxification treatment of opioid dependence and maintenance 
in narcotic addiction. Recreationally, methadone is abused for its sedative and 
analgesic effects. 
 
General effects and clinical signs; The clinical or physiological signs of recent 
methadone use include dry mouth, facial flushing, nausea, constipation, respiratory 
depression, muscle flaccidity, pupil constriction, and decreased heart rate. The 
psychological effects range from dizziness and light-headedness, mood swings, 
drowsiness and sedation, through altered sensory perception including analgesia and 
depressed reflexes to clinical stupor and eventually a comatose state. The most 
serious unwanted effects of methadone result from the powerful CNS depressant 




Psychomotor effects: The major effects relevant to methadone in relation to driving 
safety are sedation, impairment of cognitive functions, mood changes including 
dysphoria and euphoria, impairment of psychomotor functions and pupil restriction. 
Sedation and cognitive impairment may be noted at initial stages of treatment but 
less so after some days or weeks. Laboratory studies have shown no significant 
psychomotor impairments when stable long-term subjects have been tested and in the 
majority of experimental clinical trials (Mintzer and Stitzer 2002).   
 
It has been reported that non-tolerant individuals receiving single doses of 
methadone have been noted to have dose-dependent reductions in reaction time, 
visual acuity, and information processing, with sedation being readily recognisable 
(Stout 2003; Couper et al. 2004). However European studies of long-term methadone 
maintenance patients have indicated that appropriately administered methadone does 
not cause significant psychomotor or cognitive impairment when administered 
regularly and when the subject abstains from all other drugs (Stout 2003; Fishbain et 
al 2003; Strand, Fjeld and Arnestad 2010). However it has been reported that opioid 
maintenance therapy OMT studies in Norway resulted in “conflicting results” due to 
some patients receiving benzodiazepine therapy in addition to the methadone 
(Bramness 2010).   
 
Current DVLA regulations permit driving licenses to be held by persons whose 
opiate addiction has been controlled following successful detoxification therapy, and 
are stabilised on daily methadone and who use no other drugs, subject to certification 





Morphine is an analgesic agent used clinically for the relief of moderate to severe 
acute and chronic pain, and also used in anaesthetic pre-operative sedation. The 
effects of these substances on any given subject will depend on the specific drug 
used, the route of administration, but also previous exposure which will be reflected 
in the individual’s tolerance to the particular drug.  
 
 
Epidemiology: Chronic opiate maintenance therapy is commonly used to control 
long-term pain in patients suffering from terminal cancer, some of whom may have 
continued mobility and use of a motor vehicle and thus drive regularly whilst 
prescribed significant dosages of morphine. 
 
 
General effects and clinical signs: The behavioural effects of opiates are recognised 
to include among other things, a feeling of well-being, euphoria, lethargy, sedation 
and mental confusion (Huestis and Smith 2009a). Clear evidence of lethargy, 
sedation and performance decrements in psychomotor tasks has been recorded in 
opiate naïve volunteers for periods of 4 to 6 hours after oral ingestion with 
significantly decreased alertness and sedation obvious and performance decrements 
such as reduced reaction time and significant deterioration in performance on divided 
attention tasks. However chronic use of oral morphine leads to tolerance, which 





Psychomotor effects: Due to the powerful narcotic effects all patients started on 
morphine therapy are warned to expect sedative side effects in the initial treatment 
phase and must be cautioned against driving if significantly affected. After a 
relatively brief period patients will develop a tolerance to the drug when taken in 
moderate regular doses. Patients stabilised on long-term opiate maintenance therapy 
who develop tolerance show no significant decrements in psychomotor performance  
(Vainio et al. 1995; Galski, Williams, and Ehle 2000; Hill and Zacny 2000; O’Neill 





Anti-histamines are used for treating allergies such as hay fever and urticaria, and 
travel-sickness. The most significant effect of antihistamines in respect of safe 
driving relates to their potential to induce sedation (Richardson et al. 2002; Turner et 
al. 2006; Theunissen, Vermeeren, Ramaekers 2006). This undesirable side effect, 
which has been most commonly observed with the first generation compounds such 
as diphenydramine, is a consequence of the depressive activity on the CNS due to 
this group of drugs’ ability to cross the blood-brain barrier. Newer agents such as 
astemizole and terfenadine do not cause significant sedation because of their poor 






Psychomotor effects: Diphenhydramine and other 1st generation antihistamines are 
linked with impairment in cognitive functions and psychomotor performance and in 
particular lethargy, sedation, drowsiness and decreased alertness with associated 
decrement in reaction time, both simple and choice; and impairment in concentration 
and attention and diminished performance in tracking ability (Couper et al 2004).  
 
The individual classes of histamine antagonists have been studied (Betts et al. 1984; 
Starmer 1985) and the researchers independently concluded these different classes of 
drugs had quite different effects on psychomotor performance and had different 
implications in respect of road safety. Their investigations found that the older H1 
antagonists were associated with sedative effects which resulted in a performance 
decrement in laboratory based tasks however the more modern H2 antagonists had 
no detrimental effects.  
 
These findings have been confirmed by multiple researchers (O’Hanlon 1988; 
Ramaekers, Uiterwijk, and O’Hanlon 1992; Ramaekers and O’Hanlon 1994; 
Vuurman, Uiterwijk, Rosenzweig, and O’Hanlon 1994; O’Hanlon and Ramaekers 
1995; Vermeeren and O’Hanlon 1998; Nicholson et al. 2002; Moskowitz and 












1.5. U.K. Government awareness of drug driving problem.  
In January 1998 the UK Department of Environment Transport and the Regions 
(DETR) published findings of the first 15 months of a 3-year study into the incidence 
of drugs in road accident fatalities (DETR 1998). There were a total of 619 road 
traffic fatalities and over 6% of these tested positive for medicinal drugs, 18% for 
illicit drugs (mainly cannabis), and 34% for alcohol. Although the incidence of 
medicinal drugs had not significantly changed from the 1985 - 1987 study it was 
noticeable that illicit drug use had increased six fold in percentage terms from 3% to 
18%. Another study undertaken in 2000 noted that at least one medicinal or illicit 
drug was detected in 24.1% of the 1184 road traffic casualties tested (Tunbridge, 
Keigan and James 2001). The research also revealed that there had been a substantial 
increase in the incidence of cannabis detected in fatal road traffic casualties from 
2.6% in 1989 to 11.9% 2001.  
 
In Scotland a study reported on blood samples submitted to the forensic science 
laboratory in Edinburgh in relation to drivers arrested under Section 4 of the Road 
Traffic Act 1988 over a 12 year period from 1996 to 2008. In total 423 samples were 
analysed. It was found cannabinoids were present in over 40%; benzodiazepines had 
doubled in frequency to over 80%; methadone had increased from 2% to 23% and 
morphine from 2% to 31%. A notable finding was the huge increase in poly-drug use 
with samples containing 4 or more drugs increasing from 4% in the 1996 to 2000 







1.5.1. U.K. Legislation drugs and driving. 
The legal consequences of driving under the influence of alcohol and/or drugs are 
regulated as crimes in specific road traffic laws throughout the United Kingdom. The	  
statutory	  offence	  relating	  to	  drugs	  and	  driving	  is	  contained	  under	  Section	  3A	  and	  4	  
of	  the	  Road	  Traffic	  Act	  1988	  (as	  amended	  by	  S4	  of	  the	  Road	  Traffic	  Act	  1991).	  
• The Road Traffic Act of 1988 – Sections 5 and 4. 
• The Railways and Transport Safety Act of 2003.  
 
 
1.5.2. Road Traffic Act 1988 – Section 4.  
This legislation empowers police officers to arrest the driver of a “mechanically 
propelled” motor vehicle if there is suspicion that the person has either been driving 
or has been attempting to drive the vehicle while unfit through drugs.   
The Road Traffic Act 1988 amended section 4(1) states -  
“A person who, when driving or attempting to drive a motor vehicle on a road or 
other public place, is unfit to drive through drink or drugs shall be guilty of an 
offence”.  
 
Under the legislation of the Road Traffic Act (1988) the term “drugs” is defined as 
any intoxicant other than alcohol – which infers any substance, which has the 
potential to affect the normal function of the Central Nervous System. The 
“Impairment” based regulations require proof that the driver is unfit to drive as a 




 Robinson (1996) has observed that the Road Traffic Act 1988 has defined “unfit” as 
follows – “A person shall be taken to be unfit to drive if his ability to drive properly 
is for the time being impaired”  
 
However Stark et al. (2002) have noted - 
“Impairment is not defined under the Act; it is a decision reached by the Court after 
hearing evidence from several sources including any witnesses, arresting police 
officers, police doctor, and forensic toxicologist.”   
 
 
Study of recent publications indicates some difference of opinion exists regarding the 
responsibility of the forensic medical examiner (FME) called by police to examine 
any motorist suspected of drug-related impairment of driving, in compliance with the 
requirements of Section 4 of the Road Traffic Act 1988.  
 
Sexton et al. (2000) in the Transport Research Laboratory Report 477 state –  
“The aim of the examination is two-fold; firstly to ensure that the person is fit to be 
in a police station – that there is no evidence of injury (e.g. head injury following a 
road traffic accident) or a medical condition (e.g. hypoglycaemia) requiring 
treatment, and secondly to determine whether the person is impaired to drive or 
whether there is a condition that might be due to a drug.”  
 
Wall and Karch (2005) take a different view –  
“In the U.K. it is not necessary to prove impairment, as Section 7 (3) of the RTA 
states the suspected offence is one under Section 7 3(A) or 4 of this Act and the 
constable has been advised by a medical practitioner that the condition of the person 
required to provide the specimen might be due to the effect of some drug. It is for the 
court to decide whether the driver is unfit to drive on the evidence before it.”  
 
As a result of nationwide training programmes it should now be beyond doubt that 
the FME is not required to diagnose impairment but simply to state whether or not 




1.5.3. Preliminary Field Impairment Tests (PIT / FIT). 
Strathclyde Police Scotland, in conjunction with several other forces in the United 
Kingdom, conducted a trial in July and August 1999, during which period, Field 
Impairment Tests (FIT) which are identical to Standardised Field Sobriety Tests 
(SFSTs), were applied to suspect drivers at the roadside. Following completion of the 
trial which was perceived to be successful, the techniques were presented to the 
Association of Chief Police Officers with the recommendation FIT be incorporated 
into a national training package for police officers and FMEs.  
 
These SFSTs which were pioneered in the U.S.A. almost 40 years ago, have 
influenced training in various countries, and have been claimed to have been 
validated, both in laboratory and roadside conditions (Burns 1995). The tests which 
assess the psychomotor status and cognitive functions also include a “divided 
attention” component designed to assess the ability of the subject to pay attention, 
follow simple instructions, and to divide attention between multiple tasks and 
demands made simultaneously. The “divided attention” assessment is purported to be 
relevant in respect of the multiple tasks required to satisfactorily drive a motor 
vehicle. It has been suggested (Fleming and Stewart 1998) – “The individual who is 
unable to divide his or her attention will frequently forget part of the instructions”.  
 
A pupillary assessment and four specific tests were recommended for use:  
• The One Leg Stand Test 
• The Walk & Turn Test 
• The Finger to Nose Test 




It is important to acknowledge that these “tests” which have been validated for the 
effects of alcohol-related impairment at blood alcohol concentration (BAC) of 0.10   
(100 mg alcohol per 100 ml blood) remain to be validated for drug-related evidence 
of driving impairment (AFP 2003; FFLM in North 2010d; Stark 2010).  
It is also important to acknowledge no direct or causal link has yet been established 
between poor performance in FIT and the recognised effects or side-effects of drugs 
(Hartley 2001; Irvine 2002). It is questionable what relevance such dated tests for 
alcohol effect have in relation to impairment of driving ability following drug use.  
Furthermore these tests have been widely criticised Trocino (1997); Head (2001); 
Hartley (2001); Johnson and Ramsey (2003) and as such are open to legal challenge.  
However perhaps the major problem with FIT/PIT is that despite the name, they are 
not tests of driving impairment - Read (2003). 
 
 
1.6. Impairment of driving ability. 
Impairment of driving ability is not defined within the Road Traffic Act 1988 
however may be described as a reduction in the ability to adequately perform the 
various elements of the driving task in order to travel safely on public highways. 
These elements include maintaining alertness and vigilance, awareness and 
perception of potential hazards; judgment and decision-making; and the appropriate 




The Department for Transport Road Safety Division (2001) has declared that 
impairment of driving may be related to general health and physical conditions; 
psychological conditions; inappropriate consumption of alcohol, drugs and/or other 
substances; fatigue and sleep deprivation; and distraction from the driving task.  
 
The concern that certain drugs may impair driving skills is shared by the medical 
community, regulatory bodies, the transport industry and not least by the general 
public. This issue is of particular importance because drug use in general, has 
increased markedly in recent years, not only due to a rise in the use of prescription 
medicines among an expanding and ageing population, but also to the increased use 
of illegal “street drugs” in the general population which is known to have increased 
dramatically in recent years North (2010a). It has been reported by that there are 
consistent patterns to the drugs which show up most frequently in drivers with 
cannabis, cocaine, amphetamines, benzodiazepines, and opiates invariably appearing 
in the top five irrespective of jurisdiction (Logan 2010).  
 
Both prescription drugs and illicit drugs are frequently detected in populations being 
studied, including arrested drivers (de Gier 1998; Jones et al. 2007); fatally injured 
drivers (Schwilke et al. 2006; EMCDDA 2008f; road trauma patients Longo et al. 
2000a; Walsh et al. 2005); and roadside survey or checkpoint subjects (Hildegard 







1.6.1. Evidence of Impairment and psychomotor tests.  
When we consider Section 4(1) of the Road Traffic Act 1988 it should be 
acknowledged that there is an essential difference between detecting psychomotor 
performance deficits in a subject who has a detectable level of a drug in their system; 
and testing for the presence of impairment of driving ability which has been caused 
directly by the effect of a specific drug.  
 
Laboratory type tests may be applied and these tests can be subdivided in to two 
categories namely -  
(i) psychological  
(ii) physiological  
The first assesses how a drug affects psychological performance, such as attention, 
vigilance, temporal processing and psychomotor functions such as reaction time and 
tracking ability.  
The second type of test examines the effect of drugs on physiological functions such 
as balance and co-ordination, locomotor function, eye movements, pupil size, visual 
ability, blood pressure and pulse rate.  
 
A pre-requisite of any test including drug impairment tests, is that it must fulfil 
certain criteria before it can be used confidently and reliably by any law enforcement 
agency or legislative body or process, particularly in a judicial arena.  
The pre-requisites with which the test must comply are - 
(i) Sensitivity 
(ii) Reliability 




Regarding the use of drugs and driving, any test fit for purpose must therefore -   
 
• Be capable of measuring a specific effect  
 
• Measure the effect accurately and reliably  
 
• Have a standardised simple and easy administration procedure  
 
• Measure tasks related to the act of driving  
 
• Have a valid pass/fail criterion level  
 
• Measure what is claimed to be measured  
 
• Be fair with respect to language, culture, age, gender, experience 
 
• Be appropriate to population norms  
 




The validity of experimental tests measuring driving skills or skills related to driving 
has been the subject of detailed scrutiny (Owens and Ramaekers 2009a) who 
concluded  - 
“Although various investigators have claimed that their task or battery taps driving 
related skills, most studies show no proof for such a claim or even a reasonable 




1.6.2. Impairment of Driving - Clinical Tests of Impairment. 
A significant problem with the laboratory tests relates to the validity of the test 
battery in general, and the face validity in particular. In an attempt to address these 
shortcomings and to design tests more likely to assess the skills related to the driving 
act, various clinical tests have been formulated and the great majority appear to be 




These SFSTs were developed in the 1970s to assist police officers to detect a BAC or 
blood alcohol level greater than .10 which equates to 100 mg/100 ml blood, however 
despite this these SFSTs have been renamed as field Impairment Tests (FIT) and 
have been adopted as tests of drug-related impairment by the United Kingdom, 
several E.U. countries, Canada and Australia. An enhanced clinical test battery is 
used in Norway involving 25 Clinical “subtests” known as the Norwegian CTI25 
tests (Bramness, Skurtveit and Morland 2003). 
 
The methods which have been used in the USA are - 
1. The Drug Evaluation and Classification programme (DEC) which uses the 
drug recognition experts (DREs) and a 12 step examination process. 
2. The Standardised Field Sobriety Tests (SFSTs). 
 
The method used in the U.K. is the roadside Field Impairment Testing process (FIT), 
now known as the Preliminary Impairment Test (PIT). This method was adopted in 




1.6.3. The U.S.A. Drug Recognition Expert (DRE). 
In the early 1970s officers from the Los Angeles Police Department (LAPD) found 
that a growing number of drivers stopped under suspicion of being impaired were 
testing negative on the breathalyser however appeared to be impaired. LAPD officers 
worked with a local medical examiner to formulate a systematic programme whereby 
police officers could be trained to observe, and document, known signs and 




field-tested over a number of years before it was eventually accepted by the LAPD 
and introduced in 1979. The programme is called the Drug Recognition Expert 
programme (DRE) and, under the system, the medical examiner is replaced by the 
DRE who is a trained police officer. The programme is also known as the Drug 
Evaluation and Classification (DEC) programme.  
The purpose of the DRE examination is threefold -  
1) To confirm impairment is not consistent with the alcohol effects 
 
2) To determine whether the impairment is drug related or caused by a medical 
condition or injury.  
3) To determine the category/categories of drugs responsible for the impairment.  
 
In order to do this, the DRE carries out a 12-step examination process: 
1.    Breath alcohol test- this is carried out by the arresting officer.  
2.    Interview with the arresting officer to gather baseline information. 
3.    Preliminary examination including first recording of pulse. 
4.    Eye examination for horizontal and vertical gaze nystagmus, and convergence.  
5.    Divided attention tests are conducted.  
6.    Vital signs examination - BP, temperature, and a 2nd pulse count are taken.  
7.    Darkroom examination - pupil size is measured  
8.    Muscle tone - limb tone is assessed for rigidity and flaccidity.  
9.    Injection site examination - plus a third pulse reading is taken.  
10.  Interrogation - a structured interview about the use of drugs is carried out.  
11.  Opinion - the DRE forms an opinion as to drug impairment and the type of drug.  
12.  Toxicology testing - samples are obtained for toxicological examination, either     




1.6.4. Standardised Field Sobriety Tests (SFSTs). 
Six specifically selected tests were evaluated in the study as follows. 
1. One Leg Stand:     
2. Walk and Turn:     
3. Finger to Nose:   
4. Finger count: 
5. Horizontal Gaze Nystagmus (HGN) 
6. Finger Tracing:  
Evaluation studies suggested a high degree of sensitivity and specificity and tended 
to validate this procedure. The study authors concluded that all of the field sobriety 
tests examined were “alcohol sensitive”, but that the Walk and Turn, One Leg 
Stand, and Horizontal Gaze Nystagmus tests were the most effective at correlating 
with BACs of .10% or more and it was concluded that these were the best tests for 
further development (Tharp, Burns and Moskowitz 1981; Burns and Adler 1995). 
However subsequent detailed analysis of the results of the limited studies conducted, 
suggested that the results of the DRE assessment might not have been sufficiently 
accurate to permit a reliable evidence base to be presented in court. Doubt had been 
cast on their “expert” status particularly by specialist legal defence agents (Erwin 
1995; Trocino 1997; Head 2001; and Rubenzer 2008).  
Indeed Trocino (1997) claimed a lack of impartiality on the part of the author of the 
initial studies which tended to validate the DRE programme, Dr Marcelline Burns, a 
research psychologist whom he claimed - “was intimately associated with the DRE 




A thorough and detailed review of the SFST was produced (Fazzalaro 2000) which 
declared no scientific basis for the tests, which had never been validated for drug 
related impairment of driving. 
 
1.6.5. Validation of the SFST Battery (1995). 
Intriguingly, the SFST test battery was “validated” by one of the original main 
authors in the 1995 Colorado validation study finally completed in August 1998 
(Stuster and Burns 1998). NHTSA commissioned the principal researcher Dr Burns 
of the Southern California Research Institute who concluded that for the 234 subjects 
who provided samples, the police officers decisions to arrest or release were correct 
in 86% of the cases.  
 
1.6.6. Criticism of the SFST Research. 
Criticism of the SFST battery has been voiced by various defence agents regarding 
alleged deficiencies in the research supporting Field Sobriety Tests in general and the 
SFST battery in particular. It has been asserted that the tests are inherently subjective 
as opposed to being appropriately objective.  
 
It has been claimed that multiple external factors including the unusual nature of the 
tests, the delivery of the tests, pressures placed upon the driver, and the individual 




However the major criticism of the use of the “Field Sobriety Tests” was the fact that 
these tests were being used for a purpose they had not been designed for - essentially 
to identify impairment of driving ability. It was noted the primary purpose for 
developing the SFST battery was to assist a police officer in making an arrest 
decision. However the tests were specifically designed to determine whether a 
subject's BAC was above or below .10%. The tests were not designed to detect 
whether or not a person's driving ability was impaired, and certainly not impaired 
due to the effects of drugs. 
 
Regarding the initial studies (Stuster and Burns 1998) which claimed that DRE 
opinions were confirmed by toxicology in the 74 to 92% of cases when the DRE 
concluded that the suspect was impaired, it has been highlighted that published trials 
in which blood levels were measured before and during the DRE examination, have 
shown that DRE assessment agreed with the toxicology findings only in 32 to 44% 
of cases (Wall and Karch 2000; Wall and Karch 2005).  
 
More recent opinion (Rubenzer 2008) has strongly re-inforced the position taken by 
Erwin (1995) following his assessment of the tests in relation to relevant scientific, 
psychometric, and legal issues and concluded –  
“The research that supports their (SFST) use is limited, important confounding 
variables have not been thoroughly studied, reliability is mediocre, and that their 
developers and prosecution-oriented publications have oversold the tests. Further, 
case law since their development has severed the tests from their validation data, so 
that they are not admissible on the criterion for which they were validated (blood 
alcohol concentration), and admissible for a criterion for which they were not 




1.6.7. U.K. Field / Preliminary Impairment Tests (FIT / PIT).  
FIT currently in use in the U.K. and now known as Preliminary Impairment Tests 
(PIT) are identical to the original Standardised Field Sobriety Tests minus the 
Horizontal Gaze Nystagmus Test and the Finger Count and Tracing Tests which 
were first introduced nearly 40 years ago to assess the blood-alcohol level. FIT/PIT 
assess the psychomotor status and cognitive functions and also include a “divided 
attention” component, which assesses the ability to pay attention, follow simple 
instructions, and divide attention between multiple tasks. This multiple task or 
“divided attention” assessment is purported to be relevant in respect of the multiple 
tasks required to satisfactorily drive a motor vehicle.  
 
It has been suggested that the individual who is unable to divide his attention will 
frequently forget part of the instructions (Fleming and Stewart 1998).  
 
A pupillary assessment and four specific tests are involved: The Walk and Turn 
Test;  The One leg Stand Test; The Finger to Nose Test; The Romberg Test.  
 
The pupillary assessment consists of a “measurement” of the eyes using a basic and 
unsophisticated hand-held gauge to assess whether constriction or dilation of the 
pupils is present with a range of 3.0 mm to 6.5 mm claimed by police officers as 
normal. This crude assessment permits at best an approximate estimation of pupil 
size in millimetres, is highly subjective, and prone to error. This is not reliable and 
should be contrasted for example with the practice of using a calibrated pupillometer 
and applying the Neurological Pupil index (NPi), which is an algorithm developed by 




The claim made that the normal pupil size lies within the range of 3.0 mm to 6.5 mm 
is open to question and is not supported by clinical textbooks or by peer-reviewed 
publications. No reference is made of the intensity of ambient light at the time of the 
pupillary measurement, which is known to affect the natural physiological response 
in pupil size. It is accepted beyond dispute that “normal” or natural pupil size will 
differ depending upon the degree of ambient light present, with pupillary constriction 
occurring automatically in bright direct light, and pupillary dilation occurring in dark 
environments. No peer-reviewed publications have endorsed this suggested “normal” 
range in pupil size of 3.0 mm to 6.5 mm, and virtually all academic studies have 
measured pupil size in healthy normal volunteers under varying light conditions 
(Winn et al 1994; Witting and Goyal 2003; Twa et al. 2004). 
 
A further valid criticism of this alleged “normal” range of pupillary size relates to the 
lack of consideration for the normal physiological reduction in pupil size, which 
occurs with increasing age, both in light and dark conditions (Birren et al. 1950).  
 
Most relevantly however, a specific study was undertaken to determine normative 
values and ranges for pupillary responses using the specific DEC programme 
protocols for pupil testing in non-impaired subjects, and also to appraise the 
suitability of the 3.0 to 6.5 mm pupil range as a potential sign of impairment under 
three separate lighting conditions (Richman et al. 2004). 250 healthy volunteers who 
had no visual or neurological problems were studied and the study authors (Richman 
et al. 2004) reported – 




The Walk and Turn test involves the subject standing in a fixed position with one 
foot in front of the other while listening to 9 separate instructions and two questions 
prior to starting the test. The subject must walk and count out nine steps heel-to-toe 
in a straight line, turn by pivoting on his left foot, and walk nine heel-to-toe steps 
back without swaying, stopping, stumbling, using his arms for balance, taking too 
few or too many steps, or walking in other than a straight line. The relevant “clues”, 
or indicators of impairment, displayed during the walk and turn test include 
observing the individual who stops walking, misses heel/toe, raises arms, steps off 
the line, does not turn as instructed and/or does not take nine steps in each direction, 
and if the individual does not count out loud as instructed.  
            The One Leg Stand test involves the subject standing with heels together, arms at 
sides, one leg raised 6 inches off the ground with the foot parallel to the floor, 
holding that position whilst counting for 30 seconds without swaying, or using arms 
for balance, or putting the foot down. A “clue” is displayed if, during the test, the 
individual sways, hops, puts a foot down, and/or raises his/her arms, or does not 
count as instructed.  
            The Romberg test assesses the ability of the subject to stand with eyes closed and 
head tilted back and estimate the passage of 30 seconds. Temporal disintegration is 
regarded to be present if the subject under-estimates or over-estimates the time 
interval, with a period of 20 to 40 seconds regarded as within acceptable levels. A 
further “clue” is displayed if the driver sways, steps, raises their arm(s), raises their 





The Finger to Nose test assesses the body position awareness and requires the 
subject to stand with eyes closed and head tilted back and then to touch the tip of the 
nose with the tip of an outstretched finger in a specific sequence of left, right, left, 
right, right, left. During the finger to nose task a “clue” is displayed if the individual 
is unable to touch his/her nose as instructed and/or sways, steps, raises arms, raises 
head or opens eyes whilst standing. 
 
These tests are rigidly conducted without the slightest deviation in instruction and are 
assessed in an equally rigid manner with no scope for leeway in the procedure.  
 
The Scottish Police Training College describe the tests as follows –  
“The Preliminary Impairment Test (PIT) relatively simple to perform when sober, 
but sufficiently complex to divide the suspect’s attention. The PIT process is a 
systematic standardised method of examining a suspect to determine whether or not 
that person’s ability to drive is impaired. In reaching a conclusion as to whether a 
suspect’s ability to drive, is or is not impaired, is based on the overall results of the 
test and not on any one aspect.”    
 
The entire procedure which must be rigorously followed in every case is detailed 
fully in Appendix A. 
 
Current legal processes involved in assessing fitness to drive in a motorist suspected 
of being impaired through drugs are clearly outlined in legislation and have been 
outlined in diagrammatic form in the flowchart in Figure 1. These procedures are 
adopted in every case. Initially all drivers are required to provide a sample of breath 
analysed for alcohol content using a hand-held device and will then be processed 
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1.6.8. U.K. Guidance for Medical Assessment suspect drug drivers.  
A guideline regarding the clinical examination of a suspect drug-driver has been 
documented in the pro-forma issued by the Education and Research Department of 
the Association of Police Surgeons (Wall 2002) and this continues to be 
recommended by the Faculty of Forensic and Legal Medicine. The form is provided 
to assist the FME in determining whether a suspect driver “has a condition, which 
may be due to drink or drugs” and not necessarily due to “Impairment”.  
 
The form also reminds the police surgeon that in the UK the essential question 
required to be answered is - 
 
“Has the suspect driver clinical evidence of a condition which might be due to some 
drug?”  
 
It is not necessary for the doctor to determine “Impairment” or “Unfitness to drive”.  
 
1.6.9. Challenges in respect of the “Impairment” approach.  
The legal basis for appropriate prosecution of suspect “drug drivers” is the state of 
impairment and not simply the presence of any drug in the suspect driver. However 
in the U.K. to successfully prosecute a driver under Section 4 of the Road Traffic Act 
1988 it is necessary to establish a direct and causal link between - 
1) The observed abnormality in performance as recorded in the CTI indicating 
that the subject appeared to be under the influence of drugs based on 
observations of their behaviour and demeanour; or of their driving.  
2) The presence of the drug in the driver.  




Whilst it is not an essential pre-requisite of the Road Traffic Act, it might be 
desirable to have evidence of impaired driving since it has been recorded in the 
North Report (2010) cases have been rejected as –  
“In England and Wales some Magistrates and the CPS required evidence from the 
police that driving was impaired.” Also – “Magistrates insistence that evidence of 
impaired driving was required to convict.” 
 
 
It has been long acknowledged that most research based and clinically proven data 
known about alcohol and driving performance is not available for most drugs. A 
panel of experts reached a consensus concerning drug concentrations and driving 
impairment (Blanke et al. 1985) and reported - 
   
     “In order to establish that use of a drug results in impairment of driving skills, and to     
       justify a testing programme to respond to this hazard, certain facts must be 
available.  
 
1) The drug can be demonstrated in laboratory studies to produce a dose 
related impairment of skills, associated either with driving, or with related 
psychomotor functions.  
 
2) Concentrations of the drug and/or its metabolites in body fluids can be 
accurately and quantitatively measured and related to the degree of 
impairment produced.  
 
3) Such impairment is confirmed by actual highway experience.  
 
4) Simple tests such as can be done at the roadside by police officers with 
modest training can indicate the presence of such impairment to the 
satisfaction of the courts.  
 
5) A range of concentrations of the drug can be incorporated in laws relating to 
impaired driving as ipso facto evidence”.  
 
 
The panel concluded – 
 
           “These criteria have been met for alcohol. It is not certain they may be met for 




Beirness (2010) has identified the strengths and weaknesses of the Impairment 
approach and regarded – 
1) The strengths as the focus on the ability to drive safely, and the absence 
of the requirement for toxicological analysis of any type of sample. 
2) The weaknesses being that the clinical signs (manifestations) may be 
subtle and difficult to recognise; such clinical signs produced are not 
similar to alcohol; the clinical examination process was time consuming 
and required significant training.           
                                      
                                                      Mercier-Guyon (2010) has questioned whether best evidence might arise from 
clinical or behavioural signs, or indeed both. He queried the nature of impairment 
and suggested clinical signs of impairment in drivers following use of sedatives may 
be visible by experts, however signs were not always visible following use of 
stimulants. He stated the matter was further complicated when drivers had used both 
types of drugs in combination. He acknowledged the limitations of current clinical 
tests of impairment, particularly in relation to stimulant drugs, combinations of drugs 
and the new synthetic drugs recently being used and concluded that new “test 
batteries” should be proposed to detect drug related impairment of driving. 
  
Porath-Waller and Beirness (2010) questioned which signs might best assist the DRE 
to identify types of drugs used by drivers and suggested a compromise between the 
drug recognition expert (DRE); the drug evaluation and classification (DEC) 12 step 




Verstraete and Legrand (2010) reported on the effectiveness of FIT as a checklist for 
clinical signs of impairment and detection of drugs in saliva on 250 subjects 
comprising 50 drivers and 200 subjects attending a methadone clinic.  They reported  
“Most parameters did not correlate significantly with drug intake. The pupils test 
seemed to be the best predicting parameters, especially for amphetamine and THC. 
The signs were often observed when high drug concentrations were found in saliva, 
but in many cases with high saliva drug concentrations, no signs were observed. In 
general, the checklist (FIT) correlated badly with drug presence in this population of 
chronic drug users, but our results also confirm other studies that found the (FIT) 
checklists are not very sensitive.”  
 
It would thus appear reasonable to acknowledge the limitations of current CTI 
batteries and FIT/PIT in particular, in respect of stimulant drugs, combinations of 
stimulant and sedative drugs, and the new synthetic drugs, which have recently 
becoming available. This re-inforces the need for thorough evaluation of FIT and 




1.7. Monitoring the effectiveness of FIT.            
An independent report was commissioned by the DfT (Department for Transport) in 
an attempt to ascertain the effectiveness of Field Impairment Tests in identifying 
drugged drivers. Researchers from Glasgow University in Scotland conducted a 
detailed study and delivered their findings in the DfT Road Safety Research Report 
No. 63 - “Monitoring the Effectiveness of U.K. Field Impairment Tests” (Oliver et al. 
2006). The	  authors	  sought	  to monitor the effectiveness of the overall battery of tests; 




impaired through drug use and those not impaired or drug free. They endeavoured to 
achieve	   this	   by	   calculating	   the	   degree	   of	   “correct”	   assessment	   of	   “Impairment”	  
following	   use	   of	   FIT	  when	   correlated	   to	   the	   toxicological	   analysis	   of	   the	   samples	  
received.	   They	   also	   attempted	   to	   determine	   the	   degree	   of	   correct	   assessment	   of	  
“Non-­‐Impairment”	   in	   drivers	   assessed	   to	   have	   successfully	   completed	   FIT	   and	  
whose	  voluntary	  samples	  were	  analysed.	  	  
 
For the purpose of this particular study the police assessment of each individual 
driver’s performance of FIT was judged against an objective measure, which was the 
presence of drugs in any sample obtained. In drivers arrested the biological sample 
was blood however in those drivers who were adjudged to have performed 
appropriately in FIT the sample was saliva. The authors acknowledged that the 
detection of drugs in blood or saliva did not indicate impairment; however suggested 
that the presence of significant concentrations of drugs confirmed the presumption of 




Data for this project was collected from the eight Scottish police forces and 14 forces 
in England, Wales and Northern Ireland ending 30
th 
July 2003. In total 991 cases 
were reported and from these 334 cases were deemed suitable for inclusion in the 
evaluation process and the information was used to calculate –  
• the sensitivity (the proportion of true positive cases detected)  
• the specificity (the proportion of true negative cases detected)  





Moderate sensitivity (65%) and specificity (77%) and accuracy (66%) were recorded 
for FIT as a whole. Drugs were confirmed in 94% of all drivers judged to be 
impaired at the roadside and in whom the FME agreed there might be a condition due 
to the effects of a drug (i.e. positive predictive value).  
It was a finding of note however that of those classed as not impaired by the police 
only 29% were found to be drug free (i.e. poor negative predictive value).  
 
 
The study authors concluded - 
1. FIT as studied was an effective screening test to identify drugged drivers.   
2. Further development of FIT is necessary to improve the specificity and the 
negative predictive value of the tests. 
3. The high number of drug positive drivers classed as “Not Impaired” is a cause 
for concern. 
4. Further development of FIT is necessary and should include a control group of 
drug free individuals of varying ages such that “normal responses to the use of 




1.8.  Hypothesis and objectives of the thesis. 
The aim of this thesis is to investigate the validity of the current Field Impairment 
Tests (FIT) in relation to their stated function as indicators of impairment in driving 
ability due to the effects of recent drug use. The thesis has tested the overarching 
hypothesis – “Field Impairment Tests (FIT) are not reliable or valid indicators 





The specific questions in respect of FIT which the thesis will address are: 
1. Can FIT reliably identify or detect evidence of recent drug use in subjects? 
2. Can FIT be accepted as reliable and valid indicators of drug-related 
impairment in driving ability? 
 
In order to address these questions various research tools have been utilised and the 
results analysed. These include postal questionnaire surveys of three separate groups 
of forensic physicians (FPs) experienced in examining suspect “drug-drivers”. 
Detailed analysis of these surveys clearly indicates that a significant percentage of 
33% of FPs (p<0.0001). also known as forensic medical examiners (FMEs) consider 
FIT to be an inappropriate test battery for their stated purpose. 
 
More importantly however, the clinical research studies conducted on the three 
separate core groups, each of 100 subjects who were examined and assessed using 
FIT and also conventional psychomotor tests of alertness, balance and co-ordination, 
revealed a surprising percentage of individuals were unable to perform FIT 
satisfacorily despite being known to have been drug free for a period of at least 8 
hours prior to testing. These findings strongly support the hypothesis - “FIT are not 
reliable or valid indicators of drug-related impairment in driving ability”. 
 
In view of the findings of the research studies, an attempt has been made to develop a 
more appropriate and more sensitive clinical test battery or algorithm which would 
be more suitable and more reliable as a diagnostic indicator of drug-related 
impairment of driving. The proposed clinical test of impairment (CTI) battery is 




CHAPTER 2.  FIT Research Studies - methods and materials 
 
This chapter wil explain why the research procedures were considered to be both 
worthwhile and important. The aims and objectives, methods, results, and 
conclusions drawn as the research projects developed will be fully described.  
 
 
2.1. Background to UK Introduction of FIT - surveys 1 and 2. 
In January 1998 the UK Department of Environment Transport and the Regions 
(DETR) published findings of the first 15 months of a 3 year study into the incidence 
of drugs in road accident fatalities DETR which revealed there had been a total of 
619 road traffic fatalities in the U.K. and over 6% of these had tested positive for 
medicinal drugs, 18% for illicit drugs (mainly cannabis), and 34% for alcohol. 
Although the incidence of medicinal drugs had not significantly changed from the 
1985 - 1987 study it was noticeable that illicit drug use had increased six fold in 
percentage terms from 3% to 18% (Tunbridge, Keigan and James (2001). These 
results provoked government concerns and stimulated initiatives in an attempt to 
counteract the problems posed by “drug-drivers”.  
 
Strathclyde Police in Scotland had however, previously taken the initiative and in 
1997 had sent two officers to the United States to assess the training programmes for 
police officers in respect of the Drug Evaluation and Classification (DEC) 
programme and also the Drug Recognition Examiners (DREs) being used at that time 
in California. As a result of their experiences Fleming and Stewart (1998) produced a 
training package of Field Impairment Tests (FIT), which were in fact simply the   
Standardised Field Sobriety Tests (SFSTs) which had been used in California since 




Following discussions between the Association of Chief Police Officers (ACPO) FIT 
became the subject of a trial throughout the Strathclyde region in Scotland and six 
police areas in England over a 15 month period from early 1999. Following analysis 
of this pilot, which was perceived to be a success, a training course was established 
for police officers and FMEs in respect of the formal introduction of FIT.  
 
2.1.1. Overview of FIT – Initial demonstration and FME opinion. 
In June 2000, following conclusion of the pilot and prior to the introduction of FIT, 
Strathclyde Police invited me as a senior FME of some 20 years experience to attend 
a demonstration of FIT performed by police officers. Also in attendance were senior 
police officers and Procurators Fiscal. Following a full demonstration of FIT by 
police officers, comments were invited from the attendees and it became 
immediately evident that the senior police officers and the fiscals present considered 
the tests to be eminently suitable and voiced their approval heartily.  
The five components of FIT in the UK test battery are – 
• Pupillary examination  
• The Walk and turn test  
• The One leg stand test  
• The Romberg test 
• The Finger to nose test.  
 
Due partly to what I considered to be the over-complex nature of the tests and also to 
the rather stringent assessment of “clues” or “indicators” of impairment, I voiced my 
opinion regarding FIT which I considered to be unnecessarily difficult and physically 
onerous for certain individuals. I further advised that due to the complexity of the 




might have difficulty in understanding and remembering the instructions, thereby 
limiting their chances of completing the tests in a satisfactory manner. However my 
concerns were promptly dismissed by the police demonstrators who advised that 
these tests had been developed in the U.S.A. by “experts”. It was obvious to me that 
my concerns were not shared by any others and the consensus was that the proposed 
FIT was a welcome development to be used in the detection of “drug drivers”.  
 
 
2.1.2. Setting of FIT training day – Survey 1 and Preliminary hypothesis. 
In October 2000 Strathclyde Police arranged a full day training session on FIT for 
FMEs and 31 doctors attended. I had anticipated this event to be an opportunity to 
canvass the opinion of my colleagues regarding the suitability of FIT and had printed 
a brief questionnaire for them to complete at the end of the session (Appendix B).  
The doctors were requested to indicate their level of experience and whether or not 
they held a postgraduate qualification in forensic medicine. Following a full 
demonstration of the tests the attendees were divided into small groups and each 
doctor was individually subjected to all aspects of FIT. The majority of doctors 
managed the tests satisfactorily however most groups had at least one participant 
who had difficulty with the procedures and performed poorly and displayed evidence 
of the “clues” or “indicators” of impairment. At the conclusion of the training, a 
plenary session was held which 25 FMEs attended and expressed their views and a 
“straw poll” conducted revealed that only a slight majority of the doctors were 
entirely happy with the proposed tests and a sizeable percentage of FMEs expressed 
reservations. This was confirmed by the responses in the completed questionnaires 




concerns regarding FIT other experienced FMEs supported my opinion that FIT were 
not suitable as clinical tests of impairment of driving ability due to drugs.   
 
It is not disputed that FIT are tests of balance, co-ordination and to an extent 
cognitive awareness, however my hypothesis was, and is, straightforward –  
“FIT are not reliable or valid indicators of drug-related impairment of driving 
ability”.   
 
2.1.3. Postal questionnaire of FMEs in Strathclyde Police - survey 2. 
As a result of the responses from the FMEs, I was reassured that I was not a “lone 
dissenter” in respect of my concerns regarding FIT and I was encouraged to seek the 
opinion of all FMEs in Strathclyde (n = 101) and who represented the overwhelming 
majority of FMEs in Scotland who numbered approximately 130 in total. I requested 
and received from Strathclyde Police, a postal listing for all FMEs and in November 
2000 I posted identical questionnaires with a full description of the proposed FIT and 
a stamped addressed envelope, to all my colleagues in Strathclyde. This resulted in a 
reasonable if not entirely satisfactory response rate of 45%. I had, as before, asked 
the doctors to give their opinion on FIT, but also enquired as to their views on the 
“2nd examination” procedure used at that time for suspect drivers, and whether they 
felt an “Aggregate Clinical Score” might be of value. To further analyse the 
responses I asked, as previously, for the doctors to include any post-graduate 
qualifications held in forensic medicine, and finally to list their number of years 
experience as an FME.  
The results received from this wider survey were similar to those of survey 1 and this 




 FIT QUESTIONNAIRE - STRATHCLYDE FMEs - SURVEYS 1 AND 2.  
 
The purpose of this questionnaire is solely to gauge the consensus of opinion within 









1. Do you consider the tests as outlined and recommended to us for adoption as     
    standard procedures, are, or may be regarded as  - 
 
 
 (i) more difficult than they need to be?    YES / NO 
 




2. Walk & Turn Test: considering the test as outlined and the recommendation this  
     test is adopted as a matter of routine, are you –  
 
 (i)  happy to accept in full ?     YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 




3. One Leg Stand Test: considering the test as outlined and the recommendation  
    this test is adopted as a matter of routine, are you -  
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





4. Finger Nose Test: considering the test as outlined and the recommendation this  
    test is adopted as a matter of routine, are you – 
 
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





5. Romberg Test: considering the test as outlined and the recommendation this test  
 
    be adopted as a matter of routine, are you -   
 
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





6. Section 4 R.T.A.  2nd Examinations:  In previous years when a suspect driver 
was found to be impaired, Form F97 was completed with appropriate findings 
listed. The suspect driver was detained in custody for some 8 to 12 hours, then 
subsequently re-examined, almost always with the absence of previously noted 
signs of impairment. 
           
      Do you consider a second examination of suspect initially found impaired – 
 
 (i) Essential?              YES / NO 
 
 (ii) Worthwhile?   YES / NO 
 
 (iii) Worthless?    YES / NO 
 






7. Overall Assessment of impairment / lack of impairment : 
 
Do you feel there would be any merit in developing and adopting a procedure  
whereby clinical signs which may be consistent with impairment due to drugs, 




  Low score                 =   normal or no impairment. 
 
  Intermediate score   =   borderline or possible  impairment. 
 
  High score                =   definite impairment. 
 









How many years experience as a police surgeon do you have?   0 -  5  Years 
 
  6 - 10 Years 
 
11 - 20 Years 
 





Do you have a post grad qualification such as –   D.M.J. ? YES / NO 
 












2.2. Research project 3 – Aims and objectives.  
The purpose of the survey was to gain as widespread a view as possible of FMEs 
working throughout the UK in respect of their opinion on the suitability of FIT as 
appropriate or reliable indicators of impairment of driving ability due drugs.  
 
 
2.2.1. Research project 3 - methods and materials. 
Following approval from the Education and Research committee of the Association 
of Police Surgeons (APS) I contacted the secretary of the APS and received a full 
mailing list of all registered police surgeons / FMEs. With the benefit of financial 
assistance from the W.G. Johnston Memorial Trust Fund to cover printing and 
postage costs, I produced 960 questionnaires and posted these with enclosed stamp 
addressed envelopes to all members of the APS on the current mailing list.  
 
 
2.2.2. Modified design of survey 3.  
The questionnaire was re-designed in order to eliminate any possible question of 
bias, subliminal or otherwise, which was present in the initial two surveys. The 
FMEs were posed questions in respect of various aspects of FIT and asked to give 
their opinion not simply as a YES / NO response, however were invited to give their 
opinion in one of five possible responses as follows – much too easy; too easy; about 
right; too difficult; much too difficult. The FMEs thus had a far greater range of 
response and were obviously not restricted to a simple YES /NO response, and this 




were invited to provide comments on the tests in general and were asked specifically 
to give their opinion on the value of an “aggregate clinical score” and the potential 
benefit, if any, in a 2nd examination of suspect drivers. 
 
 
2.2.3. Timescale of survey 3. 
The questionnaires were posted in August 2002 and responses received between 
September and November 2002. Data was collected and analysed with the results 
submitted in time for a presentation to the 30th Annual Conference of the Association 




2.2.4. Results of survey 3. 
The surveys undertaken show that whilst the majority of FMEs felt that FIT were 
“about right” a significant percentage of well qualified and experienced doctors felt 
that FIT were too difficult and a small number felt that FIT were entirely unsuitable. 
It was also clear that the doctors with less experience were most satisfied with the 
tests whereas more experienced doctors had expressed concerns about FIT.   
 
   
2.2.5.  Statistical Analysis of Survey 3. 
 
All appropriate responses were collated and a basic preliminary analysis of the 
results was conducted. I received specialist help from Dr Linda Williams, Centre for 
Population Health Sciences, University of Edinburgh, who conducted detailed 




2.2.6. Hypothesis and questions in relation to surveys 1, 2 and 3. 
My principal hypothesis is that FIT are not reliable or valid indicators of drug-related 
impairment in driving ability. It is my submission that I am not a lone dissenter in 
this respect and having received evidence of other experienced FMEs’ concerns in 
relation to FIT, my questions are – 
 
1. Can FIT reliably detect and identify evidence of recent drug use in subjects? 
2. Can FIT be accepted as a reliable and valid indicator of drug-related 
impairment in driving ability? 
 
2.3. Research study groups A, B and C – overview, hypothesis and questions. 
Since my main hypothesis - which is that FIT are not reliable or valid indicators of 
drug-related impairment of driving ability - needed to be tested, it was my intention 
to apply FIT to specially selected groups known to be drug-free at the time of 
assessment to discover how these groups performed.  
 
This work is important because although there have been several studies in which 
subjects have been given measured doses of specific drugs and then subjected to FIT, 
no studies have been published in respect of FIT being applied to subjects known to 
be drug-free at the time of the assessment.  
The questions I wish to address in these specific study groups are – 
1. How do “normal” drug-free individuals perform on FIT? 
2. What percentage, if any, of drug-free individuals perform poorly on FIT? 
3. Which test(s), if any, cause difficulty in drug free subjects?  




2.3.1. Design of research studies 
I purposely selected my three specific study groups from persons who had been 
detained in custody for a period of at least 8 hours. My reasons were two-fold – 
 
(i) I wished to be certain that the subjects had taken no drugs in the previous 
8 hours. 
(ii) These particular core groups are similar in age and socio-economic 
background to persons regularly stopped by police as suspected of driving 
under the influence of drugs and required by police to participate in FIT. 
 
2.3.2. Ethical approval.   
Ethical approval was not required for these particular studies since all data used in 
the research was extracted from clinical records, which were reviewed following 
normal and routine audit of my clinical practice for the examination of detained 
prisoners. Prior to examination of all detainees it is, and always has been, my 
practice to receive valid and fully informed consent from the detainees who are of 
course my patients at the time of the examination. The clinical notes are retained in a 
confidential Forensic Medical Examination book however notwithstanding this, the 
patients have been anonymised and identifiable only by age and study number.  
 
 
2.3.3. Study settings. 
All subjects were examined within the confines of the medical examination suites of 
Strathclyde Police in “Q” division following their specific request to be seen and 




Hamilton, East Kilbride and Rutherglen which are situated in South Lanarkshire in 
Scotland and which cover a population of approximately 300,000.    
 
 
2.3.4. Time course of research studies. 
The study process was particularly long due to the slow progress made in the 
selection of suitable subjects who had been detained for 8 hours prior to the clinical 
examination. The study began in April 2007 and concluded in November 2011. 
 
 
2.3.5.  Method of subject recruitment - Inclusion criteria.  
Subjects were selected from detained prisoners who had requested medical attention. 
All detainees were known to have been in custody for at least 8 hours prior to the 
examination and this was confirmed by simply checking their custody records. They 
were selected and included into three distinct groups – 
 
 Group A. Detainees who claimed to be “in withdrawal” from the effects of     
                             illicit heroin abuse and had requested medication for relief of their  
                             symptoms. 
 
 Group B. Detainees who were in receipt of legally prescribed methadone and  
                            who required thorough medical assessment prior to administration  
                            of their methadone.  
 




2.3.6. Exclusion criteria. 
I excluded all detainees who appeared to be suffering from any of the following – 
• Intoxication due to alcohol 
• Intoxication due to drugs 
• Any acute physical injury 
• Any chronic locomotor disability 
• Any neurological condition 
• Any acute psychiatric disorder 
• Any acute medical problems 
• Any significant chronic health problems  
 
 
2.3.7. Clinical assessment and data collection. 
The clinical examinations conducted were thorough and incorporated the standard 
elements of clinical examination including – consent; history of presenting 
complaint; past medical history; recent health; drug history - both prescribed and 
illicit; clinical examination; diagnosis; treatment; and continuation of care plan. All 
patients were anonymised and identified by number and age. 
 
A detailed medical history was taken in order to ensure the absence of any exclusion 
criteria. The subjects were examined for evidence of recent injury and any significant 
deformities or abnormalities. The general appearance and demeanour of the patient 
was noted, and the conscious level and mental state was assessed. Clinical 
examination included an assessment of the speech in both manner and content. A 
cardiovascular assessment was performed with pulse, blood pressure and heart rate 
recorded and the skin was examined for colour, temperature and sweating. The eyes 




hyperaemia (bloodshot); nystagmus (flickering lateral eye movements or lack of 
smooth lateral eye movement); and lack of convergence. Reflexes and simple 
reaction time were assessed. FIT was conducted and finally a straightforward simple 
memory test was performed. A diagnosis was made in respect of the subject’s 
general condition and fitness for detention. Medical treatment by way of drug 
therapy, if necessary, was given and clear instructions for regular administration of 
medications were left with custody staff. Finally advice regarding the regularity of 
observations of the detainee was left in writing and signed, timed and dated.     
 
During the research study period I examined in excess of 2,000 detainees who 
claimed either addiction to heroin or receipt of legally prescribed methadone and the 
subjects chosen for this research represent a convenience sample. My personal 
experience, which is shared by the Faculty of Forensic and Legal Medicine, is that 
many drug dependent detainees who are addicted to heroin claim to be suffering 
from “withdrawals” immediately after their arrest and request urgent medical 
treatment. A difficulty facing the FME is that it is impossible for the clinician to 
know what substances the detainee might have taken immediately prior to their 
arrest, and such substances may not illustrate any immediate clinical effects. It can be 
a difficult clinical judgement to make regarding the level of drug substitution 
therapy, which would be both appropriate and safe to administer to the detainee. 
Many experienced FMEs regard it prudent to delay examination and treatment in 
these particular groups of patients for approximately 6 to 8 hours, to allow for a 
natural “drying out” period to minimise contamination from drugs used prior to 




It is important to acknowledge that despite being in custody for a period of 8 hours it 
is not possible to be certain that the detainees have not secreted drugs in a body 
cavity such as the rectum and have ingested psychoactive substances subsequent to 
their detention since body searches, when conducted by police and force support 
officers, involve only a visual inspection of the buttocks and anus, as opposed to an 
intimate body search involving examination of body cavities conducted by an FME 
in a hospital setting with full medical support and resuscitative facilities. 
 
Thorough handwritten medical records of all detainees examined in custody, whether 
included in the study or not, are recorded in the “Police Surgeon’s Examination 
Book” dated and timed at the individual examination and held by the Custody 
Officer. These records are essential to illustrate that an appropriate standard of 
medical care has been provided to the detainee, and also for any potential evidential 
purpose. These records were used to prospectively populate the database for this 
research, and in addition the patients gave their fully informed valid consent for the 
examination process, which is obtained as a matter of routine and normal procedure. 
 
The research subjects were allocated to group A, B or C depending on the nature of 
their request for medical care. Each of the subjects in each group was assessed by 
three separate methods -  
1) In strict accord with FIT procedures and using “clues” or “indicators” of 
impairment 
2) Using FIT but without reference to “clues” or “indicators”  




The data from the clinical assessments was collected and recorded in a standard 
Microsoft Excel package with each subject identified sequentially by number. 
 
Assessments were made on the basis of whether each subject could perform the tests 
satisfactorily – either YES or NO, and by the three separate methods. A satisfactory 
performance was marked YES and scored 1 whereas an unsatisfactory performance 
was marked NO was scored 0 in each individual case. I collected the gross scores for 





2.3.8. Statistical analysis. 
All results were collated and I conducted a basic preliminary analysis of the results. I 
received specialist help from Dr Linda Williams, Centre for Population Health 
Sciences, University of Edinburgh who conducted a detailed statistical analysis of 















CHAPTER 3.   Field Impairment Tests - Fit for purpose? Evidence from FMEs.  
 
3.1. Survey 1 – A survey of FMEs attending FIT training day. 
The objective of this small-scale survey was to determine the opinion of forensic 
medical examiners (FMEs) within Strathclyde Police who had attended a full day 
training session on Field Impairment Tests (FIT) in suspected drug-impaired drivers. 
31 FMEs attended the course and 25 FMEs remained for the final plenary session.  
 
3.1.1. Material and methods.  
The 25 FMEs who attended a full-day training programme and plenary session in 
respect of “Drugs and Driving and Impairment Tests” were asked to complete a 
questionnaire relating to the tests (2.1.3. and Appendix B). The doctors were asked 
demographic questions about their length of experience as FMEs; whether they held 
a postgraduate qualification in forensic medicine; and to indicate their level of 
satisfaction with the proposed FIT.  
  The FMEs were essentially asked if they approved of the tests in general -  
 Question 1. Are you happy to accept the tests as recommended?  YES / NO 
 Question2.   Are the tests more difficult than they need to be?     YES / NO 
 Question 3. Are the tests more harshly assessed than they need be?   YES / NO 
They were asked to consider each test individually. Finally the doctors were asked to 
indicate whether or not they approved of –  
(1) A 2nd examination several hours after the first examination for the purpose of 
comparing any change in performance, if detected (Appendix B Question 6). 
(2) An Aggregate Clinical Score, which might quantify the degree of clinical signs 




3.1.2.   Survey results and analysis.   
Of the 31 conference attendees, 25 FMEs completed the questionnaire with the 
responses recorded in tables 3.1 and  3.2.  
 
Question 1. In respect of whether the FMEs approved of the tests in general,  54% (n 
= 14) declared themselves happy to accept the tests, with 46% (n = 11) stating the 
tests were either too difficult and/or too harshly assessed. the Walk and Turn test had 
48% (n = 12) approval and 52% (n = 13) dissent.  The One Leg Stand test had 44% 
(n = 11) approval and 56% (n = 14) dissent. The Finger Nose test had 64% (n = 16) 
approval and 36% (n = 9) dissent. Similarly the Romberg test had 64% (n = 16) 
approval and 36% (n = 9) dissent.  
 
Question 2. In respect of the question whether or not the FMEs considered the tests 
more difficult than necessary, none of the 56% (n = 14) who had approved the tests 
considered them too difficult, whereas all 44% (n = 11) who had not approved the 
tests stated they were more difficult than necessary. 
 
  Question 3. In respect of the question whether or not the FMEs considered the tests 
more harshly assessed than necessary, none of the 56% (n = 14) who had approved 
the tests considered them too harshly assessed, whereas all 44% (n = 11) who had not 
approved the tests stated they were more harshly assessed than necessary.  
 
A 2nd examination procedure found favour with 96% (n = 24) with no support in 4% 
(n = 1). An “aggregate clinical score” system for a suspect driver was thought to be 





These responses were analysed further by virtue of assessing responses from doctors 
holding recognised qualifications in forensic medicine such as the diploma in 
Medical Jurisprudence (DMJ) or the diploma in Forensic Medicine (DFM) and 
comparing them to those of doctors without such qualifications. 
 
 
(i) Doctors without post graduate forensic qualifications (14)  
71% (n = 10) of doctors approved of FIT with 29% (n = 4) expressing reservations.  
The Walk and Turn test had 50% (n = 7) approval and 50% (n = 7) dissent.  
The One Leg Stand test had 50% (n = 7) approval and 50% (n = 7) dissent.  
The Finger Nose test had 71% (n = 10) approval with 29% (n = 4) dissent.  
The Romberg test had 79% (n = 11) approval and 21% (n = 4) dissent.  
A 2nd examination found favour in 100% (n = 14) with no dissenters.  
An “aggregate clinical score” was thought to be of value in 86% (n = 12) with 14% 
(n = 2) regarding it worthless. 
 
 
(ii) Doctors with post graduate forensic qualifications (11)  
36% (n = 4) of doctors approved of FIT with 64%  (n = 7) expressing reservations.  
The Walk and Turn test had 36% (n = 4) approval and 64% (n = 7) dissent.  
The One Leg Stand test had 27% (n = 3) approval and 73% (n = 8) dissent.  
The Finger Nose test had 64% (n = 7) approval with 36% (n = 4) dissent.  
The Romberg test had 45% (n = 5) approval and 55% (n = 6) dissent. 
 A 2nd examination found favour in 91% (n = 10) with 9% (n = 1) dissent.  
An aggregate clinical score was thought to be of value in 73% ( n = 8) with 27%  




Table 3.1. Survey 1. All responses received from FMEs.  
	   	  	  	  	  All	  responses	  	  
	  	  	  	  	  	  	  (n	  =	  25)	  
Without	  DMJ/DFM	  
	  	  	  	  	  	  	  	  	  	  	  (n	  =	  14)	  
With	  DMJ/DFM	  
	  	  	  	  	  	  	  	  (n	  =	  11)	  
Approval	  rate	  	   	  	  	  	  	  





Tests	  in	  general	   	  	  54%	  (n	  =14)	   	  	  	  	  	  71%	  (n	  =	  10)	   	  	  	  	  36%	  (n	  =	  4)	  
Walk	  &	  Turn	   	  48%	  (n	  =	  12)	   	  	  	  	  	  50%	  (n	  =	  7)	   	  	  	  	  36%	  (n	  =	  4)	  
One	  Leg	  Stand	   	  44%	  (n	  =	  11)	   	  	  	  	  	  50%	  (n	  =	  7)	   	  	  	  	  27%	  (n	  =	  3)	  
Finger	  -­‐	  Nose	  	   	  	  	  64%	  (n	  =	  16)	   	  	  	  	  71%	  (n	  =	  10)	   	  	  	  	  64%	  (n	  =	  7)	  
Romberg	   	  	  	  64%	  (n	  =	  16)	   	  	  	  	  79%	  (n	  =	  11)	   	  	  	  	  45%	  (n	  =	  5)	  
2nd	  Examination	   	  	  	  96%	  (n	  =	  24)	   	  	  	  100%	  (n	  =	  14)	   	  	  	  	  91%	  (n	  =	  10)	  
Aggregate	  score	   	  	  	  84%	  (n	  =	  21)	   	  	  	  	  86%	  (n	  =	  12)	   	  	  	  	  73%	  (n	  =	  8)	  
 
The responses were further analysed by assessing the responses from doctors split 
into groups depending on length of experience as practising police surgeons – less 
than 5 years; 6 to 10 years; 11 to 20 years; and 20 years plus. It is acknowledged 
however that increasing length of experience does not always correlate directly to 
increasing familiarity with examination of suspect “drug drivers” or indeed FIT. 
Table 3.2. Survey 1.Responses received from FMEs by experience.  
	   	  	  	  	  0	  –	  5	  years	  	  
	  	  	  (n	  =	  3)	  
6	  –	  10	  years	  
	  (n	  =	  7)	  
11	  –	  20	  years	  
	  	  	  	  (n	  =	  10)	  
	  20	  years	  plus	  
	  	  	  	  	  (n	  =	  5)	  	  
Approval	  rate	   	  	  	  	  	  






Tests	  in	  general	   	  67%	  	  	  (n	  =	  2)	   	  	  43%	  (n	  =	  3)	   	  50%	  (n	  =	  5)	   	  60%	  (n	  =	  3)	  
Walk	  &	  Turn	   	  100%	  (n	  =	  3)	   43%	  (n	  =	  3)	   	  50%	  (n	  =	  5)	   	  40%	  (n	  =	  2)	  
One	  Leg	  Stand	   	  67%	  	  	  (n	  =	  3)	   43%	  (n	  =	  3)	   	  50%	  (n	  =	  5)	   	  40%	  (n=	  2)	  
Finger	  -­‐	  Nose	  	   	  100%	  (n	  =	  3)	   71%	  (n	  =	  5)	   70%	  (n	  =	  7)	   	  60%	  (n	  =	  3)	  
Romberg	   	  100%	  (n	  =	  3)	   	  	  86%	  (n	  =	  6)	   	  60%	  (n	  =	  6)	   	  60%	  (n	  =	  3)	  
2nd	  Exam.	   100%	  (n	  =	  3)	   	  86%	  (n	  =	  6)	   	  90%	  (n	  =	  9)	   100%	  (n	  =	  5)	  









3.1.3. Summary and conclusions. 
The survey findings clearly indicated that only a slight majority of FMEs who had 
attended the training session and undertook FIT personally were content to fully 
accept FIT as proposed. The notable findings from this brief survey were –  
 
1. A significant percentage (46% n = 14) of FMEs did not approve FIT.  
2. A majority of FMEs (52% n = 13) disapproved of the Walk & Turn test. 
3. A majority of FMEs (56% n = 14) disapproved of the One Leg Stand test. 
4. FMEs with least experience showed highest level of approval for FIT. 
5. The majority of FMEs with postgraduate qualifications in forensic 
medicine disapproved of FIT (64% n = 7) whwereas the majority of 
FMEs without postgrad. qualifications  (71% n = 10) approved of FIT.  
6. A “2nd Examination” was approved by a majority (96% n =24) of FMEs. 
7. An “Aggregate Clinical Score” also received high (84% n = 21) approval. 
 
 
3.1.4. Limitations of survey 1. 
The main limitations of this survey were the low sample size of only 25 subjects, 
particularly the FMEs who had less than 5 years experience (n = 3),  and the specific 
wording of the questionnaire. However although the number of FMEs surveyed was 
small, this survey group had the benefit of being experienced forensic medical 
examiners who regularly examined suspect drivers and were entirely familiar with 
this process, but perhaps more importantly they had “first-hand” experience of FIT 





The specific wording of the questionnaire might reasonably be subject to criticism 
since the FMEs were invited only to give their opinion on whether they considered 
the tests “too difficult” or the assessment of FIT “too harsh”, when in the interest of 
fairness, they should also have been invited to state whether or not they considered 
the tests or the assessments “too easy” or not. This would have eliminated the 
question of any bias in the questionnaire, subliminal or otherwise. It is also accepted 
that the question regarding “approval” has the potential to bias the results.  
 
An explanation, which to an extent, might account for these shortcomings is that the 
training session and conference was arranged with little advanced notice given to the 
FMEs and the questionnaire was prepared in haste.   
 
 
3.2.  Survey 2 - A survey of all Strathclyde Police FMEs.  
The principal objective was to ascertain the opinion of FMEs working throughout the 
Strathclyde region in Scotland regarding FIT. This survey offered the possibility to 
canvass the opinion of a larger number of FMEs (n = 101) and compare their 
responses with those of survey 1. This survey was undertaken only a matter of two 
weeks after survey 1, and prior to me having any discussion regarding the findings 
with my experineced colleagues in other areas of the United Kingdom. Having 
composed the questionnaire personally, I was unaware of the limitations of the 
wording of the initial survey and replicated it exactly in survey 2 such that the wider 
study might be analysed and the results compared on a “like for like” basis with the 





3.2.1. Material and methods. 
The Police Surgeon Co-ordinator of Strathclyde Police was approached and given a 
full explanation of the proposed questionnaire survey and the reasons for undertaking 
the project. After a detailed discussion and following the specific request, the names 
and addresses of all FMEs who provided forensic medical services to Strathclyde 
Police were released.  
 
An identical questionnaire to that of survey 1 (see 2.1.3. and Appendix B), and a 
stamped addressed envelope was posted to all 101 FMEs on the Strathclyde Police 
database.  
 
As before, the doctors were asked demographic questions about their length of 
experience as FMEs; whether they held a postgraduate qualification in forensic 
medicine. 
 




3.2.2. Survey 2 – results and analysis. 
The survey yielded a moderate 45% response rate (n = 45) and the results were 
analysed in a similar manner to survey 1. The results of this survey were very similar 
to those of survey 1 with 52% (n = 23) declaring their approval of the tests in 
general, as compared to 54% (n = 14) of respondees in survey 1 (Table 3.3).  
It is acknowledged that, as for survey 1, this was a qualitative analysis as opposed to 




Question 1. The findings were intriguing and somewhat anomalous in that although 
a very small majority 52% (n = 23) of the FMEs stated their approval of the tests in 
general, when they considered each test individually no single tests at all was 
approved by the majority of respondees. The Walk and Turn test and the One Leg 
Stand test had identical and low levels of approval of 35% (n = 16), whereas the 
Romberg and Finger Nose tests found a higher level of approval of 47% (n = 21) and 
49% (n = 22) respectively. 
 
 
Question 2. In respect of the question whether or not the FMEs considered the tests 
more difficult than necessary, once again the findings were somewhat contradictory 
in that 8 of the 23 FMEs who stated their approval of the tests felt at least one of the 
tests was too difficult and 6 of the 23 FMEs felt two tests were too difficult. Less 
surprisingly, all FMEs who disapproved of the tests considered both the One Leg 
Stand and the Walk and Turn tests too difficult.  
 
 
Question 3. In respect of the question whether or not the FMEs considered the tests 
more harshly assessed than necessary, the 8 FMEs who had approved the tests in 
general but had considered at least one test too difficult, had also considered them 
too harshly assessed. whereas all FMEs who had not approved of the tests stated they 





A 2nd examination procedure found favour with 87% (n = 39) of postal respondees 
and an “Aggregate Clinical Score” system for a suspect driver was thought to be of 
value in 78% (n = 35). 
 
 
As before, the responses were analysed further by virtue of assessing responses from 
doctors holding recognised qualifications in forensic medicine such as the diploma in 
Medical Jurisprudence (DMJ) or the diploma in Forensic Medicine (DFM) and 




Table 3.3. Survey 2. All responses received from FMEs.  
 
	   	  	  	  	  All	  responses	  	  
	  	  	  	  	  	  	  (n	  =	  45)	  
Without	  DMJ/DFM	  
	  	  	  	  	  	  	  	  	  	  	  (n	  =	  27)	  
With	  DMJ/DFM	  
	  	  	  	  	  	  	  	  (n	  =	  18)	  
Approval	  rate	  	   	  	  	  	  	  





Tests	  in	  general	   	  	  52%	  (n	  =23)	   	  	  	  	  	  55%	  (n	  =	  15)	   	  	  	  	  42%	  (n	  =	  8)	  
Walk	  &	  Turn	   	  35%	  (n	  =	  16)	   	  	  	  	  	  40%	  (n	  =	  11)	   	  	  	  	  28%	  (n	  =	  5)	  
One	  Leg	  Stand	   	  35%	  (n	  =	  16)	   	  	  	  	  	  44%	  (n	  =	  12)	   	  	  	  	  22%	  (n	  =	  4)	  
Finger	  -­‐	  Nose	  	   	  	  	  49%	  (n	  =	  22)	   	  	  	  	  	  52%	  (n	  =	  14)	   	  	  	  	  44%	  (n	  =	  8)	  
Romberg	   	  	  	  47%	  (n	  =	  21)	   	  	  	  	  	  52%	  (n	  =	  14)	   	  	  	  	  39%	  (n	  =	  7)	  
2nd	  Examination	   	  	  	  91%	  (n	  =	  41)	   	  	  	  	  	  89%	  (n	  =	  24)	   	  	  	  	  94%	  (n	  =	  17)	  












3.2.3. Survey 2 – summary and conclusions. 
Several findings were clearly noted: 
(1) The responses from FMEs in survey 2 were similar to those of survey 1. 
(2) Only a very slight majority of FMEs (52% n = 23) approved of the tests 
whereas 48% considered them either too difficult or too harshly assessed.  
(3) More than 50% of all FMEs had concerns in every test, with 67% (n = 30) 
of FMEs expressing concern with Walk & Turn and 1 Leg Stand Tests.  
(4) FMEs who held a post-graduate qualification in forensic medicine had a 
lower approval rate for FIT (42% n = 19) compared to FMEs who had no 
post-graduate qualifications and approved tests (56% n = 25). 
(5) The majority of FMEs with post-graduate qualifications (58% n = 10) 
disapproved of the tests with the One Leg Stand test being criticised by 
78% (n = 14) and the Walk and Turn test criticised by 72% (n = 13). 
(6) The proposal of a 2nd examination of suspect drivers was considered to be 
of value by an overwhelming majority (91% n = 41) of all FMEs. 
(7) An “Aggregate Clinical Score” was also approved by a large majority 
(75% n = 34) of all FMEs. 
 
3.2.4. Limitations of survey 2. 
This survey was conducted very shortly after survey 1 was completed and similar 
criticism may be levelled due to the small number of responses analysed as a result 
of the poor response rate of FMEs who completed and returned the questionnaire.  
Since the questionnaire was identical in format to survey 1, yet again the specific 




3.3. Survey 3 - A survey of the Association of Police Surgeons (APS).  
This was a major survey of 960 FMEs who were members of the Association of 
Police Surgeons of Great Britain and who provided forensic medical services to all 
police forces throughout the UK.  
The aims and objectives of the study were as outlined below - 
1) To discover the opinion of FMEs in relation to FIT in general. 
2) To gauge overall opinion as to how difficult or easy the FMEs 
considered FIT to be for suspect drivers. 
3) To consider the degree of difficulty in each of the 4 tests. 
4) To gauge opinion regarding the “indicators” or “clues”. 
5) To assess opinion as to the value of an “aggregate clinical score”. 
6) To receive specific comments relating to FIT. 
 
3.3.1. Materials and methods. 
A postal survey was conducted among 960 registered members of the Association of 
Police Surgeons of Great Britain with a view to canvassing their opinion of FIT. Of 
the 960 questionnaires circulated to members of APS, 539 were returned, yielding a 
56.2% response rate. Of these, 159 responses were excluded since the FMEs were 
not regularly involved in general police work due to their status as - Sexual Offence 
Examiners (n = 57); retired (n = 57); “unknown at current address” (n = 16); resigned 
(n = 15); forensic odontologists (n = 5); forensic pathologists (n = 3); infrequent 
practice (n = 3), deceased (n = 3). This resulted in 380 doctors who were regularly 
involved in the examination of suspect “drug-drivers” who completed the 




The doctors were asked to indicate their level of experience according to the 
following groups; 0 - 5 years; 6 - 10 years; 11 - 20 years; and 20 plus years. They 
were asked to indicate whether or not they held a postgraduate qualification in 
forensic medicine such as the Diploma in Medical Jurisprudence or the Diploma in 
Forensic Medicine (Table 3.4). The doctors were asked how difficult they considered 
the impairment tests to be for the arrested drivers to perform (Table 3.5). They were 
also asked their opinion of the standards for assessing the tests, i.e. the criteria or 
“clues” which might indicate impairment (Table 3.7). The doctors were asked to 
consider each test individually, such that any significant variations, if found, could be 
related to individual tests (Tables 3.9; 3.11; 3.13; 3.15). Finally the doctors were 
asked their opinion of an “Aggregate Clinical Score” in relation to the clinical 
findings (Table 3.17) and were invited to offer any further comments.  
 
In order to address the limitations of the previous surveys the format of the questions 
was changed. The FMEs were invited to encircle one of the following responses –  
     much too easy;    too easy;    about right;   too difficult;   much too difficult  
 
Completed questionnaires were received from the following groups – 
 
Table 3.4. Survey 3. Responses received from all FMEs. 
Years	  experience	   With	  DMJ/DFM.	   Without	  DMJ/DFM	   	  	  	  	  	  Total	  	  
	  	  	  	  	  	  0	  to	  5	  years	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9	   	  	  	  	  	  	  	  	  	  	  	  	  	  50	   	  	  	  	  	  	  	  59	  
	  	  	  	  	  	  6	  to	  10	  years	   	  	  	  	  	  	  	  	  	  	  	  	  	  30	   	  	  	  	  	  	  	  	  	  	  	  	  	  72	   	  	  	  	  	  102	  
	  	  	  	  11	  to	  20	  years	   	  	  	  	  	  	  	  	  	  	  	  	  	  41	   	  	  	  	  	  	  	  	  	  	  	  	  	  99	   	  	  	  	  	  140	  
	  	  	  	  20	  plus	  years	   	  	  	  	  	  	  	  	  	  	  	  	  	  28	   	  	  	  	  	  	  	  	  	  	  	  	  	  51	   	  	  	  	  	  	  	  79	  



























3.3.2. Survey 3 - results and analysis.  
Table 3.5. Question 1. How difficult are the tests in general are for drivers to perform? 
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
374/380 1  16 234 116 7 
  98.4%  0.3%  4.3% 62.6% 31% 1.9% 
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
0 -5      (n = 59) 0  6 (10%) 43 (72.9%) 10 (16.9%) 0 
6 -10    (n = 101) 0  3 (3%) 67 (66.3%) 29 (28.7%) 2 (2%) 
11- 20  (n = 136) 0  5 (3.7%) 82 (60.3%) 45 (33.1%) 4 (2.9%)  
20 plus (n = 78)  1 (1.3%)  2 (2.6%) 42 (53.8%) 32 (41%) 1 (1.3%) 
 















Much	  too	  easy	   Too	  easy	   About	  right	   Too	  difUicult	   Much	  too	  difUicult	  











Much	  Too	  Easy	   Too	  Easy	   About	  Right	   Too	  DifUicult	   Much	  Too	  DifUicult	  
How difficult do you think the tests in general are for suspect drivers to 
perform? 




  Question 1: FME Responses - overall. 
 
The ‘about right’ category of response has been excluded as being uninformative, 
and the balance of responses on either side has been investigated. It is found then that 
there is a statistically significant lean towards ‘too difficult’ (including ‘much too 
difficult’) when compared with ‘too easy’ (including ‘much too easy’). These 
categories have been collapsed together due to very small numbers in the ‘much too’ 
categories. Thus, there is 17 in one category and 123 in the other. On the assumption 
of a binomial distribution with an expected event probability of 0.5, the chance of 
randomly dividing 140 people into two groups and ending up with 17 in one and 123 
in another is exceedingly small (p<0.0001). 
   
 
Table 3.6. Question 1: FME responses - By experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 response 
    Total too easy about right too hard 
experience 0-5 years 6 43 10 59 
6-10 years 3 67 31 101 
11-20 years 5 82 49 136 
20+ years 3 42 33 78 
Total 17 234 123 374 
 
 
Table 3.6 shows that by simple χ2 test of association, there is evidence to suggest that 
the distribution of responses is not independent of experience (p=0.025). However, if 
the χ2 test is applied for trend, where it is suspected that there is a linear relationship 
between response and experience, then p=0.001.  
 
Looking at table 3.6, it would appear that less experienced responders are more likely 
to choose ‘too easy’ or ‘about right’, while the most experienced are more likely to 
choose ‘too hard’. To demonstrate this effect, taking the proportion of ‘too hard’ in 
each experience group, we get 17%, 31%, 36% and 42% of responders in each 




Table 3.7. Question 2. What is your opinion of the standards for assessing the tests?  
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
368/380 3 23 221 110 11 
   96.8% 0.8% 6.3% 60% 30% 3% 
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
0 -5       (n = 58) 0 3 (5.2%) 41 (70.7%) 14 (24.1%) 0 
6 – 10    (n = 101) 0 8 (7.9%) 63 (62.4%) 26 (25.7%) 4 (4%) 
11 - 20  (n = 134) 1 (0.7%) 9 (6.7%) 78 (58.1%) 42 (31.3%) 4 (2.9%)  





















Much	  too	  easy	   Too	  easy	   About	  right	   Too	  difUicult	   Much	  too	  difUicult	  










Much	  Too	  Easy	   Too	  Easy	   About	  Right	   Too	  DifUicult	   Much	  Too	  DifUicult	  
What	  is	  your	  opinion	  of	  the	  standards	  for	  assessing	  the	  tests	  in	  general?	  




Question 2: FME responses - overall. 
 
As with the question 1 the ‘about right’ category has been disregarded as 
uninformative and the responses either side have been analysed. It is found again that 
there is a statistically significant lean towards ‘too difficult’ (including ‘much too 
difficult’) when compared with ‘too easy’ (including ‘much too easy’) with the group 








Table 3.8. Question 2: FME responses - by experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 
 response 
Total too easy about right too hard 
experience 0-5 years 3 41 14 58 
6-10 years 8 63 30 101 
11-20 years 10 78 46 134 
20+ years 5 39 31 75 




Table 3.8 shows by both χ2 test of association (p=0.44) and χ2 test for trend (p=0.09), 
there is no evidence to suggest that there is a significant association between 





Table 3.9. Question 3: What is your opinion of the Walk & Turn Test? 
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
379/380 3 24 221 122 9 
  99.2% 0.8% 6.4% 58.1% 32.4% 2.4% 
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
0 - 5      (n = 59) 2 (3.4%) 5 (8.5%) 35 (59.3%) 16 (27.1%) 1 (1.7%) 
6 -10     (n = 102) 0 5 (4.9%) 69 (67.6%) 25 (24.5%) 3 (2.9%) 
11-20    (n = 140) 0 7 (5%) 81 (57.9%) 50 (35.7%) 2 (1.4%)  
20 plus  (n = 78) 1 (1.3%) 7 (9%) 36 (46.2%) 31 (39.7%) 3 (3.8%) 
 
 
















Much	  too	  easy	   Too	  easy	   About	  right	   Too	  difUicult	   Much	  too	  difUicult	  










Much	  Too	  Easy	   Too	  Easy	   About	  Right	   Too	  DifUicult	   Much	  Too	  
DifUicult	  
What	  is	  your	  opinion	  of	  the	  Walk	  &	  Turn	  Test?	  




Question 3: FME responses - overall. 
 
As with the previous questions the ‘about right’ category has been disregarded as 
uninformative and the responses either side have been analysed. It is found again that 
there is a statistically significant lean towards ‘too difficult’ (including ‘much too 
difficult’) when compared with ‘too easy’ (including ‘much too easy’) with the group 








Table 3.10. Question 3: FME responses – by experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 
 response 
Total too easy about right too hard 
experience 0-5 years 7 35 17 59 
6-10 years 5 69 28 102 
11-20 years 7 81 52 140 
20+ years 8 36 34 78 
Total 27 221 131 379 
 
 
 Table 3.10 shows that by the χ2 test of association, there is borderline evidence to 
suggest an association between response and experience (p=0.06).  
 








Table 3.11. Question 4: What is your opinion of the One Leg Stand Test? 
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult  
379/380 1 15 198 155 10  
  99.7% 0.3% 4.0% 52.5% 40.6% 2.6%  
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult  
0 -5       (n = 58) 0 4 (6.9%) 32 (55.2%) 20 (34.5%) 2 (3.4%)  
6 -10     (n = 102) 0 3 (2.9%) 59 (57.8%) 38 (37.3%) 2 (2%)  
11- 20   (n = 140) 1 (0.7%) 4 (2.9%) 70 (50%) 62 (44.3%) 3 (2.1%)  
20 plus  (n = 79) 0 4 (5.1%) 37 (46.8%) 35 (44.3%) 3 (3.8%)  
 
 
















Much	  too	  easy	   Too	  easy	   About	  right	   Too	  difUicult	   Much	  too	  difUicult	  








Much	  Too	  Easy	   Too	  Easy	   About	  Right	   Too	  DifUicult	   Much	  Too	  DifUicult	  
What	  is	  your	  opinion	  of	  the	  One	  Leg	  Stand	  Test?	  




Question 4: FME responses - overall. 
 
As with the previous questions the ‘about right’ category has been disregarded as 
uninformative and the responses either side have been analysed. It is found again that 
there is a statistically significant lean towards ‘too difficult’ (including ‘much too 
difficult’) when compared with ‘too easy’ (including ‘much too easy’) with the group 





Table 3.12. Question 4: FME responses – by experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 
 Response 
Total too easy about right too hard 
Experience 0-5 years 4 32 22 58 
6-10 years 4 59 40 103 
11-20 years 5 70 65 140 
20+ years 4 37 38 79 
Total 17 198 165 380 
 
 
Table 3.12 shows there is no evidence to suggest an association between experience 














Table 3.13. Question 5: What is your opinion of the Finger Nose Test? 
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
378/380 3 50 285 38 2  
  99.5% 0.8% 13.2% 75.4% 10.1% 0.5%  
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult  
0 - 5      (n = 59) 0 12 (20.3%) 43 (72.9%) 4 (6.8%) 0  
6 - 10    (n = 102) 0 14 (13.7%) 79 (77.5%) 8 (7.8%) 1 (1%)  
11 – 20  (n = 140) 2 (1.4%) 19 (13.6%) 101 (72.1%) 18 (12.9%) 0  
20 plus  (n = 77) 1 (1.3%) 5 (6.5%) 62 (80.5%) 8 (10.4%) 1 (1.3%)  
 
 

















Much	  too	  easy	   Too	  easy	   About	  right	   Too	  difUicult	   Much	  too	  difUicult	  











Much	  Too	  Easy	   Too	  Easy	   About	  Right	   Too	  DifUicult	   Much	  Too	  DifUicult	  
What is your opinion of the Finger Nose Test? 




Question 5: FME responses - overall. 
 
As with the previous questions the ‘about right’ category has been disregarded as 
uninformative and the responses either side have been analysed.  
 
For this test, the balance between ‘too easy’ and ‘too difficult’ is not significantly 







Table 3.14. Question 5: FME responses – by experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 
 Response 
Total too easy about right too hard 
Experience 0-5 years 12 43 4 59 
6-10 years 14 79 9 102 
11-20 years 21 101 18 140 
20+ years 6 62 9 77 
Total 53 285 40 378 
 
 
Table 3.14 shows that in this question there is no evidence to suggest an association 
between experience and response with the χ2 test of association (p=0.38), although 
there is some suggestion of a linear trend by the χ2 test for trend (p=0.04). The 









Table 3.15. Question 6: What is your opinion of the Romberg Test? 
 
No. of respondees Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
380/380 1 24 297 54 4 
  100% 0.3% 6.3% 77.9% 14.5% 1.1% 
Yrs Experience Much Too Easy Too Easy About Right Too Difficult Much Too Difficult 
0 - 5      (n = 59) 0 5 (8.5%) 49 (83.1%) 5 (8.5%) 0 
6 - 0      (n =102) 0 3 (2.9%) 83 (81.4%) 14 (13.7%) 2 (2%) 
11- 20   (n = 140) 1 (0.7%) 12 (8.6%) 101 (72.1%) 25 (17.9%) 1 (0.7%)  
20 plus (n = 79) 0 4 (5.1%) 64 (81%) 10 (12.7%) 1(1.3%) 
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Question 6: FME responses - overall. 
 
As with the previous questions the ‘about right’ category has been disregarded as 
uninformative and the responses either side have been analysed. It is found that there 
is a statistically significant lean towards ‘too difficult’ (including ‘much too 
difficult’) when compared with ‘too easy’ (including ‘much too easy’) with the group 






Table 3.16. Question 6: FME responses – by experience. 
Collapsing the groups either side of the ‘about right’ response yields the table below: 
 response 
Total too easy about right too hard 
experience 0-5 years 5 49 5 59 
6-10 years 3 83 16 102 
11-20 years 13 101 26 140 
20+ years 4 64 11 79 
Total 25 297 58 380 
 
Table 3.16 shows in this question there is no evidence to suggest an association 
between experience and response, either with the χ2 test of association (p=0.23) or χ2 












As indicated in Appendix B question 7 – the FMEs were asked if they considered 
there to be any merit in adopting a procedure whereby clinical signs which might be 
considered consistent with clinical impairment due to drugs, are individually scored 
and aggregated, resulting in a “grand total” or “aggregate clinical score”. 
 
The responses are listed diagrammatically above. 272 FMEs approved of an 
aggregate score; 83 FMEs disapproved; and 25 were uncertain.  
   
With the “don’t know” responses excluded, it is highly unlikely that the distribution 
between YES and NO is equal, given that these numbers (272 vs 83, p<0.0001).  
 
If the “don’t know” group are included with the no group, it is still unlikely that YES 
and NO are equal (p<0.0001). In conclusion, there are significantly more people 
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     Figure 3.16. Question 7.” FMEs with postgraduate qualifications and response to  










Table 3.17. Question 7: FME responses – by postgraduate experience. 
 
 DMJ DFM Total 
Yes 52 21 73 
No 20 6 26 
Don’t know 4 5 9 




There is no evidence to suggest that the proportions of each response are different for 































Table 3.18: Question 7: FME responses – by postgraduate experience. 
 
 
Table 3.18 shows that in terms of the simple χ2 test of association, there is some 
evidence to suggest that there is an association between the level of FME experience 
in forensic matters and answering ‘yes’ to the merit of an “aggregate clinical score” 
(p=0.047). However, this is not a trend (p=0.10). 
86.4%	  
66.7%	  












0-­‐5	  years	   6-­‐10	  years	   11-­‐20	  years	   20	  plus	  years	  
 
response 
Total Yes No 
experience 0-5 years 51 8 59 
6-10 years 68 34 102 
11-20 years 98 42 140 
20+ years 55 24 79 




3.3.3. Comments received from survey respondees. 
A notable feature in relation to the comments received from the doctors, was that less 
than 10% of doctors who considered the tests “about right” provided any written 
comments on the tests, in contrast to the doctors who considered tests “more 
difficult” and “much more difficult” where comments were received from 90% and 
100% respectively. Only one FME who considered the tests “too easy” provided a 
suggestion, which was that the One Leg Stand test should be performed blindfolded. 
 
The following are a sample of the comments received and are exactly as submitted 
by the FMEs – 
 
Ø “The tests are not relevant to the driving act. Failure to pass the tests does 
not equate to impairment of driving ability.”  
Ø “These tests are essentially tests for ataxia with an added cognitive aspect.”  
Ø “There are naturally clumsy people who cannot pass the tests particularly if 
anxious.”  
Ø “Some groups (low IQ) will not be able to understand and follow such 
complicated instructions. Normal people may also have difficulty, if 
anxious.”  
Ø “The tests are too difficult even in non-intoxicated circumstances.”  
Ø “What we really need is a protocol of tests which assess concentration, co-
ordination and reaction time.” 
Ø “The tests are over-elaborate and over-complicated.”  
Ø “The tests are about right but the “marking” is much too harsh.”  




Ø “These tests have no relevance whatsoever to the safe driving of a motor 
vehicle and will not provide proof of drug-related impairment of driving. 
Tests more relevant to the tasks associated with safe driving are needed.” 
Ø “The tests have been validated for alcohol, NOT for drugs.”  
Ø “These tests are irrelevant and meaningless, not to mention unfair.” 
Ø “What results does the normal non drugged population have when tested?”  
Ø “Courts might find it easier to relate to a score system as suggested.”  
Ø “Videoing these tests would give the court more idea of impairment.”  
Ø “Helpful in court to have some kind of scoring measurement system.”  
Ø “These tests have not been validated for normal values, or for age.”  
 
Perhaps the most reasoned comments regarding the tests were –  
 
Ø “I do not believe there is sufficient clinical or scientific correlation between 
the ability to perform these tests and the ability to drive. There is also not 
sufficient correlation between the ability to perform the tests and the possible 
effects or side effects of specific drug use.” (Irvine 2002). 
Ø “These tests have an academic structure and a non-medical experimental 
appearance that renders them wholly inappropriate for any field test 
conducted by a lay (i.e. non-medical trained) individual. They lack any form 
of sensitivity in application and any interpretive element is missing. In the 
field, i.e. when applied as planned, they fail to recognise the physiological 
stress, which exists within the subject, which, if not accounted for, renders 
them UTTERLY USELESS in clinical terms for any form of evaluation. 
There is also no adequate means of assessing if other reasons exist medically 




3.3.4. Survey 3 – Summary and conclusions. 
 
The results of this survey clearly indicate that – 
 
(1) The majority of FMEs (63% n = 234) considered the tests “about right” but a 
significant group of 33% (n = 123) of FMEs (p<0.0001) thought the tests “too 
difficult, whereas only 4.6% (n = 17) thought the tests “too easy”. 
(2) The majority of doctors (56%) considered at least one test “too difficult”.  
 
(3) Statistical analysis indicates that there is a statistical lean towards “too 
difficult” when compared to “too easy” in all questions relating to FIT with 
the exception of question 5 the Finger Nose test.  
(4) Tests with the highest approval rate were the Romberg test (77.9%) and the 
Finger - Nose test (75.4%).  
(5) Tests with the lowest approval rate were the One Leg Stand and the Walk and 
Turn with 43% and 34.8% of FMEs considering them more difficult than 
appropriate.  
(6) The group of doctors with least experience (0 - 5 years) had the highest 
percentage (72.9%) of doctors who felt the tests “about right”.  
(7) The group of doctors with greatest experience (20 plus years) had the 
smallest percentage (53.8%) of doctors who felt the tests “about right”.  
(8) The percentage of doctors who supported the tests decreased in direct 
proportion to their level of experience.  
(9) An Aggregate Clinical Score found favour with the great majority of all 
doctors with between 66% and 70% throughout all ranges of experience 
however the least experienced group (0 - 5 years) most strongly supported 




3.3.5. Survey 3 - Summary of coments received from FMEs. 
It was a finding of note that the numbers of doctors who felt the tests to be “about 
right” decreased as their experience increased (Table 3.7). The question thus arises 
whether or not the doctors with the greatest experience as FMEs, and who probably 
had the greatest exposure to examination of suspect drivers and who were likely to 
be the oldest, had subconsciously allowed their own personal performances (on the 
tests) to influence their judgements on the suitability of the tests. 
 
Notwithstanding the above, the most common comments made by FMEs, from all 
experience levels, and irrespective of postgraduate qualifications were – 
 
(1) FIT were too difficult – even for “normal” individuals.  
(2) FIT “clues” or “indicators” of impairment were too harsh.  
(3) FIT were complex tests of balance, co-ordination and memory but not 
of impairment in driving ability.  
(4) FIT had no relevance to the driving task. 
(5) FIT had been validated for alcohol but not for drug use. 
(6) FIT involved too many instructions to be easily remembered.    
 
These responses, and in particular the comments received from the FMEs, reinforced 
my conviction that I had not been wrong in criticising FIT at their initial presentation 
by Strathclyde Police in June 2000 prior to their introduction under the Railways and 
Transport Safety Act 2003. The responses and comments received encouraged me to 
develop the independent study of drug-free individuals in study groups A, B and C 




3.3.6.  Discussion of FIT in respect of responses to surveys 1, 2 and 3. 
  
It is accepted that the introduction of a standardised clinical test battery which FMEs 
can adopt such that all suspect “drug-drivers” are assessed uniformly, professionally 
and fairly would be both welcome and desirable. The general objectives of the 
standardised Field Impairment Tests (FIT) should be welcomed in principle however 
the tests must be clearly seen to achieve their purpose – to test and accurately 
identify drug related impairment of driving skills in drivers. However several 
questions must be asked regarding FIT. 
 
1.  Can FIT reliably identify or detect evidence of recent drug use in subjects? 
2.  Can FIT reliably identify or detect impairment in driving ability? 
3.  Can FIT be accepted as reliable and valid indicators of drug-related 
impairment in driving ability? 
 
Early studies (Burns and Adler 1995), which suggested these tests accurately indicate 
impairment due to drugs in a high percentage of cases, remain to be confirmed. 
Indeed controlled trials when toxicology assays were taken, before and during these 
tests conducted by Drug Recognition Experts, have clearly shown when cases 
involving alcohol are excluded, the accuracy level has fallen to 32% - 44% (Wall and 
Karch 2000).      
 
It must also be noted, in these previously claimed “highly accurate tests” (Burns & 
Adler 1995; Stuster & Burns 1998) the suspect drivers were all questioned in detail 




to an opinion being given. This knowledge of recent drug intake might have 
influenced the DRE, subconsciously or otherwise, in the decision making process. 
 
 
Notwithstanding the above, when we consider survey 3 it is clear that the majority of 
comments received from FMEs surveyed were negative in respect of FIT. Certain 
findings are notable from the returned questionnaires, particularly the high 
percentage of doctors who considered an “Aggregate Clinical Score” to be of value 
in the overall assessment of suspect “drug-drivers”.  
 
 
Certainly this concept has been successfully implemented in judicial processes 
relating to Incapacity Benefits within the Social Security (Incapacity for Work) 
(General) Regulations (1995). In these situations a claimant is examined by a 
medical practitioner for the presence of evidence of physical conditions which might 
restrict their ability to perform “routine day to day” functions, for “mental” signs or 
symptoms which might have a disrupting effect to the extent their daily routine is 
significantly affected, or indeed for a combination of both. In these circumstances, 
points are awarded and an aggregate “score” is produced. Should the claimant amass 
a total of 15 points (physical, or physical + “mental”) or a total of 10 points on 
“mental” parameters alone, they are deemed to be incapacitated to the extent they are 
unfit for work and thereby entitled to Incapacity Benefits.   
 
 
Other recognised processes, which successfully apply this concept of aggregate 




• The Glasgow Coma Scale – (Jennett and Teasdale 1997) 
• The Mini Mental Scale  - (Folsten 1975)  
• The Revised Trauma Scale – (Champion 1989)   
 
All the above have been validated and their clinical value is beyond doubt. Adoption 
of an  “Aggregate Clinical Score” process might greatly enhance the efficacy of FIT. 
 
 
Tasks more directly related to the act of driving were suggested by some doctors, 
irrespective of their opinion on the current format of FIT. Several FMEs considered 
FIT were essentially tests for ataxia with an added cognitive element, however were 
by no means specific indicators of the ability to adequately and safely perform the 
driving task.  
 
 
Finally, several respondees suggested that a “2nd examination” several hours later, 
of a driver who had shown evidence of impairment thought to be due to the effects of 
a drug or drugs, would be useful for purposes of comparison. Any significant change 
in performance, particularly an improvement, might be considered corroborative 
evidence of the doctor’s opinion that the previously recorded evidence of 
“impairment” was due to the effects of some drug(s) whose effect had by then “worn 
off”. This suggestion would however carry financial implications for the police who 
would keep the driver in detention, but would also have implications in respect of the 
liberty of the individual concerned. While this proposal would be likley to clarify the 
question of drug-impaired driving in the individual concerned, both police and civil 




However in Scotland such a situation currently exists and has been thoroughly 
detailed (Wheatley 2000). This procedure was used for many years as a matter of 
routine by FMEs in Strathclyde Police when dealing with “drunk drivers” and the 
invariable improvement in performance in the 2nd examination was led by police as 
strong evidence that the poor performance in the initial tests had been due to alcohol 
intoxication, and that this intoxication  had “worn off” naturally by the time of the 
second examination.     
 
In conclusion, evidence from the surveys undertaken clearly indicates that a 
significant number of FMEs in the U.K. who are experienced in dealing with suspect 
“drug-drivers” have expressed concern regarding the suitability of FIT as reliable 
indicators of drug-related impairment of driving ability. 
 
 
3.3.7. Limitations of Survey 3. 
A great number of comments (100 plus) were received from FMEs who disapproved 
of FIT, however very few (less than 20) from FMEs who approved of FIT. It may be 
considered that those FMEs who provided comments were particularly strident in 
their opinion, however there is no evidence to suggest that this was the case. 
 
It may be considered that there is no direct correllation between length of years 
experience as an FME and the amount of experience examining suspect drug-drivers 
using FIT procedures, and this is acknowledged. Indeed this was one of the factors 
which was a stimulus for me, as a very experienced FME using FIT procedures to 




CHAPTER 4. Evaluation of drug-free detainees – How do they perform FIT? 
 
The validity of FIT has been questioned (Erwin 1995; Trocino 1997; Head 2001; 
Hartley 2001; Boyd 2002; Irvine 2002; Johnston and Ramsey 2003; Rubenzer 2008; 
FFLM in North 2010d; Stark 2010; Verstraete and Legrande 2010) and the ability of 
the tests to withstand challenge in court is a legitimate question which as yet, remains 
to be answered. Indeed the question of how drug-free individuals perform FIT is 
crucial when assessing their relevance as indicators of impairment of driving ability 
due to the effects of recent drug use.  
 
For this reason I have specifically chosen to apply FIT and also conventional tests of 
psychomotor function to three separate core groups who were known to have taken 
no drugs for a period of at least 8 hours prior to undertaking the Field Impairment 
Tests since  they had been detained in police custody for at least 8 hours prior to my 
examination (data are available in Appendices F; G and H). 
 
Group A were detainees who claimed to be addicted to heroin and who claimed  
suffering from “withdrawals”. 
 
Group B were detainees who had formerly been addicted to heroin but were now  
stabilised on legally prescribed methadone as substitution therapy.  
 






Group A: The majority of these subjects presented as unwell, showing evidence of 
physical and psychological distress, and exhibiting signs of multiple complaints 
including - sweating, tremors, muscle cramps and spasms, abdominal pains, 
diarrhoea, restlessness, anxiety, irritability, and agitation. Under test conditions, these 
clinical states had the potential to be both physically and mentally disabling, and to 
varying degrees, adversely affect the subjects’ ability to perform the tests.  
 
Group B: The majority of subjects presented as entirely well with no physical 
complaints or abnormal clinical signs. Although they had requested administration of 
their legally prescribed medication (methadone) upon which they were dependent, 
they showed no evidence at all, of either physical or mental distress, and this was 
entirely consistent  with the 24 hour action of methadone. It was clinically evident 
that these individuals were physically and psychologically comfortable and were not 
at all hindered by their medical condition in performing the tests. 
 
Group C: The majority of subjects presented as well, with no abnormal physical or 
pscyhological problems which might have hindered them in performing the tests.  
 
 
4.1.  Questions to be addressed in respect of FIT.  
The questions I wish to address in relation to study groups A; B; and C are – 
1. How well or how poorly do these drug-free individuals perform FIT? 
2. Which test(s), if any, cause difficulty in these drug free subjects?  





4.1.1. Study Group A: Detainees “in withdrawal” - Methods. 
Study Group A comprised 100 male detainees who had been in custody for at least 
8 hours and had requested medical attention due to their claimed addiction to heroin 
and who claimed to be suffering “withdrawal” effects. All subjects were examined 
within the confines of the medical examination suites of Strathclyde Police “Q” 
Division Lanarkshire following their request to be seen and treated by a doctor. 
Group A subjects aged from 18 years to 38 years with a median age of 27 years. 
 
Any detainee showing clinical evidence of any of the following was excluded - 
• Acute intoxication due to alcohol 
• Acute intoxication due to drugs 
• Acute physical injury 
• Chronic locomotor disability 
• Neurological condition 
• Acute psychiatric disorder 
• Acute medical problems 
• Significant chronic health problems  
 
A detailed medical history (appendix E) was taken in order to ensure the absence of 
any exclusion criteria. The subjects were then examined for evidence of recent injury 
and any significant deformities or abnormalities. Their general appearance and 
demeanour was noted, and conscious level and mental state were assessed. Clinical 
examination included an assessment of the speech in both manner and content. A 
cardiovascular assessment was performed with pulse, blood pressure and heart rate 
recorded and the skin examined for temperature and sweating. The eyes were 
examined with specific reference to pupil size and reaction to light; hyperaemia; 




Each of the subjects was assessed by three separate methods –  
1) In strict accord with FIT procedures and using “clues” or “indicators”.  
2) Using FIT but without reference to “clues” or “indicators”.  
3) Using conventional psychomotor tests.  
 
The conventional psychomotor tests included an assessment of reflexes and simple 
reaction time, with traditional straightforward tests of balance and co-ordination 
including standing with eyes closed, standing on one leg, walking in a straight line, 
and picking up small objects and placing them carefully in a specific manner as 
instructed. In addition a simple memory test was conducted with the subject simply 
asked to remember my name and repeat it when asked, at the end of the examination.    
 
The subjects were assessed and scored in respect of their performance on each test 
parameter – FIT; FIT minus “clues”; and conventional psychomotor tests. Initially 
the performance of each individual subject was studied on each of the four individual 
tests in FIT (Walk & Turn; One Leg Stand; Finger Nose; Romberg) on a “pass/fail” 
basis applying strict FIT criteria (appendix A). The same performance for that 
individual was then assessed using FIT minus “clues”, again on a “pass/fail” basis. 
Finally the performance of the same subject was assessed using conventional 
assessments of psychomotor function, which had been part of the general clinical 
examination. This process yielded the preliminary results, which can be used for 
comparison with those of subjects in groups B and C (Tables 4.1 and 4.4). 
 
 Subjects who completed the tests satisfactorily according to the test criteria were 




were scored zero. The scores were amalgamated for each group and all counts were 
scored out of 100. This allowed for more detailed analysis of the performance on 
individual tests and enabled more accurate interpretation of the findings. 
 
 
4.1.2. Study Group A - Results and preliminary analysis 




	  	  	  	  	  	  	  	  	  	  FIT	   	  	  FIT	  minus	  “clues”	   	  Conventional	  Tests	  
Walk	  &	  Turn	  	   	  	  	  	  	  	  	  	  	  	  27	   	  	  	  	  	  	  	  	  	  41	   	  	  	  	  	  	  	  	  	  88	  
One	  Leg	  Stand	   	  	  	  	  	  	  	  	  	  	  18	   	  	  	  	  	  	  	  	  	  28	   	  	  	  	  	  	  	  	  	  93	  
Finger	  Nose	   	  	  	  	  	  	  	  	  	  	  21	   	  	  	  	  	  	  	  	  94	   	  	  	  	  	  	  	  	  	  99	  
Romberg	   	  	  	  	  	  	  	  	  	  	  82	   	  	  	  	  	  	  	  	  96	   	  	  	  	  	  	  	  	  	  99	  
 
Table 4.1. shows that :- 
In general, group A subjects performed very poorly in FIT, and FIT minus “clues”, 
with the exception of the Romberg and Finger Nose tests. 
 
All subjects performed each test better when assessed without observation of “clues” 
or “indicators” of impairment, and better again when assessed using conventional 
psychomotor trests of balance and co-ordination.  
 
Using strict FIT criteria the One Leg Stand test and Walk and Turn caused the most 




Using strict FIT criteria, it was notable that the subjects had difficulty maintaining 
balance when standing prior to beginning the test, and also standing on one leg with 
foot raised and parallel to the floor, but only when required to look at the raised foot. 
 
Using strict FIT criteria the subjects appeared to be unable to fully remember the 
instructions in order to successfully complete the Walk and Turn, Finger-Nose, and 
One Leg stand tests.  
 
 Using strict FIT criteria the subjects who did not successfully complete the finger-
nose test had used the pad of the finger despite being told and reminded to use the 
tip. However this might not accurately reflect their ability to perform  the test. 
 
It was notable that many subjects presented as anxious, restless and agitated and 
exhibited a lack of patience throughout all of the examination processes.  
 
All subjects who failed to successfully perform the Romberg test estimated the 30 
second time interval in less than 20 seconds and this was consistent with their 
general impatience throughout the examination process.  
 
Although many of the subjects in group A presented as impatient, only those who 







4.2.1.  Study Group B (methadone dependent detainees). 
Study Group B comprised 100 male detainees who had been in custody for at least 8 
hours and had requested administration of their legally prescribed methadone whilst 
in custody. The age range in Group B subjects was from 25 years to 46 years with a 
median age of 31 years. 
 
4.2.2.  Study Group B – Results and preliminary analysis. 
 




	  	  	  FIT	   	  	  FIT	  minus	  “clues”	   Conventional	  Tests	  
Walk	  &	  Turn	  	   	  	  	  	  	  	  	  	  	  	  	  63	   	  	  	  	  	  	  	  	  	  	  	  88	   	  	  	  	  	  	  	  	  	  	  	  	  	  98	  
One	  Leg	  Stand	   	  	  	  	  	  	  	  	  	  	  	  56	   	  	  	  	  	  	  	  	  	  	  	  83	   	  	  	  	  	  	  	  	  	  	  	  	  	  98	  
Finger	  Nose	   	  	  	  	  	  	  	  	  	  	  	  88	   	  	  	  	  	  	  	  	  	  100	   	  	  	  	  	  	  	  	  	  	  	  100	  
Romberg	   	  	  	  	  	  	  	  	  	  	  	  92	   	  	  	  	  	  	  	  	  	  100	   	  	  	  	  	  	  	  	  	  	  	  100	  
 
 
Table 4.2. shows that :- 
 
Group B subjects performed significantly better than group A subjects in all tests 
with the exception of the Romberg test, in which they performed only slightly better. 
 
As before, all subjects performed each test better when assessed without observation 
of “clues” or “indicators” of impairment, and better again when assessed using 





Using strict FIT criteria, a notable number of subjects were unable to maintain 
balance when standing either with one foot in front of the other, or standing on 
either leg with foot raised and parallel to the floor, however this was much less than 
noted in group A subjects. 
 
 
Although a small number of subjects appeared to be impatient during the 
examination process, none displayed any significant degree of anxiety or agitation.  
 
 
Using strict FIT criteria during the Finger-Nose test the only subjects who failed to 
successfully complete the test had used the pad of the finger despite being told and 
reminded to use the tip.  
 
 
As before, the subjects who failed to successfully perform the Romberg test had 
estimated the 30 second time interval in less than 20 seconds and this was consistent 
with their general impatience throughout the examination process. 
 
 
As previously noted in Group A subjects, the tests which presented most difficulty 







4.3.1. Study Group C – Drug-free “control” detainees. 
Study Group C comprised 100 male detainees who had been in custody for at least 8 
hours and had denied any illicit drug abuse. The same strict exclusion criteria were 
applied as in Group A. years. This group was included as a “control” group as they 
had no history of previous drug use. The age range was from 19 years to 49 years 
with a median age of 32 years. 
 
4.3.2.  Study Group C - Results and preliminary analysis. 
 




	  	  	  	  	  	  	  	  	  	  	  FIT	   	  	  	  FIT	  minus	  “clues”	   	  Conventional	  Tests	  
Walk	  &	  Turn	  	   	  	  	  	  	  	  	  	  	  	  	  78	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  92	   	  	  	  	  	  	  	  	  	  	  	  	  	  98	  
One	  Leg	  Stand	   	  	  	  	  	  	  	  	  	  	  	  81	   	  	  	  	  	  	  	  	  	  	  	  	  	  91	   	  	  	  	  	  	  	  	  	  	  	  	  	  97	  
Finger	  Nose	   	  	  	  	  	  	  	  	  	  	  	  91	   	  	  	  	  	  	  	  	  	  	  	  100	   	  	  	  	  	  	  	  	  	  	  	  100	  
Romberg	   	  	  	  	  	  	  	  	  	  	  	  96	   	  	  	  	  	  	  	  	  	  	  	  100	   	  	  	  	  	  	  	  	  	  	  	  100	  
 
Table 4.3. shows that :- 
Group C subjects performed FIT, both with and without “clues” or indicators” better 
than groups A and B with the exception of the Finger Nose and Romberg tests. 
 
All subjects performed the tests better when assessed without observation of 
“clues”, and better again when assessed using conventional psychomotor trests, with 





Using strict FIT criteria, it was notable that in this group of “normal” detainees, who 
gave no history of medicinal or illicit drug use, only 78% managed to successfully 
complete the Walk and Turn test; and 81% the One Leg Stand Test. 
 
Using FIT, both with and without “clues” or “indicators”, the subjects who were 
unable to successfully complete the Walk and Turn test had a degree of difficulty 
maintaining balance when standing with one foot in front of the other, or completing 
the turn in the apropriate manner. 
 
Using FIT, both with and without “clues” or “indicators”, the subjects who were 
unable to successfully complete the One Leg Stand test had a degree of difficulty 
maintaining balance without raising their arms or swaying slightly. 
 
All subjects who were unable to successfully perform the finger-nose test did touch 
the tip of their nose with the correct finger however used the pad of the finger 
despite being able to touch the tip of their nose with the tip of their finger.  
 
Subjects who failed to complete the Romberg test successfully had good balance 
with closed eyes however did not estimate 30 seconds within the required range. 
 
 
4.4. Comparison of results from Groups A, B and C. 
There is an evident disparity in the performance of the three groups (Table 4.4) with 
group A performing particularly poorly in both FIT and FIT minus “clues”, when 
compared to groups B and C. However there is less disparity between the groups in 
respect of their performance in conventional psychomotor tests. The performance of 




“clues” and conventional tests. However when using strict FIT criteria group B 
performed less well in the One Leg Stand and Walk & Turn tests than group C.  
It was noted when using strict FIT criteria a large number of subjects from groups A 
and B were unable to complete the tests satisfactorily, however a number of subjects 
from group C were also unable to perform the Walk & Turn and One Leg Stand tests.  
 
In conclusion, it is evident that a number of subjects from each group were unable to 
perform FIT despite being known to be drug free at the time of testing. 
 
Table 4.4. Percentage of subjects who successfully completed individual tests. 
 
 
Walk & Turn Group A Group B Group C 
FIT 27 63 78 
FIT minus “clues” 41 88 92 
Conventional tests 88 98 98 
 
 
One Leg Stand Group A Group B Group C 
FIT 18 56 81 
FIT minus “clues” 28 83 91 
Conventional tests 93 98 97 
 
 
Finger-Nose Group A Group B Group C 
FIT 21 88 91 
FIT minus “clues” 94 100 100 
Conventional tests 99 100 100 
 
 
Romberg Group A Group B Group C 
FIT 82 92 96 
FIT minus clues 96 100 100 




Table 4.4. clearly shows that the drug dependent detainees in Group A and B, who 
were known to have taken no drugs in the previous 8 hours and who showed no 
clinical evidence of intoxication due to any CNS active drug, performed more poorly 
in all tests, and even more so in FIT, than the “normal” or “control” detainees in 
Group C. It is also evident that while virtually all subjects in Group C managed to 
complete the conventional tests successfully, a number of these “normal” individuals 
were unable to complete FIT successfully, with the Walk and Turn test (n = 22), and 
One Leg Stand test (n = 19) in particular. 
 
Statistical analysis was undertaken and the results of each test in each group were 
compared, with one point awarded for successful completion of a test. All counts are 
out of 100. Values in the cells indicate the number of passes in each group/test. 
Logistic regression is a form of general linear model with a binary outcome ‘y’ 
variable. In these analyses, allowance has been made for the correlation between the 
tests, due to each test being done by the same set of individuals. For simplicity, a χ2 
test has also been used to compare groups A and C. Where numbers are small (very 




The Walk and Turn Test. 
Analysing the results of the Walk & Turn test by logistic regression (Table 4.4) 
shows there are significant differences between the tests and the groups (both 
p<0.0001). Also, taking the “normal” group, C, as the comparator group, both group 
A (p<0.0001) and group B (p=0.023) are significantly different from C (overall, 
having taken the test into consideration already). As group B should be similar to 




The p-values here have been adjusted for multiple comparisons using Tukey’s 
method. Both FIT and FIT minus clues are significantly different from the 
conventional test (both p<0.0001). 
 
In simpler terms, looking at group A vs. group C for each test individually with the 
χ2 test, we have: 
 
FIT: p<0.0001, group A’s scores are significantly different from group C’s scores. 
FIT minus clues: p<0.0001, group A’s scores are significantly different from group 
C’s scores. 
Conventional: p=0.006, group A’s scores are significantly different from group C’s 
scores, although by a lower margin. 
 
 
The One Leg Stand Test. 
Analysing the results of the One Leg Stand test by logistic regression (Table 4.5.) 
shows there are significant differences between the tests and the groups (both 
p<0.0001).  
 
Again, as with the Walk & Turn test, A is significantly different from C (p<0.0001) 
and B is significantly different from C (p=0.002). As group B should be similar to 
group C, this clearly indicates that this is not the case. 
 






Looking at A vs. C, we have: 
FIT: p<0.0001, group A’s scores are significantly different from group C’s scores. 
FIT minus clues: p<0.0001, group A’s scores are significantly different from group 
C’s scores. 
Conventional: p=0.19, group A’s scores are not significantly different from group 
C’s scores. The conventional test is unable to distinguish between group A and group 






The Finger-Nose Test. 
Analysing the Finger-Nose test by logistic regression (Table 4.5.) shows there are 
significant difference between the tests and the groups (both p<0.0001).  
 
However, in this case, only group A is significantly different from group C 
(p<0.0001), group B is not significantly different from C (p=0.37).  
 
Both FIT and FIT minus clues are significantly different from the conventional test 
(p<0.0001 and p=0.027, respectively). 
 
 
Looking at A vs. C, we have: 
FIT: p<0.0001, group A’s scores are significantly different from group C’s scores. 
FIT minus clues: p=0.03, group A’s scores are significantly different from group 
C’s scores*. 




The Romberg Test. 
 
Analysing the results of the Romberg test by logistic regression (Table 4.5.) shows 
there are significant differences between the tests and the groups (both p<0.0001).  
However, again only group A is significantly different from group C (p<0.0001), 
group B is not significantly different from group C (p=0.16).  
 
Additionally, the FIT test is significantly different from the conventional test 
(p<0.0001), but the FIT minus clues test is not significantly different from the 
conventional test (p=0.13).  
 
 
Looking at A vs. C, we have: 
FIT: p=0.002, group A’s scores are significantly different from group C’s scores. 
FIT minus clues: p=0.12, group A’s scores are not significantly different from group 
C’s scores*. 





* These tests were performed using the Fisher’s Exact Test, due to small expected 











4.4.1. Summative results of all tests in Groups A, B, and C. 
 
An alternative use of the data would be to count the number of tests that the subject 
successfully performed, to test the opposing hypotheses - 
 
1. FIT are reliable and valid tests of drug-related impairment to drive - all 
groups should pass all tests and score equally since all are drug-free.  
 
2. FIT are not reliable and valid tests of drug-related impairment to drive - 
and are too difficult for some groups of drug-free individuals to perform. 
 
Summative scores for each group may be calculated as follows –  
FIT = Walk & Turn score + One Leg Stand score + Finger-Nose score + Romberg 
score, where a yes answer counts as 1 point. The range of FIT (or FIT minus “clues” 
or conventional tests) can vary from 0 to 4. 
 




A B C  







1.00 52 4 7 63 
2.00 6 25 10 41 
3.00 12 7 5 24 
4.00 12 (8.3%) 56 (38.9%) 76 (52.8%) 144 




Table 4.5 shows that although it is less likely that a score of zero came from a person 
in group C, it is not possible to completely discount the possibility, as 7.1% (2/28) of 
scores of 0 appear in group C. Similarly, it is possible, although unlikely, that a score 
of 4 came from a person in group A (8.3%, 12/144). It would be even more difficult 





Table 4.6. FIT minus “clues” scores for groups A, B, and C 
 
Group 











1.00 2 0 0 2 
2.00 53 12 8 73 
3.00 13 5 1 19 
4.00 28 (13.9%) 83 (41.1%) 91 (45.0%) 202 
Total 100 100 100 300 
 
Table 4.6 shows that although this looks more promising, with all scores of 0 coming 
from patients in group A, the probability of this distribution of the data is 1 in 15 
(p=0.067) by random chance. Scores of 1 are also only recorded in group A. Also, it 
is still not possible to assign or exclude a score of 4 to any particular group with any 
degree of certainty, as 13.9% of scores of 4 come from group A. 
Table 4.7. Conventional test scores for groups A, B, and C. 
    
Group Total 










2.00 6 2 2 10 
3.00 5 0 1 6 
4.00 88 (31.1%) 98 (34.6%) 
 
97 (34.3%) 283 
Total 100 100 100 300 
 
Table 4.7 shows that very few subjects scored less than 4 in the conventional tests 
(5.7%). Although the single score below 2 came from group A, this is insufficient 
evidence to accept as a valid test. Even amalgamating scores of 0-3, 70.6% (12/17) 
come from group A, with 11.8% (2/17) and 17.6% (3/17) from B and C respectively. 
Similarly, for scores of 4, there is a roughly equal distribution across the groups 




4.4.2. Confounding subjects in Group A - re-analysis. 
Following my examination of  Group A subjects it was evident to me that certain 
individuals (n =12) had shown no evidence whatsoever of the normal clinical signs 
of opiate withdrawals, specifically no cold or sweaty skin with “gooseflesh” which is 
a common indicator of opiate withdrawal syndrome, however most importantly no 
evidence of grossly dilated pupils which is virtually pathognomonic. These 12 
individuals were given no drug replacement therapy since I detected no clinical 
evidence which supported their assertions of drug withdrawals and thus no 
therapeutic indication to provide drug replacement therapy. Indeed I was not entirely 
convinced they were habitual drug abusers to any considerable extent.  
 
It is my opinion that these 12 individuals were “confounders” since I am confident, 
based on my experience of 30 years experience of dealing with detainees and in 
particular “drug-dependent” detainees, that they were simply claiming to be “in 
withdrawal” and making misleading claims regarding their condition in an attempt to 
receive drugs simply to make their period of detention less uncomfortable.  These 12 
individuals had thus distorted the results of group A and it was felt approppriate to 
re-analyse the results of Group A with these subjects excluded (Table 4.8). 
 
 
Further analysis of Group A was undertaken with the 12 “confounders” excluded. 












FIT	   FIT	  minus	  “clues”	   Conventional	  Tests	  
Walk	  &	  Turn	  	   17	  (27)	  *	   33	  (41)	  *	   86.4	  (88)	  
One	  Leg	  Stand	   6.8	  (18)	  *	   18.2	  (28)	  *	   92	  (93)	  
Finger	  Nose	   10.2	  (21)*	   93.2	  (94)	  	   99	  (98.9)	  
Romberg	   79.5	  (82)	   95.5	  (96)	   98.9	  (99)	  
 
* indicates a significant difference between excluded and non-excluded patients. 
Table 4.8 shows very little difference is noted in the conventional tests. However, 
significant differences are noted in some FIT and FIT minus “clues” categories.  
 
In the Walk & Turn/FIT test, all 12 excluded subjects successfully performed the 
test, compared with 17% of the non-excluded subjects. This is a statistically 
significant difference with the χ2 test (p<0.0001). 
 
In Walk & Turn/FIT minus clues, again, all 12 excluded patients were successful, 
compared with 33% of the non-excluded. Statistically significant result, p<0.0001. 
 
One Leg/FIT, all 12 excluded patients performed successfully, compared with only 
6.8%, p<0.0001. 
 
One Leg/FIT minus clues, all 12 excluded patients performed successfully, 
compared with only 18.2%, p<0.0001. 
 
Finger-Nose/FIT, all 12 excluded patients performed successfully, compared with 
only 10.2%, p<0.0001. 
 
Finger-Nose/FIT minus clues, all 12 excluded patients performed successfully, 
compared with 93.2%, not significantly different, p=0.35. 
 
Romberg/FIT, all 12 excluded patients performed successfully, compared with 
79.5%, not significantly different, p=0.08. 
 
Romberg/FIT minus clues, all 12 excluded patients performed successfully, 




 Table 4.9. Percentage of subjects who successfully completed the Walk & Turn test. 
 
Walk & Turn Group A Group B Group C 
FIT 15/88 (17%) 63 78 
FIT minus “clues” 29/88 (33%) 88 92 
Conventional tests 76/88 (86.4%) 98 98 
 
Table 4.9 shows that using the logistic regression techniques, there is very little 
change to the overall results. Differences have become more marked (i.e. more 
significant), but as they were already p<0.0001, it makes no difference to the 
conclusions. The comparison of B with C has changed marginally (p=0.027), likely 
due to the influence of the overall variability due to the reduced numbers in group A. 
 
By the χ2 test, looking at A compared with C, the conclusions for FIT and FIT minus 
clues are unchanged. Looking at the conventional test, p is now 0.002, so more 




   Table 4.10. Percentage of subjects who successfully completed One Leg Stand test. 
 
One Leg Stand Group A Group B Group C 
FIT 6/88 (6.8%) 56 81 
FIT minus “clues” 16/88 (18.2%) 83 91 
Conventional tests 81/88 (92%) 98 97 
 
Table 4.10 shows the differences between the groups and tests are still highly 
significant (p<0.0001). A is still highly significantly different from C (p<0.0001), 
although it is slightly less significant. Similarly, B is still significantly different from 
C, but at a lower level (p=0.007). FIT and FIT minus clues remain significantly 
different from conventional, but again, marginally less so. 
 
By the χ2 test, looking at A compared with C, FIT and FIT minus clues remain 
statistically significant (p<0.0001). Looking at the conventional test, p is now 0.13, 






Table 4.11. Percentage of subjects who successfully completed the Finger-Nose test. 
 
Finger-Nose Group A Group B Group C 
FIT 9/88 (10.2%) 88 91 
FIT minus “clues” 82/88 (93.2%) 100 100 
Conventional tests 87/88 (98.9%) 100 100 
 
Table 4.11 shows that group and test remain highly significantly different. A is still 
highly significantly difference from C (p<0.0001), and B remains non significant 
(p=0.35). FIT is still highly significantly different from conventional (p<0.0001), and 
FIT minus clues has become slightly more significantly different with p=0.023. 
 
By the χ2 test, A vs C, FIT remains highly significant (p<0.0001). FIT minus clues 
has become marginally more significant (p=0.01*), and conventional remains non-
significant (p=0.47*). 
 
As before, tests performed with the Fisher’s Exact Test have been indicated with *. 
 
 
   Table 4.12. Percentage of subjects who successfully completed the Romberg test. 
 
Romberg Group A Group B Group C 
FIT 70/88 (79.5%) 92 96 
FIT minus clues 84/88 (95.5%) 100 100 
Conventional tests 87/88 (98.9%) 100 100 
 
Table 4.12 shows that group and test are still highly significantly different 
(p<0.0001). A is still highly significantly difference from C (p<0.0001), and B 
remains non significant (p=0.15). FIT is still highly significantly different from 
conventional (p<0.0001), and FIT minus clues remains non-significant (p=0.12). 
 
By the χ2 test, A vs C, FIT has become more highly significant (p<0.0005). FIT 




There has been very little change in terms of the conclusions drawn from the results. 
Only one result has changed from non-significant to significant (Romberg FIT minus 




4.4.3.  Summative results of tests – Groups A (minus “confounders”), B, and C. 
Table 4.13. FIT scores for groups A, B, and C 
 
Group 
Total A B C 
FIT  
 
.00 18 (64.3%) 8 (28.6%) 2 (7.1%) 28 
1.00 52 4 7 63 
2.00 6 25 10 41 
3.00 12 7 5 24 
4.00 0 (0%) 56 (42.4%) 76 (55.6%) 132 
Total 88 100 100 288 
 
Table 4.13 shows with removal of the 12 suspect subjects, none of group A now 
manage all 4 tasks. However, it is still not possible to discount subjects with a score 
of 0 from group C. 
 
Table 4.14. FIT minus “clues” scores for groups A, B, and C 
 
Group 
Total A B C 
FIT minus 
clues 
.00 4 (100%) 0 (0%) 0 (0%) 4 
1.00 2 0 0 2 
2.00 53 12 8 73 
3.00 13 5 1 19 
4.00 16 (8.4%) 83 (43.7%) 91 (47.9%) 190 
Total 88 100 100 288 
 
Table 4.14 shows although lower, the percentage of subjects scoring 4 in group A is 
still too high to use it as a method of discrimination. 
 
Table 4.15. Conventional test scores for groups A, B, and C 
 
Group 
Total A B C 
Conventional .00 1 (100%) 0 (0%) 0 (0%) 1 
1.00 0 0 0 0 
2.00 6 2 2 10 
3.00 5 0 1 6 
4.00 76 (28.0%) 98 (36.2%) 97 (35.8%) 271 
Total 88 100 100 288 
 
Table 4.15 shows the majority of subjects are still scoring 4 in this test (94.1%), thus 
a good score is not at all discriminatory. There is still no significant difference 





4.5.  Limitations of the studies. 
There may be some concern that all subjects in the study groups were male, however 
male drivers within the age group of those subjects studied (18 to 49 years) are 
exactly representative of the drivers stopped by police as suspect drug-drivers. I 
would add that in my 30 years of experience as an FME dealing with several 
hundreds of suspect drug-drivers I have, on only one occasion, examined a female 
suspect drug-driver.  
  
There might also be some concern that not all individuals in the study groups who 
had been in custody for at least 8 hours, were drug-free since diazepam has a half-life 
of approximately 30 hours and methadone a half-life of 15 to 72 hours with a mean 
of around 22 hours (Drummer 2001; NHTSA 2004), thus some subjects might still 
have been under the sedative influence of benzodiazepines or methadone at the time 
of the examination. However due to the strict exclusion criteria applied (4.1.1.) it is 
very unlikely that I would have been unable to detect the clinical signs of acute drug 
intoxication, and those of benzodiazepines or methadone in particular. 
 
In addition there might be some concern whether or not the groups studied were in 
fact truly representative of car drivers and it is acknowledged that none of the 
subjects were asked if they held a current driving licence or had passed a driving test. 
However it is also acknwoledged that some drivers stopped by police and subjected 
to FIT have no valid driving licence. In any event the purpose of the research was to 





4.6.  Summary and conclusions. 
Preliminary Field Impairment Tests (FIT) are presented as, and claimed to be, 
reliable tests of drug-related impairment of driving ability (Sexton et al. 2000; Sexton 
et al. 2002; Railways and Transport Safety Act 2003; North 2010) and as such it is 
reasonable and logical to expect drug-free individuals will be able to successfully 
perform these tests without any significant difficulty. However the results of the 
research studies undertaken clearly demonstrate this is not the case.  
 
Following analysis of the studies, certain findings were notable. 
 
Although all the subjects in the three groups were known to have taken no drugs 
for at least 8 hours prior to testing, and may reasonably described as free from the 
acute effects of drugs, all subjects did not perform equally well on the tests. 
 
All subject groups performed best on the conventional psychomotor and 
cognitive tests, least well on FIT, and better on FIT minus “clues”. 
 
Group A subjects clearly performed less well on all tests than individuals from 
groups B and C. 
 
Group C subjects who claimed no involvement with drugs, performed better than 
groups A and B, however not all group C subjects could successfully perform 
FIT, although virtually all (97-100%) could successfully perform conventional 




Throughout all the groups, the One Leg Stand and Walk and Turn tests proved 
most difficult to perform (Table 4.4). 
 
The results of all test groups, most notably group A, less so group B, however 
also notably group C, support the assertions held by significant numbers of FMEs 
(p<0.0001) that FIT are too difficult, with the One Leg Stand (43% of FMEs 
Table 3.11) and Walk and Turn (35% of FMEs Table 3.9) tests in particular.     
 
All subject groups performed well in conventional psychomotor tests with groups 
B and C scoring 98-100% success rates. Group A had a lower, though still high 
success rate of 88-99% (Table 4.4). 
 
All groups showed a greater degree of consistency in performing the 
conventional psychomotor tests than FIT. 
 
The results of the studies clearly show that FIT are considerably more difficult to 
perform than conventional psychomotor tests for all of these groups of drug-free 
individuals.  
 
 However the main finding is evident - that the results of the studies lend very 
powerful support to Hypothesis 2 (4.4.3.) –     
 
“FIT are not reliable and valid tests of drug-related impairment to drive and 





CHAPTER 5. FIT: General discussion and conclusions. 
It is clear from the studies undertaken that considerable numbers of drug-free 
individuals in each of the three study groups were noted to be unable to perform FIT 
successfully (Table 4.4) and it is both reasonable and logical to assume there may be 
factors unrelated to drug use responsible for their lack of ability to successfully 
perform FIT. It must reasonably be considered possible, that a suspect driver who has 
performed poorly in these tests might have some naturally occurring problem with 
balance and co-ordination, or some undiagnosed condition such as dyslexia or 
dyspraxia, both of which are prevalent in the general population (Smythe 1999; 
Wassell 2000; POST 2004). Also labyrinthitis, an infection or inflammation of the 
inner ear, which causes dizziness and loss of balance and is frequently associated 
with a viral infection such as influenza and the common “cold” can result in poor 
performance in tests of balance. 
 
We should therefore be mindful of the problems which might be encountered in these 
tests (FIT) by drug-free individuals who may have a naturally occurring condition 
leading to difficulties with the seemingly normal process of understanding and 
remembering a lengthy sequence of several instructions and commands, while 
assuming a fixed unnatural position, performing unusual and unfamiliar tasks of 
balance and co-ordination, all the while in a stressful environment.    
 
5.1. Objective analysis of FIT.          
It is important to analyse in detail the components of each individual test in FIT and 
also to consider the implications of how the tests are conducted and how the tests are 




Walk And Turn Test.  
a) In this test there are ten separate instructions, which the suspect has to 
remember prior to attempting to follow instructions to the satisfaction of the 
police officer conducting the test. This will present some individuals with a 
greater degree of difficulty than others. Indeed it is not considered possible 
for a dyslexic subject to be able to retain the sequence of information and 
then recall how to perform the test (Smythe 1999). Dyslexia affects 10% of 
the population and for this group alone, the Walk and Turn test is entirely 
inappropriate. 
 
b) Throughout the instruction phase of the test the subject is required to 
maintain a fixed unnatural balance without moving, with the right foot in 
front of the left. It is a requirement of the test that the right foot is positioned 
in front of the left and it is questionable why the suspect is not permitted to 
assume his preferred position, provided one foot is in front of the other.  
 
c) It is noted that both arms have to be held rigidly at the sides throughout the 
test. This unnatural position does not assist balance, indeed the converse is 
the case (c.f. tightrope walker).  
 
d) The suspect is required to watch his/her feet at all times throughout the test. 
This again is an unnatural position or situation and it does not assist or 
facilitate balance (c.f. tightrope walker). It in fact makes the procedure more 





One Leg Stand Test.  
a) This test requires the subject to remember 6 separate instructions prior to 
commencing the test, and again subjects with learning difficulties will have 
considerable problems recalling the sequence of instructions. 
 
b) The requirement for the subject to stand with the leg outstretched and with 
the sole of the foot elevated 8 inches and parallel to the ground is an 
unnatural posture to adopt which does not assist or facilitate balance, indeed 
the reverse is more likely. The question arises why the subject is not 
permitted to stand with the knee flexed, which would facilitate balance. 
 
c) With both arms fixed to the sides, this is an abnormal posture. The question 
arises why the subject is not permitted to raise the arms, as long as the 
balance is seen to be steady (c.f. tightrope walker)?  
 
d) The requirement for the subject to constantly look at the raised foot for a 
period of 30 seconds is an unnatural posture to adopt and does not assist or 
facilitate balance; indeed again the reverse is more likely. The question arises 
is - why looking ahead at a fixed reference point which assists balance (c.f. 
tightrope walker) is not permitted? 
 
e) The duration of this test of 30 seconds is a long time to adopt this unnatural 
posture, particularly for an older subject in whom fatigue might influence 
ability to perform the test, for an overweight individual, or a vulnerable 





Finger To Nose Test.  
a) This test requires the subject to remember 7 separate instructions prior to 
commencing the test, and again persons with learning difficulties will have 
significant difficulty recalling the sequence of instructions (Smythe 1999). 
 
b) When the test starts the suspect is obliged to tilt his head back and close his 
eyes, which alters and affects the balance and makes the test more difficult.  
 
c) Having the eyes closed from the outset makes the test more difficult than if 
initially tested with the eyes open then testing again with the eyes closed.  
 
d) The alteration of sequencing (right, left, right, left, left, right) makes the test 
more difficult than it need be, particularly in a subject under stress and who 
has anticipated the systematic alternating process to be continued.  
 
e) Police officers are required to regard any subject who touches the tip of the 
nose with the pad of the finger to have incorrectly performed the test. 
 
The Romberg Test.  
a) This test requires the subject to remember 5 separate instructions prior to 
commencing the test, and again persons with learning difficulties will have 
difficulty recalling the sequence of instructions. 
 
b) Conducting this test with the head tilted back will not facilitate or assist 
balance - in fact the reverse is likely to be the case. There is no requirement 




5.2. Discussion of Preliminary/Field Impairment Tests.  
If one considers comprehensively and dispassionately what exactly Field Impairment 
Tests (FIT) actually assess, the answer must be that they assess a variety of physical, 
neurological, intellectual and cognitive functions which interlink information 
processing, organisational skills, short- term memory, spatial awareness, balance and 
co-ordination, but not the least, the ability to perform these rigid and complicated 
tests under stress. However no evidence has been presented that the tasks undertaken 
in FIT have any relevance to the safe driving of a motor vehicle (Hartley 2001). 
  
There are several conditions which might account for poor performance in FIT which 
are unrelated to drug use and these include common conditions such as dyspraxia and 
dyslexia; plus the less common but by no means rare, autistic spectrum disorder such 
as Asperger’s Syndrome. It is important to be aware that these conditions might not 
be so significantly disabling to the extent that the subject is aware of any specific 
problem, and their condition might be unrecognised and undiagnosed.  
 
Dyslexia is a not uncommon condition affecting 10% of the population with 4% 
severely affected although estimates vary between 5% and 15% (Parliamentary 
Office of Science and Technology 2004). Dyslexia is a specific learning difficulty 
related to disorder of information processing and apart from causing difficulty with 
the acquisition of reading, writing and spelling, may encompass some or all of the 
following – difficulty with organisational skills; making errors with numbers; 
mistakes with instructions; problems with explaining ideas and concepts; difficulty 
with orientation; confusing left and right; confusing dates and forgetting 




Dyspraxia is a not uncommon condition affecting approximately 10% of the 
population (Dyspraxia Foundation 2005), which can be defined as motor difficulties 
caused by perceptual problems, especially visual motor and kinaesthetic motor 
difficulties (Portwood 1999). It has also been defined as an immaturity of the brain 
resulting in messages being improperly transmitted to the body. It affects at least 2% 
of the population in varying degrees and although a genuine disability, those affected 
do not look disabled. Some of the common problems caused by dyspraxia are – 
clumsiness; poor posture; awkward gait; poor short-term memory; poor body 
awareness; poor sense of direction; inability to hop or skip (Wassell 2000).  
 
Asperger’s Syndrome (AS) is a relatively rare condition, however the incidence of 
Asperger’s Syndrome in the general population has been estimated at 0.29% to 
0.71%, with a 4 to 15-fold predominance in males (Weimer et al. 2001). AS is a 
pervasive developmental disorder marked by significant impairment in social 
interaction and restricted or stereotyped interests or behaviours. In addition to the 
social deficits, Asperger and autistic individuals also exhibit motor control 
abnormalities such as impaired gait, balance, manual dexterity and grip (Gowen & 
Miall 2005). Motor impairment has frequently been described and it has been 
estimated that 80% of subjects with AS display "motor dyspraxia," or clumsiness. 
Studies have been conducted where a battery of motor tests was administered to 
subjects with AS and these subjects were found to perform more poorly than controls 
on tests of apraxia, one-leg balance with eyes closed, tandem gait, and repetitive 





Extreme fatigue, coupled with a degree of sleep deprivation might account for 
poor performance on these tests. Williamson and Feyer (2000) studied normal 
subjects and noted that after 17 to 19 hours without sleep, performance on some tests 
was equivalent or worse than that recorded in the same subjects who had a blood 
alcohol concentration of 50 mg per 100mls blood. Reaction times were up to 50% 
slower for some tests and accuracy measurements were significantly poorer.  
 
The relevance and validity of FIT as tests of drug-related impairment of driving 
ability has been questioned, and whilst confirmed by some investigators (Burns 
1995; Burns and Adler 1995; Sexton et al. 2000; Sexton et al. 2002; Collier 2010; 
North 2010) has been refuted by others (Erwin 1995; Trocino 1997; Head 2001; 
Hartley 2001; A.F.P. 2003; Johnston and Ramsey 2003; Rubenzer 2008; FFLM in 
North 2010d; Mercier-Guyon 2010; Stark 2010; Porath-Waller and Beirness 2010; 
Verstraete and Legrande 2010). Indeed the ability of the tests to withstand challenge 
in court is a legitimate question which remains to be answered. 
 
Burns (1995) has been widely quoted in her study in which she claims validation for 
the Standardised Field Sobriety Test (SFST) battery. However her authority has been 
challenged in court (Trocino 1997).   
“It has to be acknowledged the author of the initial studies which tended to validate 
the DRE programme, Dr Marcelline Burns, was intimately associated with the DRE 
protocol and involved in the Los Angeles test which “touted” the DRE accuracy”.  
 
 
Furthermore it was found by a New Mexico Court of Appeal  (Head 2001) - 




The Transport Research Laboratory Reports TRL 477  and TRL 543 have stated  -  
 
“Sobriety tests are of value in deciding whether a participant is impaired. The 
analysis of the sobriety tests showed that there is validation evidence in this test 
battery.”  (Sexton 2000).“It was judged that the general medical examination and 
standardised impairment testing applied by the police surgeons were generally 
effective in determining impairment.”  (Sexton et. al 2002). 
 
It is of note however, that the initial report related to cannabis and driving, whereas 
the more recent report related to the influence of cannabis and alcohol on driving.   
 
Hartley (2001) has given his opinion on FIT –  
“It is arguable the SFSTs will be of little assistance in establishing the link between 





Johnston and Ramsey (2003) are particularly critical of FIT and have stated – 
“No evidence has been presented that there is any correlation between a person’s 
performance on any aspect of the battery of tests used in FIT (Field Impairment 
Testing) and that person’s ability to drive. It is our belief that the use of these tests 
has led, and will continue to lead, to the arrest and conviction of motorists whose 
only crime is that they cannot “pass” the FIT procedures.” 
 
 
However most notably and importantly, the professional bodies who are responsible 
for the education, training, and maintenance of sound professional standards for 
forensic physicians (FPs) and forensic medical examiners (FMEs) have repeatedly 
stated that FIT remain yet to be validated as reliable indicators of drug-related 
impairment of driving ability (AFP 2003; FFLM in North 2010d; Stark 2010). This is 
of course, in addition to the significant number (p<0.0001) of 33% of FMEs survyed, 




A major concern must be that the results of FIT which have been conducted and 
interpreted by police officers with limited training and without any form of medical 
experience or qualifications, are led in courts throughout the UK as evidence of 
imapirment in driving ability due to drugs. This is despite the clear statement from 
the Research Programme Manager, Head of Impairment Studies, Road Safety 
Division, Dept for Transport  (Read 2003) –  
“Field Impairment Tests are not test of impairment to to drive, but part of an 
assessment by a police officer at the roadside. At the conclusion of this assessment 
the officer will decide, on everything he knows about the driver, including the 
performance on FIT, whether there is sufficient evidence to arrest the him or her 
under Section 4 of the Road Traffic Act”. 
 
 
Poor performance in FIT, presented as evidence of drug-related impairment in 
driving ability has become established practice and indeed has been accepted, 
perhaps in part, due to the official sounding name of the tests, however perhaps also 
to a lack of challenge to the validity of the tests. Certainly in the USA these FIT have 
been successfully challenged (Erwin 1995; Nowaczyk and Cole 1995; Trocino 1997; 
Hartley 2001; Head 2001). 
 
 
5.3.  Summary of findings from recent research. 
The question of how best to address the problem posed to road safety by drivers of 
motor vehicles who have taken drugs is extremely complex for a variety of reasons, 





It might be prudent to consider what exactly is known regarding the problem of 
drugs and driving.  
 
There has been little research into the problem of drug use and driving 
conducted in recent years in the UK and the level of evidence on drug driving 
is poor (North Report 2010 c), however a significant body of work has been 
undertaken throughout member states of the European Union (DRUID 2012). 
Unfortunately the DRUID research, which encompasses 18 EU member 
countries, does not include the United Kingdom. 
 
      With particular reference to FIT, there are currently no reliable data available 
and this prevents forming any definite conclusions on the reliability of FIT, 
since in order to ascertain the effectiveness of FIT it would be necessary to 
have accurate data on the number of FIT procedures conducted, the number 
of subjects declared to be impaired by the police officers, the results of 
toxicological analysis of the blood samples, and also the judicial outcome of 
the cases involved (North 2010).    
 
      The research study “Monitoring the effectiveness of FIT” has reported that 
FIT may be considered a useful “screening device” for suspect drug-drivers 
(Oliver et al. 2006), however there have been no peer reviewed publications 
which have validated FIT as tests of drug-related impairment in driving 






      FIT/PIT as currently used in the UK has been the subject of criticism from a 
variety of sources including legal practitioners and toxicologists (Erwin 1995; 
Nowaczyk and Cole 1995; Trocino 1997; Hartley 2001; Head 2001; Johnston 
and Ramsey 2003; Rubenzer 2008) however most importantly by the Faculty 
of Forensic and Legal Medicine (AFP 2003; FFLM in North 2010d; Stark 
2010) and a significant percentage (p<0.0001) of 33% of Forensic Medical 
Examiners (FMEs) who responded to the research projects (see chapters 




      The Australian clinical test of impairment (CTI), which has incorporated 
some aspects of FIT, notably the One Leg Stand Test and the Walk and Turn 
Test, has been claimed to be a “moderate predictor of impairment” following 
use of THC (Papafotiou et al. 2005). However this opinion must be qualified 
by the fact that this CTI battery has been subject to the addition of the novel 
and somewhat subjective sign of “head movement jerks” (HMJ). 
 
 
      Recent expert opinion voiced at the ICADTS T2010 conference in Oslo 
identified the shortcomings of FIT and indicated the need for a new test 
battery of CTI to be devised based on a cognitive and behavioural approach, 
however the basis of the test battery has yet to be devised (Mercier-Guyon 





      The North Report (2010) contains claims that FIT has been validated as an 
effective test of impairment in drug drivers however these claims have only 
come from police sources (Collier 2010) a former Road Police Training 
Officer who developed the National Drug Drive Instructor Training for FIT, 
and who quoted the Florida Validation Study of 1997 in which the study 
author (Burns 1995) validated her own tests and was regarded as not entirely 
impartial (Trocino 1997).  
 
The specific research undertaken in this thesis has established clear evidence 
that some drug-free individuals have difficulty successfully completing FIT, 
as opposed to conventional psychomotor tests (Table 4.4). These results have 
validated the opinion of the FMEs surveyed who had stated that they 




5.4. Proposals to assist in the diagnosis of drug-related impairment.         
When we consider FIT/PIT it is clear they have been the subject of criticism (Erwin 
1995; Trocino 1997; Head 2001; Hartley 2001; A.F.P. 2003; Johnston and Ramsey 
2003; Rubenzer 2008; Mercier-Guyon 2010; Porath-Waller and Beirness 2010; 
Verstraete and Legrande 2010) and the challenge is to produce a system or method 
which will eliminate the claimed specific deficiencies and deliver a product which is 





In essence the process, after due study and trials, must be seen to be and accepted as, 
“Fit for Purpose”. Any new clinical tests of impairment (CTI) should specifically 
address the activities relevant to the safe operation of a motor vehicle, involving both 
the cognitive and motor functions including alertness, attention and vigilance; 
orientation in time, place and person; demeanour and mood; balance and co-
ordination and particularly eye-limb co-ordination; reaction time; and dual tasking.  
 
It is essential any new test battery should also include an assessment of the clinically 
recognised psychological and physiological effects of drugs, including intellectual 
and cognitive functioning. Therefore an examination for drug-related abnormal 
findings including deficit in intellectual and cognitive functions, motor co-ordination, 
and “vital signs” including pulse or heart rate; blood pressure; temperature; and 
respiratory rate. An examination of the eyes for abnormality in pupil size and 
reaction to light; lack of convergence; presence of nystagmus or hyperaemia, 
undertaken by an appropriately trained and skilled professional is considered 
essential. Finally the manner and content of speech should be assessed.      
 
 
5.4.1. Proposed Clinical Tests of Impairment (CTI).   
The seven sub-groups for clinical examination as detailed (see Table 5.1) are 
considered highly relevant to the skills necessary for safe driving and would assist in 
the diagnosis of impairment in ability to drive. The clinical findings in relation to the 
tests can be noted and referred to, in order to support a diagnosis of either “Evidence 




It is acknowledged that the presence of any individual sign or combination of signs 
may not provide a definitive diagnosis of current drug effects. However following a 
detailed and thorough examination, an experienced forensic physician (FP) or 
forensic medical examiner (FME) should be in a position to come to an appropriate 
diagnosis regarding the significance of the findings.  
 
Prior to the introduction of FIT (Railways and Transport Safety Act 2003) there was 
no standardised method or procedure for FMEs to adopt when examining suspect 
“drug-drivers”. In Scotland, Strathclyde Police FMEs used a printed proforma F97 
which had been use since the 1970s for the examination and assessment of suspect 
“drunk-drivers”. The problem with the use of form F97 was obvious in that not only 
had it been produced decades previously, it had been designed to assist the FME in 
detecting evidence of impairment in psychomotor function which was directly 
related to the effects of alcohol but not of drugs.  
 
However most FMEs in Strathclyde continued to use the F97 proforma when 
examining drivers who were suspected of being under the influence of drugs and by 
doing so they commented on the presence or absence of specific clinical signs which 
related specifically the effects of alcohol and not the effects of the various drugs used 
illicitly.  
 
Some drugs, in particular the CNS stimulants, have little or no effect on the suspect 





This proposed battery of clinical tests of impairment has been used by myself in 
forensic clinical practice for approximately 10 years, in the assessment of drug-
dependent  detainees who had requested medications to ease their claimed “drug 
withdrawal syndrome”, however more importantly as formal tests used in the 
assessment and examination of suspect “drug-drivers” arrested by police.  
 
Regarding drug-dependent detainees, of whom I have examined several thousand, I 
have applied these tests as part of my routine, thorough examination process in over 
one thousand cases. In many cases, poor performance on the tests clearly indicated 
the acute effects of drug use were still present, and the detainees were advised that 
they were not “in withdrawal”, and their their poor psychomotor function was clear 
evidence that, at the time of the examination, they were under the influence of drugs.  
 
In respect of suspect “drug-drivers” it is important to realise that the Railways and 
Transport Safety Act 2003 which introduced FIT into the legislation, made it a 
requirement for a suspect drug-driver to comply with FIT as conducted by a police 
officer, however there is no requirement for an FME subsequently called to examine 
the driver to use FIT as part of the examination process. The FME has clinical 
independence to conduct whichever examination he or she considers appropriate.  
 
I have used the proposed CTI in approximately 100 cases of suspect “drug-drivers” 
whom I have examined at the request of the police. I have given evidence in court on 
countless occasions based on interpretation of these tests (proposed CTI) and have 
been commended by the court for my assistance into the prosecution of the cases and 




almost 100 cases by defence solicitors to study all relevant evidence and provide an 
independent opinion for the court regarding any correlation between the  clinical 
condition, performance on tests as applied by the FME, and toxicology results of 
blood samples from the suspect “drug-drivers”. I have observed some very poor 
clinical examination procedures and inappropriate opinions, and noted on several 
occasions it was simply not possible to explain a link between the clinical evidence 
recorded by the FMEs and the toxicological results. As a result I became stimulated 
to devise the proposed CTI, which in my opinion more reliably detect clinical 
evidence of drug-related psychomotor impairment, and most importantly help to link 
specific clinical signs to the recognised effects of specific drugs. 
 
Whilst I have used these proposed CTI personally for several years, none are new 
tests, rather it is the specific combination of the tests which is a new approach.  
 
It is particularly important to highlight that although I used the proposed CTI battery 
on some detainees and suspect “drug-drivers” during the period in which the research 
studies were conducted, these proposed tests were conducted in an entirely separate 
group of detainees from the research study Groups A, B, and C.  
 
For the purpose of absolute clarity it is worth highlighting that the core groups A, B, 
and C were assessed using strict FIT parameters; FIT minus “clues” or “indicators”; 
and conventional tests. However these conventional tests were standard basic balance 









       
Drowsiness (extreme) Present   5     Absent  0   
Confusion Present   4     Absent  0   
Disinhibition Present   2     Absent  0   
Mood Swings Present   2     Absent  0   
Hallucinations        Present   5     Absent  0   
Memory problems Present   2     Absent  0  
SCORE =    /20 
VITAL SIGNS    
Pulse     Abnormal  1       Normal  0  
BP Abnormal  1      Normal   0  
Temperature Abnormal  1      Normal   0  
            SCORE =     /3                                                                                           
SPEECH      
Slow/ thick/ slurred            Present  1  Absent  0   
Inappropriate/bizarre   Present  1        Absent  0   
               SCORE =    /2  
EXAMN EYES    
Pupils grossly  
constricted/dilated Present  1   Absent   0  
Convergence Absent  1   Present   0  
Nystagmus  Present  2   Absent   0  
Pupil reaction Absent  1   Present   0  
Hyperaemia Present  1   Absent   0  
              SCORE =    /6 
PHYSICAL SIGNS     
Muscle rigidity Present     1     Absent   0  
Muscle flaccidity Present     1    Absent   0  
Reaction time Abnormal 1    Normal  0  
Obvious Tremor Present     1    Absent   0  
SCORE =    /4 
BALANCE & CO-
ORDINATION  
   
Manages 1 leg stand       No  3    Yes  0 NO  0 
Manages heel-toe walk       No  3    Yes  0  
Manages Finger-nose       No  3    Yes  0  
 SCORE =    /9 
ROMBERG TEST    
Sways excessively     Yes  3    No   0  
Abnormal time     Yes  3    No   0  
                    SCORE =    /6 
 




At the conclusion of the examination the FME is more likely to be in a position to 
state whether the suspect driver has a condition which might be due to the effect of a 
drug(s) than by use of either the outdated F97 proforma, or indeed FIT. Furthermore 
the FME is more likely to be in a position to make an informed judgment whether or 
not the suspect driver shows any evidence of drug-related impairment in driving 
ability. The FME would be in a position to more accurately identify the causative 
drug type involved, for example CNS sedatives; CNS stimulants; cannabinoids, or 
hallucinogens, without having to attempt to identify the specific drug. It must surely 
be accepted that this more detailed level of clinical evidence would be likely to be 
more beneficial to the courts and assist them in their judicial responsibilities. 
 
These proposed CTI are of course only in a rudimentary stage of development and 
are not offered as a final solution. Consultation with other specialists would be vital 
such that appropriate amendments to both the individual components of the test 
battery and the scoring scales might be made. Particular weight has been accorded to 
extreme drowsiness, hallucinations, confusion, disinhibition, mood swings and 
memory problems, all of which clearly constitute a hazard to safe driving.  
 
 
5.4.2. Proposed “Aggregate Clinical Score” method. 
 
Although the clinical findings noted in respect of the proposed clinical test battery 
may be used in general to support a diagnosis of impairment, there may be value in 
allocating individual “points” for each abnormal finding noted, whereas normal 
findings would attract a zero score. At the conclusion of the examination, the points 
allocated to each subject would be accumulated to provide an “Aggregate Clinical 




The obvious advantage of such as system is that it has the potential to differentiate 
individuals who display no, or very few abnormal findings from others who present 
as grossly abnormal. The current judicial processes take into consideration the level 
of blood alcohol when a driver is convicted under Section 5 RTA 1988, in relation to 
the sanctions applied and it would appear reasonable that a similar process should be 
available in respect of contravention of Section 4 RTA 1988. 
 
 
A perceived potential disadvantage might be the subject who attracts a relatively low 
number of “points” and who might be regarded as a “borderline” case. However the 
forensic physician need only advise the police whether or not the subject has a 
condition, which might be due to the effect of a drug. Subsequent toxicological 




Such a proposed scoring system would require significant research prior to its 
introduction since some clinical signs may be of greater significance than others and 
it would be appropriate to accord a degree of “weighting” to some signs, for example 
extreme drowsiness, hallucinations, disinhibition, confusion, memory problems and 
mood swings. For similar reasons it would appear reasonable and logical to accord 
“weighting” to difficulties with balance and co-ordination tests. In addition, 
consultation and collaboration with other specialists would guide the process and 
hopefully facilitate identification of an appropriate and reliable “cut off” score which 





5.4.3. Proposed 2nd Examination procedure. 
Wheatley (2000) gives a detailed account of police powers to detain persons affected 
by alcohol or drugs in relation to Section 10 RTA in his treatise entitled “Road 
Traffic Law in Scotland”.  
He highlights Section 10 of the Road Traffic Act 1988 (as amended by the Road 
Traffic Act 1991, Sch 4, para 43) as detailed below –  
 
(1) “Subject to subsections (2) and (3) below, a person required to provide a 
specimen of breath, blood or urine may afterwards be detained at a police 
station until it appears to the constable that, were the person then driving or 
attempting to drive a mechanically propelled vehicle on the road, he would 




(2) “A person shall not be detained in pursuance of this section if it appears to a 
constable that there is no likelihood of his driving or attempting to drive a 
mechanically propelled vehicle whilst his ability to drive properly is impaired 




(3) “A constable must consult a medical practitioner on any question arising 
under this section whether a person’s ability to drive properly is or might be 
impaired through drugs, and must act on the medical practitioner’s advice.” 
 
 
“This section in effect allows a police officer to detain any motorist who has been 
required to provide a specimen of breath, blood or urine at the police station until he 
is satisfied either that, in his opinion, the level of alcohol in the accused’s body is 
such that were he to drive he would no longer be committing an offence or that there 
is no likelihood of him driving. The decision in these matters is left entirely to the 
constable in question, and there is no sanction provided by the section in respect of 
any abuse of power in respect thereof other than by making a complaint in the 
normal way. However, if the accused’s condition arises from the consumption of 
drugs, the constable is required to seek out a medical practitioner’s advice on the 
question of whether the accused’s ability to drive is impaired and, having done so, 





Police officers throughout the Strathclyde Police Force in Scotland until the late 
1990’s exercised these powers in respect of drivers who, following examination by 
the forensic medical examiner (FME), were declared to be impaired in their ability to 
drive due to the effects of alcohol. Such drivers were detained in custody for a period 
of approximately 12 hours and were then re-examined by the same FME prior to the 
driver’s release from custody. The FME, as a matter of routine, would complete an 
additional separate formal medical examination report, which would be submitted to 
the Procurator Fiscal as further evidence in the prosecution case.  
 
The inference drawn in cases where the driver no longer showed evidence of clinical 
abnormalities or poor psychomotor performance was that he or she had “sobered up” 
since the effects of the alcohol had “worn off” naturally. This evidence from the 2nd 
examination was regarded as highly relevant and valuable to the understanding of the 
cause of any perceived “impairment” in the suspect driver. Indeed in some cases 
when the performance at the 2nd examination was found to be virtually identical this 
was regarded as significant forensic evidence since it pointed to an underlying 
natural or medical cause of “impairment” as opposed to intoxication. 
 
Since the legislation is currently in place in Scotland it might be appropriate for the 
authorities to give consideration to the possibility of re-introduction of the 2nd 
examination as a matter of routine in these “drug-driving” cases. Indeed the BMA 
has alluded to this ( North Report 2010 e) -  
“The BMA suggested that it might not be untoward for a doctor to make a later 
“medical” assessment to exclude a more serious cause of that impairment within a 





5.4.4. Proposed Independent Expert Forensic Medical Opinion.  
Due to the complexities involved in the various processes required for suitable and 
thorough investigation and appropriate prosecution of “drug-driving” cases, it would 
be of considerable advantage to have the benefit of an independent expert to advise 
the courts on the relevance of the findings pertinent to the specific case. 
   
The Faculty of Forensic and Legal Medicine, has stated a role exists for suitably 
qualified and experienced Forensic Physicians to act as independent “experts” for the 
Court by reviewing all the evidence of alleged impaired driving including – 
 
• The stated manner of the suspect’s driving. 
• The recorded findings on FIT.  
• The Forensic Physician’s assessment.  
• The toxicological results.  
 
The independent expert would be required to provide a detailed formal report and 
provide an opinion on whether or not the alleged manner of driving and the recorded 
clinical findings of the suspect driver was consistent with the effects normally 
associated with a person who had used drugs, and, when taken into consideration 
with the toxicological results, would result in the person being unfit to drive safely.  
 
It may be appropriate for the authorities to consider the instruction of such an expert 
in all cases where drivers are charged with contravention of Section 4(1) of the Road 





5.5. Implications of the research findings.  
The findings presented in the analysis and discussion chapters of this thesis, and also 
the process of gathering the data, have enhanced my own understanding, but will 
hopefully enhance the research literature base in respect of the complex problem 
which drug use and driving presents to road safety. 
 
Research has established that although FIT may be considered a useful “screening 
device” for suspect “drugs drivers” (Oliver et al. 2006) there have been no peer 
reviewed publications which have validated FIT as tests of drug-related impairment 
in driving ability (AFP 2003; FFLM in North 2010d; Stark 2010). 
 
The findings of the research, address the important but as yet unrecognised, or 
perhaps put more accurately “unaccepted” fact that current UK clinical tests of 
impairment - specifically FIT (now named PIT) are not tests of impairment to drive - 
as has been clearly stated by the Research Programme Manager, Head of Impairment 
Studies, Road Safety Division, Dept. for Transport (Read 2003).  
 
The research undertaken clearly illustrates that FIT, as currently used in the UK, has 
been justifiably the subject of criticism from a variety of sources including legal 
practitioners and toxicologists (Erwin 1995; Trocino 1997; Head 2001; Johnston and 
Ramsey 2003) however more importantly by the Association of Forensic Physicians 
(AFP 2003) Forensic Medical Examiners (FMEs) (see chapters 3.1.3; 3.2.3; and 
3.3.4.) who responded to the postal questionnaire surveys and most importantly the 




A crucial factor in the investigation and appropriate prosecution of “drug driving” 
cases is that the evidence presented to the court must be reliable and robust to the 
extent that it can withstand vigorous challenge. There is concern that some cases 
might fail as a result of evidence (of impairment) led in relation to a driver’s 
performance in FIT as gathered by police officers, being rejected as evidence of 
impairment to safely drive a motor vehicle. These situations could be avoided if new 
more appropriate and relevant CTI were developed by appropriate specialists, 
including of course medically qualified “experts” who would be in a position to 
commend the new test battery for acceptance as a more genuine and reliable clinical 
test of drug-related impairment of driving ability. 
 
The evidence presented to court may be enhanced, not only by the development and 
introduction of more relevant CTI, but also by the manner in which the tests are 
applied and assessed. Consideration ought to be given in relation to the possibility of 
quantifying the degree of impairment using a diagnostic tool such as the “Aggregate 
Clinical Score” as has been proposed. The possibility of a 2nd examination would 
offer further clinical evidence and would have the potential to deliver much greater 
clinical accuracy in the diagnosis of drug-related impairment to drive opinion. 
 
Finally consideration ought to be given to the use of an independent forensic 
physician “expert opinion” in all cases such that detailed independent analysis of all 
relevant evidence can be undertaken prior to the provision of an impartial opinion 
which would greatly assist the court in coming to an appropriate judgement on drug- 




5.6. Limitations of the research. 
The thesis has attempted to highlight the problems and challenges, which must be 
acknowledged and overcome when attempting to safely and reliably diagnose drug-
related impairment of driving ability, by the use of Clinical Tests of Impairment, and 
FIT/PIT in particular.  
 
The question of whether FIT as used in the UK are sufficiently sensitive, reliable and 
valid, has I trust, been appropriately addressed and answered.  
 
The question as to which measures might be implemented to facilitate control of this 
specific hazard to road safety remains to be resolved although specific proposals 
have been offered.  
 
The new test battery proposed ought to be considered as only the first step in an 
attempt to deliver a more relevant CTI which would be seen to relate to the driving 
task since the clinical functions assessed, with the exception of speech and “vital 
signs”, would be regarded as pre-requisites for safe driving. However further 
development of this proposed new tests battery is required prior to its introduction, 
and the opportunity to liaise and collaborate with other specialists in this field would 









5.7. Final Hypothesis based on research findings. 
The aim of this thesis is to investigate the validity of the current Field Impairment 
Tests (FIT) in relation to their stated function as indicators of impairment in driving 
ability due to the effects of recent drug use.  
 
Two opposing hypotheses have been tested –  
 
1. FIT are reliable and valid tests of drug-related impairment to drive - all 
groups should pass all tests and score equally since all are drug-free.  
 
2. FIT are not reliable and valid tests of drug-related impairment to drive - 
and are too difficult for some groups of drug-free individuals to perform. 
 
The results of the research studies lend strong support to the assertions of the FMEs 
surveyed (see chapters 3.1.3; 3.2.3; and 3.3.4) that FIT as currently used are too 
difficult.  
 
More importantly the study results provide powerful evidence in support of 
Hypothesis 2 -    
FIT are not reliable and valid tests of drug-related impairment to drive - 







5.8. Future Work. 
I have noted with interest that the UK government has recently commissioned the 
Department for Transport to convene an expert panel to study the available evidence 
on the problem of “drug-driving” and to submit recommendations regarding the 
proposed introduction of new legislation in relation to drug use and driving. The 
Crime and Courts Bill, which was introduced into Parliament in May 2012 makes 
provision for a new offence of driving, attempting to drive, or being in charge of a 
motor vehicle with a specified controlled drug in the body above the level specified 
for that drug. The panel made several recommendations however were clear in their 
evidence statement - “There is no universal agreement on how to objectively 
measure impairment for psychoactive drugs and driving.” (Wolff 2013). 
 
Intriguingly the European Union’s research project on Driving Under the Influence 
of Drugs, Alcohol and Medicines has also recently published its findings and has 
reported in respect of prescribed drug use - “Regarding driving under the influence 
of medicines, attempting to define a legal limit for patients undergoing long-term 
treatment is inappropriate; sanctions should be based on degree of impairment”.   
They further recommended in relation to illicit drug use and driving -“Drug 
recognition expert programmes and impairment checklists should be improved.” 
(Druid 2012). 
 
By making these recommendations, both independent bodies have acknowledged 
that current clinical tests of impairment are less than adequate and require to be 




The development of a new battery of clinical tests of impairment, which can be 
validated, for acute drug effects, remains a priority. The proposed (CTI) as detailed 
(Table 5.1) is a progressive step forward in the attempt to provide valid and reliable 
evidence of drug-related impairment in driving ability and further development and 
refinement of the proposed CTI is an area worthy of further research.  
 
 
The introduction of a quantifiable assessment of impairment based on the proposed 
“Aggregate Clinical Score” (Appendix B; Tables 3.1, 3.2; Appendix C; Tables 3.15, 
3.6, 3.17) is worthy of consideration and is a concept, which would be worthy of 
future research. Subjects who have performed reasonably well in the tests but have 
had minor problems or difficulties could easily be distinguished from those who have 
shown gross incapacity in performing the tests. Use of such a system is entirely 
likely to assist the courts in determining the relevance of the toxicological analysis of 
the blood sample provided by the suspect driver.   
 
 
Engagement with legislators regarding the possibility of adopting change in the 
procedure in which suspect “drug-drivers” are clinically examined, and in particular 
the re-introduction of a 2nd examination (Appendix B; Tables 3.1, 3.2) ought to be 
explored. The ability to compare performances has been proven to be extremely 
valuable in the interpretation of the clinical findings in respect of impaired driving 
due to the adverse psychoactive effects of alcohol, and it is entirely logical and 





Notwithstanding the previous proposals suggested, I would consider the greatest 
benefit to the investigation of any suspect “drug-driver” would be the involvement of 
an expert such as a suitably qualified forensic physician (FP), who would be required 
by the courts to study all relevant evidence including police reports; “impairment 
tests”; FME reports; toxicological evidence; and any further relevant medical 
evidence; and thereafter provide an independent opinion regarding the relevance of 
all findings.  
 
It is of course acknowledged that the final judgement regarding impairment of 
driving ability due to drugs is a judicial decision, however bearing in mind the 
questions regarding the reliability and validity of current clinical tests of impairment, 
and FIT in particular, the provision of such an independent expert opinion is likely to 
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THE WALK AND TURN TEST:  
The Walk and Turn test is a test, which divides the subject’s attention between 
balancing and information processing. It comprises two elements- Instruction and 
Walking. The test requires the subject to assume a starting position while receiving 
instructions for the test.  
 
The procedure for conducting the walk and turn test is as follows.  
1. Have the subject stand erect with his/her feet together and hands hanging down 
by their side. Have the subject place his/her left foot on the line, then place the 
right foot on the line directly in front of the left foot, with the heel of the right 
foot touching the toes of the left foot (demonstrate). Tell the subject to remain 
standing in this position while listening to the instructions and not to start the 
test until you tell them to do so. If the subject loses balance three times in this 
position, discontinue the test and go on to the next test. 
2. Tell the subject when you tell them to start they are to take 9 steps in a straight 
line touching heel to toe with his/her hands down at their sides, turn about 
pivoting on their lead foot and taking half steps in a half circle to their left 
(demonstrate), then take another 9 steps in the same manner. Tell them as they 
take each step they are to watch their feet, count each step out loud, and not stop 
until they have completed the test. Demonstrate this for them as you explain.  
3. Ask the subject if they understand the instructions.  
4. Have them perform the test.   
 
Note if the subject: a. Breaks away from the start up stance; b. Starts walking too 
soon; c. Fails to touch heel to toe (note which step); d. Steps off the line (note 
direction and which step); e. Stops walking too soon (note which step); f. Raises the 
arms out to the sides; g. Takes more or less than 9 steps (note how many); h Turns 
improperly (i.e. the wrong way); i. Fails to follow instructions.  
 
From these “indicators” as listed above N.H.T.S.A. (National Highway Traffic 
Safety Administration) guidelines are that if 2 out of the above indicators are 




ONE LEG STAND TEST.  
This test divides the subject’s attention and comprises two elements – Instruction; 
plus Balancing and Counting. 
During the instruction stage the subject stands straight with his/her feet together and 
arms by the side. During the balancing and counting stage the subject stands on one 
leg with the other held straight out, off the ground for a period of 30 seconds.  
 
The procedure for the One Leg Stand test is as follows. 
1. Have the subject stand erect with arms at sides. 
2. Instruct them not to start until advised and listen carefully to the instructions. 




4. Tell the subject when you say start, he/she must raise the right foot 6 to 8 inches 
off the ground keeping the leg straight and the toes pointing forwards, with the 
foot parallel to the ground. Demonstrate. 
5. Tell the subject he/she must keep the arms at the side and must keep looking at 
the elevated foot, while counting out loud in the following manner “ 1001, 1002, 
1003” and count for 30 seconds. After that tell the subject to stop. 
6. Ask the subject if they understand the instructions. 
7. Tell the subject to start. 
8. Repeat for the other leg.   
 
Note if the subject: a. Sways while balancing; b. Raises the arms to maintain 
balance; c. Hops; d. Places foot on the ground. 






FINGER TO NOSE TEST.  
This test assesses co-ordination and depth perception. It comprises of two elements – 
Instruction and Command. During the instruction phase the subject is told to stand 
upright with his/her feet together. The subject is told to extend both closed fists, palm 
side forward, in front of them. During the command phase the subject is told to touch 
the tip of the nose with the tip of the index finger.  
 
The procedure is as follows : 
1. Tell the subject to stand with feet together and arms at the sides. 
2. Tell the subject to extend both closed fists, palms up out in front, extend index 
finger of each hand, then hold index fingers in that position and place the hands 
palm side forward at the sides. 
3. Tell the suspect to maintain that position while you give instructions and not to 
start until told to do so – emphasise this clearly. 
4. Tell the subject when you say start he/she must tilt the head back slightly, close 
the eyes and lift the arms slightly in front of them with index fingers extended. 
Demonstrate.  
5. Tell the subject you will say either left or right at which time he/she should move 
the hand indicated directly in front with the tip of the finger touching the tip of 
the nose.  The hand should then be lowered and the subject wait until the next 
hand is indicated. Demonstrate. 
6. Check that the subject understands. 
7. Tell subject to tilt head back, close eyes, and bring hands slightly in front as 
previously shown. 
8. Call out the following hands in the following order. 
Left ; Right ; Left ; Right ; Right ; Left.  
 






THE ROMBERG TEST.  
This test is an indicator of the subject’s internal clock and body sway. It comprises of 
two stages – Instruction and Performance. During the instruction stage the subject 
must stand upright with the hands hanging by the sides. During the performance 
stage the subject must stand in the start position with the head tilted slightly back and 
the eyes closed. 
 
The procedure is as follows:  
1. Tell the subject to stand straight with feet together and hands by their sides. 
2. Tell the subject to maintain that position while you give instructions. Emphasise 
he/she should not begin until you say start. 
3. Tell the subject that, when you tell them to, they must tilt their head back slightly 
and close their eyes. Demonstrate. Tell the subject to mentally estimate 30 
seconds. Tell them at the end of 30 seconds they are to open their eyes and say “ 
time up ”. Do not tell them to count.  
4. Ask if the subject understands the instructions. 
5. Instruct the subject to begin the test. Time the subject’s time estimation with your 
watch. 
An estimation of between 20 and 40 seconds is regarded as acceptable. The test is 
terminated if 90 seconds elapse or if the subject cannot safely complete the test. 
 
Romberg Test – Clues:  
1. Subject unable to stand still or steady with feet together. 
2. The time lapse is inappropriate or unacceptable. 



























  APPENDIX B.   
  FIT QUESTIONNAIRE - STRATHCLYDE FMEs - SURVEYS 1 AND 2.  
 
The purpose of this questionnaire is solely to gauge the consensus of opinion within 









1. Do you consider the tests as outlined and recommended to us for adoption as     
    standard procedures, are, or may be regarded as  - 
 
 
 (i) more difficult than they need to be?    YES / NO 
 




2. Walk & Turn Test: considering the test as outlined and the recommendation this  
     test be adopted as a matter of routine, are you –  
 
 (i)  happy to accept in full ?     YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 




3. One Leg Stand Test: considering the test as outlined and the recommendation  
    this test be adopted as a matter of routine, are you -  
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





4. Finger Nose Test: considering the test as outlined and the recommendation this  
    test be adopted as a matter of routine, are you – 
 
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





5. Romberg Test: considering the test as outlined and the recommendation this test  
 
    be adopted as a matter of routine, are you -   
 
 
 (i)  happy to accept in full ?    YES / NO 
 
 (ii) prepared to accept with reservations ?  YES / NO 
 





6. Section 4 R.T.A.  2nd Examinations:  In previous years when a suspect driver 
was found to be impaired, Form F97 was completed with appropriate findings 
listed. The suspect driver was detained in custody for some 8 to 12 hours, then 
subsequently re-examined, almost always with the absence of previously noted 
signs of impairment. 
           
      Do you consider a second examination of suspect initially found impaired – 
 
 (i) Essential?              YES / NO 
 
 (ii) Worthwhile?   YES / NO 
 
 (iii) Worthless?    YES / NO 
 






7. Overall Assessment of impairment / lack of impairment : 
 
Do you feel there would be any merit in developing and adopting a procedure  
whereby clinical signs which may be consistent with impairment due to drugs, 




  Low score                 =   normal or no impairment. 
 
  Intermediate score   =   borderline or possible  impairment. 
 
  High score                =   definite impairment. 
 









How many years experience as a police surgeon do you have?   0 -  5  Years 
 
  6 - 10 Years 
 
11 - 20 Years 
 





Do you have a post grad qualification such as –   D.M.J. ? YES / NO 
 













APPENDIX C.   
 
FIT - QUESTIONNAIRE OF APS / UK FMEs - SURVEY 3.  
 
 
The purpose of this questionnaire is solely to gauge the consensus opinion of 
registered members of the Association of Police Surgeons in respect of the above 
tests. The tests will be considered in general, however also individually. 
 
 
Please feel free to comment on any aspect of the tests or of the questionnaire. 
 
 
There are no right or wrong answers; however each and every response is of 
value. 
 
Please indicate your response by circling appropriate answer.  
 
 
How many years experience as a police surgeon do you have? 0 – 5 Years 
 
6 – 10 Years 
 
         11 – 20Years 
 




Do you have a post graduate qualification such as –  D.M.J. ? YES / NO 
 




Are you regularly engaged in general police work?   YES / NO 
 
 
If  NO - please return the questionnaire without completing it - since your response is    
of statistical value and interest. Thank you. 
 
 
If  YES - are you familiar with the Field Impairment Tests (FIT) ?  YES / NO 
 
 
A full account of the Standardized Field Sobriety Tests / FIT is enclosed at the end of 









1. How difficult do you think the tests in general are for suspect drivers to 
perform? 
 
1              2            3                     4      5 
Much easier than    Easier than      About right   More difficult than     Much more difficult           





2. What is your opinion of the standards for assessing the tests in general? 
 
1               2   3  4     5 
 
    Much too           Slightly too         About right    Slightly too easy        Far too easy 





3. Walk & Turn Test: considering the test as outlined do you consider it?  
 
1               2   3   4    5  
 
Much easier than      Easier than it        About right    More difficult      Much more difficult             





4. One Leg Stand Test: considering the test as outlined do you consider it? 
 
1                 2     3   4    5  
 
Much easier than      Easier than it        About right    More difficult      Much more difficult             





5. Finger Nose Test: considering the test as outlined do you consider it? 
 
1                 2     3   4    5  
 
Much easier than      Easier than it        About right    More difficult      Much more difficult             






6. Romberg Test: considering the test as outlined do you consider it? 
 
1                2      3    4        5  
 
Much easier than      Easier than it        About right    More difficult      Much more difficult             





7. Overall Assessment of impairment / lack of impairment : 
 
Do you feel there might be merit in adopting a procedure whereby clinical signs 
which may be consistent with impairment due to drugs, are individually scored 
and aggregated, resulting in a grand total score for each suspect? 
 
  Low score                =   normal / no impairment. 
  Intermediate score   =   borderline / possible impairment. 
 




Would you consider a clinical sign aggregate score system of value?  
       

























APPENDIX D.    
SECTION 4 RTA PROCEDURE: PRO-FORMA AFP & FFLM. 
	  
INTRODUCTION	  AND	  GENERAL	  GUIDANCE	  
Note: This form has been designed by Dr Ian F Wall on behalf of the Education and Research 
Committee of the Association of Police Surgeons for use by Police Surgeons (also known as Forensic 
Medical Examiners or Forensic Physicians) who have been trained in the use of Standardised 
Impairment Tests. The form is provided to assist Police Surgeons in 
determining whether a person has a condition which may be due to drink or drugs and not 
necessarily due to ‘impairment’. It is to be regarded as an aide-memoire and it is therefore not 
necessary for all parts of the form to be completed. Some details are included so as to aid possible 
subsequent assessment of fitness for detention in custody. Where a test is abandoned the reasons 
should be recorded in Additional Particulars at G12. If the questions are read from a card, the wording 
should be identical to those used in this form and the card must remain available for production at 
court. On completion this form is the personal property of the examining doctor. 
 
GENERAL	  DETAILS	  
Name: Police station: 
Address: Custody record No: 
Date of birth: 
Occupation: 
Arrest date: Arrest time: 
Time called:    
Time arrived: 
Time examination started:  
Time examination completed: 
 
BACKGROUND	  INFORMATION	  
Road side breath test: Intoximeter readings: 
Information from arresting officer (PC..…………………)……………………. 
…………………………………………………………………………………. 
Field impairment test results...…….…………………………………………. 
…………………………………………………………………………………. 
…………………………………………….……………………………………. 
Information from Custody Officer (PS………………..)………………….…. 
…………………………………………………………………………………. 
Dr’s name…………………..Date……………. * Delete as Applicable Page 2 
	  
CONSENT	  
Consent witnessed by: 
“My	  name	  is	  Dr.	  ………..	  and	  I	  have	  been	  asked	  to	  examine	  you	  to	  ascertain	  
whether	  in	  my	  opinion,	  you	  have	  a	  condition	  which	  might	  be	  due	  to	  drink	  or	  
drugs.	  You	  should	  be	  aware	  that	  any	  conversation	  with	  me	  might	  not	  be	  treated	  
confidentially.	  Do	  you	  agree	  to	  a	  medical	  examination?”	  *YES/NO	  
If NO	  make observations of accused’s behaviour:……………………………. 
…………………………………………………………………………………. 
If YES, consider written consent: 







Consultation commenced at: Hours 
History of recent events:……………………………………..………………… 
….………………………………………………………………………………. 
Current medical problems:…..…….……………………………….…................ 
........................………………………………...……………………................... 
.....................……………......................................................…………………. 






VISUAL	  PROBLEMS	  	  
ASTHMA,	  DIABETES,	  EPILEPSY	  
RENAL	  IMPAIRMENT	  
HEPATIC	  IMPAIRMENT	  
Alcohol intake and times in last 24 hours:…...…………………….………… 
…….…………………….……………………………………………………… 
WEEKLY	  ALCOHOL	  INTAKE	  Units per week 
TIME	  LAST	  ATE	  
TIME	  LAST	  SLEPT	  
Past psychiatric history:…..……….…………………………………………. 
….………………………………………………………………………………. 
….…………………………………………………………………………….… 




Relevant educational history (to assess if learning disability etc):…………….. 
………………………………………………………………………………….. 








EXAMINED	  IN	  PRESENCE	  OF:	  
General demeanour:…..……….……………………….….………………….… 
…….……………………………………………………………………………. 




















Needle marks: Initial pulse: PN: Soft: 
Shivering: BP: BS: Tender: 
Yawning: Temp: Added sounds: LKKS: 
Rhinorrhoea: Heart sounds: VR: BS: 
Gooseflesh: PEFR: 
Lachrymation: 





Use the gauge below or a printed laminated card to assess pupil size: 
	  







Horizontal gaze nystagmus 
Lack of smooth pursuit 
Vertical gaze nystagmus: *YES/NO Convergence: *YES/NO 
Spectacles: *YES/NO Contact lens: *YES/NO 





“I	  would	  like	  you	  to	  perform	  a	  series	  of	  tests	  to	  enable	  me	  to	  ascertain	  whether	  
you	  have	  a	  condition	  which	  might	  be	  due	  to	  drink	  or	  drugs,	  or	  whether	  your	  
ability	  to	  drive	  is	  impaired	  by	  drink	  or	  drugs.	  The	  tests	  are	  simple	  and	  part	  of	  
my	  evaluation	  will	  be	  based	  on	  your	  ability	  to	  follow	  instructions.	  If	  you	  do	  not	  












“Stand	  up	  straight	  with	  your	  feet	  together	  and	  your	  arms	  down	  by	  your	  sides.	  
Maintain	  that	  position	  while	  I	  give	  you	  the	  remaining	  instructions.	  Do	  not	  
begin	  until	  I	  tell	  you	  to	  do	  so.	  When	  I	  tell	  you,	  you	  must	  tilt	  your	  head	  back	  
slightly	  and	  close	  your	  eyes	  (demonstrate	  but	  do	  not	  close	  your	  eyes).	  Keep	  
your	  head	  tilted	  backwards	  with	  your	  eyes	  closed	  until	  you	  think	  that	  30	  
seconds	  have	  passed,	  then	  bring	  your	  head	  forward	  and	  say	  ‘Stop’”.	  
“Do	  you	  understand?”	  YES/NO*	  
ABLE	  TO	  STAND	  STILL	  DURING	  INSTRUCTIONS:	  *YES/NO	  
EXCESSIVE	  BODY	  SWAY	  SEEN:	  *YES/NO	  
INTERNAL	  BODY	  CLOCK:	  30SECONDS	  AT	  ……………....SECS	  
How	  long	  was	  that?…………………………	  
ABLE	  TO	  COMPLETE	  TEST:	  *YES/NO	  
COMMENTS:	  
Front/Back	  view	  (Indicate	  direction	  &	  degree	  of	  sway)	  




WALK	  AND	  TURN	  TEST	  
	  
Identify	  a	  real	  or	  imaginary	  line.	  
“Place	  your	  left	  foot	  on	  the	  line.	  Place	  your	  right	  foot	  on	  the	  line	  in	  front	  of	  
your	  left	  touching	  heel	  to	  toe	  (demonstrate).	  Put	  your	  arms	  down	  at	  your	  sides	  
and	  keep	  them	  there	  throughout	  the	  entire	  test.	  Maintain	  that	  position	  whilst	  I	  
give	  you	  the	  remaining	  instructions”.	  
“Do	  you	  understand?”	  YES/NO*	  
“When	  I	  say	  start,	  you	  must	  take	  nine	  heel	  to	  toe	  steps	  along	  the	  line.	  On	  each	  
step	  the	  heel	  of	  the	  foot	  must	  be	  placed	  against	  the	  toe	  of	  the	  other	  foot	  
(demonstrate).	  When	  the	  ninth	  step	  has	  been	  taken,	  you	  must	  leave	  the	  front	  
foot	  on	  the	  line	  and	  turn	  around	  using	  a	  series	  of	  small	  steps	  with	  the	  other	  
foot.	  After	  turning	  you	  must	  take	  another	  nine	  heel	  to	  toe	  steps	  along	  the	  line.	  
You	  must	  watch	  your	  feet	  at	  all	  times	  and	  count	  each	  step	  out	  loud.	  Once	  you	  
start	  walking	  do	  not	  stop	  until	  you	  have	  completed	  the	  test”.	  
“Do	  you	  understand?”	  YES/NO*	  
	  
Any	  deviation	  from	  the	  instructions	  and	  any	  observations	  should	  be	  indicated	  below	  
and	  on	  the	  diagram	  above	  
	  
Able	  to	  stand	  still	  during	  instructions:	  *YES/NO	  
Start	  too	  soon:	  *YES/NO	  Stops	  walking:	  *YES/NO	  
Turn:	  Correct/Incorrect	  
Misses	  heel/toe:	  *YES/NO	  Steps	  off	  line:	  *YES/NO	  
Raises	  arms:	  *YES/NO	  Correct	  step	  count:	  *YES/NO	  
Notes:	  
	  




9	  8	  7	  6	  5	  4	  3	  2	  1	  L	  
ONE	  LEG	  STAND	  TEST	  
“Stand	  with	  your	  feet	  together	  with	  your	  arms	  down	  by	  your	  sides.	  Maintain	  
that	  position	  while	  I	  give	  you	  the	  remaining	  instructions.	  Do	  not	  begin	  until	  I	  
tell	  you	  to	  start.”	  
“Do	  you	  understand?”	  YES/NO*	  
“When	  I	  tell	  you	  to	  start	  you	  must	  raise	  your	  right	  foot	  six	  to	  eight	  inches	  off	  the	  
ground,	  keeping	  your	  leg	  straight	  and	  your	  toes	  pointing	  forward,	  with	  your	  
foot	  parallel	  to	  the	  ground	  (demonstrate).	  You	  must	  keep	  your	  arms	  by	  your	  
sides	  and	  keep	  looking	  at	  your	  elevated	  foot	  while	  counting	  in	  the	  following	  
manner,	  ‘one	  thousand	  and	  one,	  one	  thousand	  and	  two’	  and	  so	  on	  until	  I	  tell	  
you	  to	  stop.”	  
“Do	  you	  understand?”	  YES/NO*	  
Repeat	  procedure	  with	  each	  foot	  
	  
SWAYS	  -­‐	  YES/NO	  	  
HOPS	  -­‐	  YES/NO	  	  
PUTS	  FOOT	  DOWN	  -­‐	  YES/NO	  	  
RAISES	  ARMS	  -­‐	  YES/NO	  	  	  
	  





FINGER	  AND	  NOSE	  TEST	  
“Stand	  with	  your	  feet	  together	  and	  your	  arms	  in	  this	  position.	  (Demonstrate	  
extending	  both	  hands	  out	  in	  front,	  palms	  side	  up	  and	  closed	  with	  the	  index	  
finger	  of	  both	  hands	  extended).	  Maintain	  that	  position	  while	  I	  give	  you	  the	  
remaining	  instructions.	  Do	  not	  begin	  until	  I	  tell	  you	  to	  start.	  When	  I	  tell	  you	  to	  
start	  you	  must	  tilt	  your	  head	  slightly	  backwards	  (demonstrate)	  and	  close	  your	  
eyes.	  When	  I	  tell	  you	  which	  hand	  to	  move,	  you	  must	  touch	  the	  tip	  of	  your	  nose	  
with	  the	  tip	  of	  that	  finger	  and	  lower	  your	  hand	  once	  you	  have	  done	  so	  
(demonstrate).	  
“Do	  you	  understand?”	  YES/NO*	  
Call	  out	  the	  hands	  in	  the	  following	  order,	  left,	  right,	  left,	  right,	  right,	  left	  
	  
EXCESSIVE	  BODY	  SWAY:	  YES/NO	  
CORRECT	  HAND	  USE:	  YES/NO	  
ADDITIONAL	  COMMENTS: 
Draw lines to spots touched 
	  
	  









Is	  the	  person	  fit	  to	  be	  detained?	  *YES/NO	  
If NO	  make note of reasons and subsequent action……………………………. 
…………………………………………………………………………………. 
Is	  there	  a	  condition	  present	  which	  might	  be	  due	  to	  a	  drug?”	  *YES/NO	  
If YES	  make note of conditions:………………………………………………. 
	  
POLICE	  OFFICER	  ADVISED	  THAT	  A	  CONDITION	  
PRESENT	  THAT	  MIGHT	  BE	  DUE	  TO	  A	  DRUG	  AT:	  hours 
Is	  there	  impairment	  present?”	  *YES/NO	  
If YES	  make note of reasons:………………………………………………. 
…………………………………………………………………………………. 
If there is a condition present which might be due to a drug the police officer 




B9	  Blood/Urine	  Option	  
Are there medical reasons for the sample not to be of blood? *YES/NO	  




CONSENT	  FOR	  BLOOD	  SAMPLE	  
This section continues from B10, B12 and B13 on Form MG DD/B. 
Consent witnessed by: 
“My	  name	  is	  Dr.	  ………..	  and	  I	  have	  been	  asked	  to	  take	  a	  sample	  of	  blood	  
from	  you	  which	  will	  be	  tested	  for	  alcohol	  and	  drugs”	  
“Do	  you	  agree	  to	  a	  blood	  test?”	  *YES/NO	  
If NO	  ask:“Is	  there	  any	  medical	  reason	  why	  I	  should	  not	  obtain	  a	  sample	  of	  
blood	  from	  you?”	  
 
Make notes of accused’s reasons:……………………………..………………... 
 
If YES,	  details as below: 
Blood specimen successfully taken at………………………hours 
Site………………………….. Venting needle used? *YES/NO	  
Blood specimen given to PC…………………………….. at……………..hours 
If venepuncture unsuccessful, reasons:…………………………………………. 
………………………………………………………………………………..… 
.……....(Police can still proceed with urine option at B14 on form MG DD/B). 
It is also useful to assist the Police Officer in completion of Form MG DD/E 
Drugs Sample Information Form. 
 
Dr’s name…………………..Date……………. * Delete as Applicable  
MEDICAL	  ASSESSMENT	  FORM	  MG	  DD/G	  






CLINICAL HISTORY TAKEN FROM SUBJECTS IN GROUPS A, B and C. 
 
Detailed enquiry is made in respect of – 
 
Current health  -   dizzy, lightheaded, headache, migraine? 
      -   breathing problems, shortness of breath? 
    -   recent injuries, particularly to arms or legs?   
      -   abdominal pain, nausea or vomiting? 
 
Recent health     -    change in health? 
       -    accidental injuries?  
Medical history  -   hospital admissions? 
       -   hospital out-patient clinics? 
       -   asthma, diabetes, epilepsy, visual problems, hearing problems?
       -   anxiety, depression? 
 
Prescribed drugs -  record all medications taken including last dose 
 
Over the counter -  record all medications taken including last dose 
 
Illicit drugs         -   record all drugs taken including last dose 
 





APPENDIX F. RESULTS OF RESEARCH GROUP A (“Withdrawals”). 
 
	   	  	  	  	  	  Walk	  and	  Turn	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  One	  Leg	  Stand	  Test	   	  	  	  	  	  	  	  Finger	  -­‐	  Nose	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Romberg	  Test	  




	  	  	  test 





	  	  FIT	  	   	  FIT	  
minus	  
clues	  	  	  	  	  
Convntl.	  
	  	  test	  






	   	   	   	   	   	   	  	   	   	   	  	   	   	   	   	  
No	   Age	   Managed	  test:	  Y=1/N=0	   	  	  	  	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	  
1	   24	   0	   	  	  0	   	  	  	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
2	   21	   1	   	  1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
3	   29	   0	   	  1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
4	   33	   0	   	  1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
5	   19	   0	   	  0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
6	   22	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
7	   24	   0	   	  0	   	  	  	  	  0	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
8	   27	   0	   	  0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
9	   33	   0	   	  0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
10	   26	   1	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
11	   37	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
12	   29	   0	   1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
13	   32	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   1	   1	   1	   1	   1	  
14	   27	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
15	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
16	   34	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
17	   26	   0	   0	   	  	  	  	  0	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
18	   35	   0	   1	   	  	  	  	  1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
19	   28	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
20	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
21	   19	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
22	   27	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   0	   0	   0	   0	   0	  
23	   38	   1	   1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
24	   26	   0	   0	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
25	   30	   0	   0	   	  	  	  	  0	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
26	   33	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
27	   24	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
28	   28	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
29	   33	   0	   0	   	  	  	  	  0	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
30	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
31	   35	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
32	   21	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
33	   19	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   0	   1	   0	   0	   1	  
34	   44	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
35	   23	   1	   1	   	  	  	  	  1	   0	   1	   1	   0	   1	   1	   1	   1	   1	  
36	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
37	   34	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
38	   22	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
39	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
40	   25	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
41	   30	   0	   1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
42	   21	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
43	   26	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
44	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
45	   25	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   0	   1	   0	   0	   1	  
46	   20	   0	   1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
47	   19	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
48	   29	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
49	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
50	   18	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
51	   21	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
52	   26	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
53	   19	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
54	   22	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
55	   27	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  








	  	  	  Walk	  and	  Turn	  Test	  
Managed	  test:	  Y=1/N=0	  
Managed	  test:	  Y=1/N=0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  One	  Leg	  Stand	  Test	  
	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	  
	  	  	  	  	  	  Finger-­‐Nose	  Test	  
Managed	  test:	  Y=1/N=0	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Romberg	  Test	  
	  	  	  	  Managed	  test:	  Y=1/N=0	  





	  	  	  test	  




	  	  	  test	  




	  	  	  test	  




	  	  	  test	             minus      tests                 minus       tests         minus      tests    minus       tests 
             clues             clues  	   	   	  	  	  	  	  	  	   l s                  clues  	  
	   	   	  
56	   31	   0	   1	   	  	  	  	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
57	   29	   0	   0	   1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
58	   31	   0	   1	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
59	   24	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
60	   37	   1	   1	   1	   0	   1	   1	   0	   1	   1	   1	   1	   1	  
61	   19	   0	   0	   0	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
62	   18	   0	   0	   1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
63	   25	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
64	   19	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
65	   22	   0	   1	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
66	   29	   1	   1	   1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
67	   30	   0	   1	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
68	   33	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
69	   20	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
70	   27	   0	   1	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
71	   36	   0	   0	   1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
72	   31	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
73	   27	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
74	   29	   1	   1	   1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
75	   33	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
76	   34	   0	   1	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
77	   25	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
78	   22	   0	   0	   0	   0	   0	   0	   0	   0	   1	   0	   1	   1	  
79	   28	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
80	   19	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
81	   18	   0	   0	   0	   0	   0	   0	   0	   0	   1	   0	   0	   1	  
82	   29	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
83	   26	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
84	   30	   1	   1	   1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
85	   25	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
86	   31	   1	   1	   1	   0	   1	   1	   0	   1	   1	   1	   1	   1	  
87	   25	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
88	   38	   0	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
89	   31	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
90	   27	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
91	   36	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
92	   27	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
93	   22	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
94	   21	   0	   0	   0	   0	   0	   0	   0	   0	   1	   0	   1	   1	  
95	   29	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
96	   33	   0	   1	   1	   0	   1	   1	   0	   1	   1	   1	   1	   1	  
97	   37	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
98	   19	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
99	   22	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
10
0	  
37	   0	   0	   1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  















APPENDIX G.  RESULTS OF RESEARCH GROUP B (Methadone). 
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No	   Age	   Managed	  test:	  Y=1/N=0	   	  	  	  	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	  1	   31	   0	   	  	  1	   	  	  	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
2	   47	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
3	   39	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
4	   26	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
5	   24	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
6	   31	   0	   	  0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
7	   41	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
8	   27	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
9	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
10	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
11	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
12	   46	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
13	   19	   0	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
14	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
15	   30	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
16	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
17	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
18	   22	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   1	   1	   0	   1	   1	  
19	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
20	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
21	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
22	   19	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
23	   26	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
24	   42	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
25	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
26	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
27	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
28	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
29	   21	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
30	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   0	   1	   1	  
31	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
32	   49	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
33	   42	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   0	   1	   1	  
34	   30	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
35	   29	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
36	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
37	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
38	   37	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
39	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
40	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
41	   42	   0	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
42	   39	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
43	   19	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
44	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
45	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
46	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
47	   20	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
48	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
49	   19	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
50	   26	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
51	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
52	   24	   0	   0	   	  	  	  	  1	   0	   0	   0	   0	   1	   1	   1	   1	   1	  
53	   21	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
54	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  










	   	  	  
	  	  	  	  	  Walk	  and	  Turn	  Test	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  One	  Leg	  Stand	  Test	  
	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  Finger	  -­‐	  Nose	  Test	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Romberg	  Test	  
	   	   FIT	   	  	  	  FIT	  
minus	  
clues	  
	  	  	  	  	  Convntl	  
	  	  	  test	  
	  	  	  	  	  	  
FIT	  	  
FIT	  	  	  	  	  	  	  FIT	  
Min	  	  	  	  	  us	  
clues	  
Convntl	  
	  	  	  test	  




	  	  	  test	  




	  	  	  test	  	  
	  	  	  	  	  	  	  	  	  	  
mi
nu





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
mi
nu





	  	  	  	  	  	  	  
mi
nu












	  	  	  	  	  	  	  	  	  	  
mi
nu





	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
mi
nu





	  	  	  	  	  	  	  
mi
nu












	   	   	  	  minus	   	  	  	  	  	  	  tests	   	   	  	  	  	  	  	  	  	  	  	  	  minus	   tests	   	   	  	  	  	   inus	   tests	   	   	   inus	   tests	  
	   	  	  	  	  	  	  	  	   clues	   	   	   	  	  	  	  	  	  clues	   	   	   clues	   	  
No	   Age	   Managed	  test:	  Y=1/N=0	   	  	  	  	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	  
	  56	  	  	  	  	  	  	  38	  	   	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  1	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	   	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  1	  
57	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
58	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
59	   44	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
60	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
61	   21	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
62	   31	   0	   0	   	  	  	  0	   0	   0	   0	   0	   1	   1	   0	   1	   1	  
63	   19	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
64	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
65	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
66	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
67	   46	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
68	   35	   0	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
69	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
70	   18	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
71	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
72	   25	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
73	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
74	   46	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
75	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
76	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
77	   20	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
78	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
79	   32	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
80	   41	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
81	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
82	   37	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
83	   25	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
84	   45	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
85	   26	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
86	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
87	   29	   0	   1	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
88	   19	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
89	   23	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
90	   39	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
91	   42	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
92	   20	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   0	   1	   1	  
93	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
94	   39	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
95	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
96	   18	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
97	   40	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
98	   22	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
99	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
10
0	  














APPENDIX H.   RESULTS OF RESEARCH GROUP C (“Controls”). 
 
	   	  	  	  	  	  Walk	  and	  Turn	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  One	  Leg	  Stand	  Test	   	  	  	  	  	  	  	  Finger	  -­‐	  Nose	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Romberg	  Test	  
	   FIT	  	   	  	  FIT	  
minus	  
clues	  
	  	  	  Convntl	  
	  	  	  test 





	  	  FIT	  	   	  FIT	  
minus	  
clues	  	  	  	  	  
Convntl	  
	  test	  






	   	   	   	   	   	   	  	   	   	   	  	   	   	   	   	  
No	   Age	   Managed	  test:	  Y=1/N=0	   	  	  	  	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	  
1	   29	   1	   	  	  1	   	  	  	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
2	   27	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
3	   36	   0	   	  1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
4	   33	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
5	   29	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   0	   1	   1	   1	   1	   1	  
6	   32	   0	   	  1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
7	   29	   0	   	  0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
8	   36	   1	   	  1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
9	   30	   0	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
10	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
11	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
12	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
13	   32	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
14	   37	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
15	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
16	   34	   0	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
17	   28	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
18	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
19	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
20	   29	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
21	   39	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
22	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
23	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
24	   36	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
25	   30	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
26	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
27	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
28	   28	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
29	   33	   0	   0	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
30	   27	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
31	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
32	   31	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
33	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   0	   1	   1	  
34	   30	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   1	   1	   0	   1	   1	  
35	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
36	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
37	   34	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
38	   42	   1	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
39	   27	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
40	   25	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
41	   30	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
42	   28	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
43	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
44	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
45	   27	   0	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   0	   0	   1	  
46	   30	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
47	   39	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
48	   29	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
49	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
50	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
51	   30	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
52	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
53	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
54	   32	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  














	   	   	   	   	   	   	  	   	   	   	   	   	   	   	   	   	   	   	  	   	  	  	  	  	  Walk	  and	  Turn	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  One	  Leg	  Stand	  Test	   	  	  	  	  	  	  	  Finger	  -­‐	  Nose	  Test	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Romberg	  Test	  
	   FIT	  	   	  	  FIT	  
minus	  
clues	  
	  	  	  Convntl	  
	  	  	  test 





	  	  FIT	  	   	  FIT	  
minus	  
clues	  	  	  	  	  
Convntl	  
	  test	  






	   	   	   	   	   	   	  	   	   	   	  	   	   	   	   	  
No	   Age	   Managed	  test:	  Y=1/N=0	   	  	  	  	  	  	  	  	  	  	  	  Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	   Managed	  test:	  Y=1/N=0	  
 
56	   31	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
57	   38	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
58	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
59	   41	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
60	   29	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
61	   37	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
62	   31	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
63	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
64	   34	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
65	   31	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   0	   1	   1	  
66	   29	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
67	   31	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
68	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
69	   34	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
70	   31	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
71	   29	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
72	   30	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
73	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
74	   29	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
75	   33	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
76	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
77	   32	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
78	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
79	   31	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
80	   33	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
81	   30	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
82	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
83	   38	   0	   0	   	  	  	  	  1	   0	   0	   1	   0	   1	   1	   1	   1	   1	  
84	   36	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
85	   34	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
86	   37	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
87	   30	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
88	   42	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
89	   28	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
90	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
91	   33	   0	   1	   	  	  	  	  1	   0	   1	   1	   0	   1	   1	   0	   1	   1	  
92	   36	   1	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
93	   32	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
94	   38	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
95	   41	   0	   0	   	  	  	  	  0	   0	   0	   0	   0	   1	   1	   0	   1	   1	  
96	   33	   0	   1	   	  	  	  	  1	   0	   1	   1	   1	   1	   1	   1	   1	   1	  
97	   37	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
98	   46	   0	   1	   	  	  	  	  1	   0	   0	   1	   1	   1	   1	   1	   1	   1	  
99	   35	   1	   1	   	  	  	  	  1	   1	   1	   1	   1	   1	   1	   1	   1	   1	  
10
0	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